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ABSTRACT
Introduction
End-stage kidney disease is a more common and overwhelming disease for
Indigenous people, and the reasons for this disparity are not well researched.
Indigenous populations suffer more diabetes, hypertension and
cardiovascular disease than their non-Indigenous countrymen, but these
differences do not fully explain the two to forty-fold increased risk for end-
stage kidney disease. Policies aimed at early prevention have been hampered
by a complete absence of population-based prospective studies documenting
the early causal chain to chronic kidney disease, and the physiological and
environmental risk factors associated with the development of chronic kidney
disease. Long-term prospective research in Indigenous communities needs to
be culturally appropriate, sustainable, and be developed with the community
and alongside a consultative body, such as an advisory board.
Aims
The primary aims of this thesis were to determine:
1. The prevalence of baseline and persistent early markers of chronic
kidney disease in Australian Indigenous and non-Indigenous children.
2. The association of these markers with physiological and environmental
health determinants, such as geographic remoteness and socio-
economic disadvantage.
3. The accuracy of proteinuria dipsticks for detecting baseline and
persistent albuminuria in Indigenous and non-Indigenous children.
Methods
A population-based prospective cohort study of Aboriginal and non-Aboriginal
primary school-aged children was conducted in New South Wales, Australia.
Markers of chronic kidney disease measured were haematuria, proteinuria,
albuminuria, obesity, and systolic and diastolic hypertension. Risk factors
known and thought to be associated with the development of these markers in
Aboriginal and non-Aboriginal people were also recorded, including age,
gender, growth parameters, birth weight and environmental health
determinants: measures of geographic isolation and social disadvantage.
Follow-up measurements were performed two and four years after baseline
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testing at the primary or new high school on all available children, and the
frequency of persistent chronic kidney disease markers (marker detected at
both baseline and follow-up) was ascertained. The study aims and design
were developed in consultation with the Senior Aboriginal Health Educator on
the study, community elders, Aboriginal Education Assistants and Area Health
Workers. An Aboriginal Health Research Advisory Board was created after it
was known which communities would be participating in the study. The study
results were presented to each community at the first and final follow-up visits,
and a newsletter summarising the final study results was provided to all
communities, families and schools.
Main Findings
From 2002 to 2004,2266 children (55% Aboriginal, 51% male, mean age 8.9
years ± SO 3.0 years) were enrolled from 37 primary schools across urban,
coastal, rural and remote regions of New South Wales.
From 2004 to 2006, there were 1432 children (63%) available for re-testing at
two-year follow up (54.0% Aboriginal, 50.5% male, mean age 10.5 years ± SO
2.0 years).
At four-year follow-up from 2006 to 2008, there were 1506 children (67%) re-
tested (55.1 % Aboriginal, 51.0% male, mean age 13.3 years ± SO 3.2 years).
There were no differences in the children at follow-up compared with those
that were lost-to-follow-up with regards to ethnicity, gender, age, birth weight,
body mass index and social disadvantage. There were proportionally more
older children who were lost-to follow-up compared with those children at
follow-up.
Baseline findings
The overall baseline prevalence of haematuria was 5.5%, proteinuria 7.3%,
albuminuria 7.3%, obesity 7.1 %, systolic hypertension 7.2% and diastolic
hypertension 5.9%. Aboriginal children had almost twice the prevalence of
haematuria at baseline when compared to non-Aboriginal children (7.1 %
versus 3.6%, p=0.001). Aboriginal children had no increased risk for any other
marker of chronic kidney disease at baseline. Geographic isolation and socio-
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economic disadvantage were not associated with any markers of chronic
kidney disease in these children.
Two-year follow-up findings
Persistent obesity (5.3%) was frequent, but persistent markers of CKD were
infrequent (systolic hypertension 1.1 %, diastolic hypertension 0.2%,
haematuria 1.1 % and albuminuria 1.5%). While there were more Aboriginal
than non-Aboriginal children with baseline haematuria (7.1 % versus 3.6%,
p=0.001), after adjustment for age, gender, birth weight and socio-
demographic status, there was no increased risk for persistent haematuria,
albuminuria, obesity or hypertension in Aboriginal children.
Four-year follow-up findings
Prevalence of baseline CKD markers was frequent, but most abnormalities
found at baseline were transient. Besides persistent obesity (5.0%),
persistence of CKD markers at final follow-up were infrequent; haematuria
(1.9%), albuminuria (2.4%), systolic hypertension (1.5%) and diastolic
hypertension (0.2%). There was no difference in prevalence of persistent
markers of CKD between Aboriginal and non-Aboriginal children.
Proteinuria dipsticks had an overall sensitivity of 62% (95% CI 55-70%) and
an overall specificity of 97% (95% CI 96-98%) at detecting albuminuria at
baseline. In predicting persistent albuminuria, dipsticks had an overall
sensitivity of 75% (95% CI 53-89%), and a specificity of 93% (95% CI 92-
94%). Accuracy of proteinuria dipsticks for detection of albuminuria did not
vary with ethnicity, gender or body mass index. Accuracy was less in younger
children (4.0 to 7.9 years), and in children with haematuria.
Conclusions
The baseline prevalence of early markers of chronic kidney disease is high,
however most of these abnormalities (besides obesity) are transient. At
follow-up testing, the prevalence of persistent markers of chronic kidney
disease is low. Persistent obesity is common and strongly predicts those
children with persistent hypertension. Children who are initially found to be
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obese are likely to remain obese, and therefore early intervention at initial
diagnosis is important.
Overall only 20% of children found to have markers of early CKD have
persistent abnormalities (diastolic and systolic hypertension, albuminuria,
hematuria) 2 years later, equivalent to a population point prevalence of 1-2%
in children with a mean age of 10 years. Aboriginal children have higher rates
of baseline and transient haematuria, but no increased risk for persistent
markers of CKD. These novel findings suggest that the increased risk for CKD
in Indigenous adults is not manifest until young adulthood, and is likely to
evolve through socio-demographic inequities, and adolescence and young
adulthood is a critical time for preventative strategies.
The performance characteristics of proteinuria dipsticks make them a
portable, low-cost and reliable test instrument for detection of albuminuria in
Aboriginal and other higher risk groups of children. The reliability of the
dipstick for detecting albuminuria may be less in younger children, and in
children with haematuria.
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Chapter 1: Introduction and overview
Aims of thesis
To determine:
1. The prevalence of baseline and persistent early markers of chronic
kidney disease in Australian Indigenous and non-Indigenous children.
2. The association of these markers with physiological and environmental
health determinants, such as geographic remoteness and socio-
economic disadvantage.
3. The accuracy of proteinuria dipsticks for detecting baseline and
persistent albuminuria in Indigenous and non-Indigenous children.
Background
This thesis was undertaken to determine the natural history of early chronic
kidney disease in primary school aged Aboriginal and non-Aboriginal
Australian children. End-stage kidney disease is over-represented among
Indigenous people world wide, yet there are no epidemiological studies
documenting the development of chronic and end-stage disease, and the
contribution to risk of disease made by socio-demographic determinants.
The aim of the studies presented in this thesis were to establish and follow a
cohort of Aboriginal and non-Aboriginal children to identify the frequency, risk
factors and natural history of markers of chronic kidney disease (haematuria,
albuminuria, proteinuria, obesity and systolic and diastolic hypertension) over
a six year period. This knowledge will help us to understand the progression
to chronic kidney disease in Indigenous people, and implement effective
prevention strategies for those with persistent abnormalities.
In order to identify the magnitude of end-stage kidney disease and excess risk
in Indigenous people, a detailed review of the literature was undertaken,
listing the prevalence, incidence and risk for end-stage kidney disease as
compared with non-Indigenous people by population studied (chapter two).
The third chapter describes the frequency of markers of chronic kidney
disease (haematuria, proteinuria and albuminuria) in a population-based
2
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sample of Aboriginal and non-Aboriginal children in New South Wales, and
the association of these markers with environmental health determinants.
The fourth chapter describes the frequency of markers of cardiovascular
disease (cardiovascular disease being strongly predictive for end-stage kidney
disease); albuminuria, obesity, systolic and diastolic hypertension in this
cohort of Aboriginal and non-Aboriginal children.
The fifth chapter assesses the accuracy of proteinuria dipsticks in detecting
albuminuria at baseline and at two-year follow-up in Aboriginal and non-
Aboriginal children, and in subsets of children at higher risk for chronic kidney
disease, such as males, older children, children with haematuria, and
overweight/obese children.
Chapter six describes the frequency of persistent markers of chronic kidney
disease in Aboriginal and non-Aboriginal children at two-year follow-up, and
whether Aboriginal children are at increased risk for chronic kidney disease
after accounting for socia-demographic differences.
In chapter seven, the final results of the six-year prospective study are
presented, with a comparison of risk for persistent markers of chronic kidney
disease between Aboriginal and non-Aboriginal children.
Chapter eight provides a summary of the main findings of this thesis, with
recommendations for future research.
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CHAPTER 2: REVIEW OF THE LITERATURE - A SYSTEMATIC REVIEW OF THE
PREVALENCE, INCIDENCE AND RISK FOR END-STAGE KIDNEY DISEASE IN
INDIGENOUS PEOPLE
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Introduction
In this chapter, I summarised the background data on the frequency and risk for end-
stage kidney disease in Indigenous people worldwide compared with non-Indigenous
people.
The published prevalence rates of end-stage kidney disease in Indigenous populations
studies vary widely, both between and within different populations. The reasons for this
are unclear, and few studies have attempted to address these differences, which are
likely to result from a combination of physiological and environmental causes.
Risk factors for end-stage kidney disease in Indigenous populations are difficult to
assess from cross-sectional studies. Causal relationships can only be defined from
longitudinal studies, of which there are very few. The ARDAC study reported in this
thesis, therefore, is important research into understanding the natural history and risk
factors for persistent early chronic kidney disease markers in Aboriginal and non-
Aboriginal children and youth.
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2.1 : Abstract
Background: The disparity in rates of end-stage kidney disease between Indigenous
and non-Indigenous people varies widely and is poorly understood.
Methods: We performed a systematic review of population-based epidemiological
studies that investigated prevalence, incidence and risk for end-stage kidney disease in
Indigenous people compared with non-Indigenous people. MEDLlNE, EMBASE,
CINAHL, the Aboriginal and Torres Strait Islander (ATSI) Health bibliographic database,
the Rural Health bibliographic database, reference lists and conference proceedings
were searched to identify eligible studies. Results are expressed as odds ratio and
relative risks (OR, RR). The effect of confounders was taken into account.
Results: There were 24 publications describing prevalence and/or incidence of all
cause, non-diabetic and diabetic ESKD, and included the following Indigenous groups:
American Indian/Alaskan Natives and their tribal groups, Canadian Native Indians and
. their tribal groups, Goajiro Indians, Indigenous Australians and their tribal groups, New
Zealand Maori and Pacific Islanders. Fifteen studies documented prevalence and/or
incidence of all-cause ESKD in Indigenous people, and 16 studies documented
prevalence and/or incidence of diabetic ESKD in Indigenous people. All studies, besides
2 cross-sectional studies, were retrospective cohort study designs. Prevalence,
incidence and risk for ESKD in Indigenous people compared with non-Indigenous
people are universally greater for all-cause ESKD, and most of this excess risk is due to
higher rates of diabetic ESKD. Zuni Indians, Indigenous Australians, Maori and Pacific
Islander people have the highest risk for ESKD compared to other Indigenous groups,
however it is difficult to compare between studies due to ascertainment bias, non-
Indigenous comparators from different study bases and inconsistent adjustment for
potential confounders. Only one study accounted for socio-demographic confounders.
Of the three studies that looked at non-diabetic ESKD, the risk in Indigenous people is
reduced, no different or only slightly greater. When compared to other disadvantaged
groups, the excess risk for ESKD in Indigenous groups is modified.
Conclusions: There is a need for prospective epidemiological studies that evaluate the
physiological and environmental risk factors for ESKD, particularly diabetic ESKD, in
Indigenous people, and include a valid non-Indigenous comparator.
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2.2: Background
The incidence of end-stage kidney disease (ESKD) is increasing world wide, but most
noticeably among Indigenous populations. To coincide with this epidemic of kidney
disease in Indigenous populations, there has been a marked increase in the relevant
literature describing chronic and end-stage kidney disease.
Why Indigenous peoples have such an excess risk of ESKD is only partly understood.
The three main causes of ESKD in Indigenous people are diabetic nephropathy, primary
glomerulonephritis, and hypertension (\ A much larger proportion of ESKD in
Indigenous people is attributed to diabetic nephropathy as compared to non-Indigenous
people, however the ESKD excess is not explained solely by differences in diabetic
prevalence or co-morbidities (1). The causal chain contributing to chronic kidney
disease may start at or before birth, with maternal factors e), low birth weight and
reduced nephron mass e) (4) possibly rendering the kidney more vulnerable to diabetes
and hypertension. Marked regional differences in ESKD have been noted between
Indigenous populations (5) and in ethnically homogeneous countries such as Japan,
suggesting socio-demographic influences rather than genetic predispositions are
responsible (6). Environmental factors such as isolated liVing and socioeconomic
disadvantage, resulting in inadequate access to fresh food, comprehensive healthcare
and other important health determining factors are likely to play an important role in the
development of ESKD n.
Previous systematic reviews of Indigenous health issues have highlighted a paucity of
well-designed research, few studies of intervention, and a disproportionate number of
publications from only a few communities or regions (8)(9). Only a few studies have
collected adequate data on, or made adjustment for environmental determinants of
ESKD such as remoteness of locality and socio-demographics CO,11,12).
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Objectives
1. To determine the prevalence and incidence of end-stage kidney disease in
Indigenous populations worldwide.
2. To determine the risk for end-stage kidney disease in Indigenous people
compared with non-Indigenous people after accounting for other associated
factors, such as diabetes, non-diabetic diseases, low birth weight, age, gender,
socio-demographic status or geographical locality.
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2.3: Methods
Inclusion criteria: We included studies of Indigenous people of any age group, gender
or definition in their country of origin with a diagnosis of end-stage kidney disease.
Definitions of ESKD from the Kidney Disease Outcomes Quality Initiative (KlDOQI)
guidelines include GFR < 15 ml/min/1.73 m2, serum creatinine> 0.3 mmol/lor initiation
of kidney replacement therapy (dialysis or transplant) for treatment of complications of
decreased GFR C\ National renal failure registry and hospital ICD definitions of ESKD
were also accepted. Observational studies (cross-sectional, cohort and case-control
studies), systematic reviews and randomised controlled trials were included. Studies
were included if they had a non-Indigenous comparator group, and if they provided
enough data to perform or verify relative risk of ESKD in Indigenous people. Case
reports and case series were excluded.
Search strategy: Studies were retrieved by electronic searches performed in MEDLINE
(1966-December 2007), EMBASE (1988 - December 2007), CINAHL, ATSI and Rural
Health databases (1988 - December 2007). The following medical subject heading
terms and text words were used: the epidemiological terms risk, risk factors, cohort
studies, case-control studies, cross-sectional studies, non-randomised and
observational studies, aetiology, epidemiology, prevalence, incidence, and follow-up
studies were combined with the diagnostic terms renal replacement therapy, end-stage
kidney failure, kidney transplant, and the population group terms Oceanic ancestry
group, American Native continental ancestry group, Alaskan Native, Canadian Native,
Canadian Aboriginal, Aboriginal, Torres Strait Islander, Pacific Islander, Maori, Pima,
Navajo, Inuit and Eskimo. Studies were considered without language restriction.
Reference lists from all identified articles were searched and information about
unpublished studies was sought from experts in the field. Appendix 5 describes the
search strategy in detail.
Data extraction and quality assessment: From all included studies, data were
extracted on criteria used for diagnosis of end-stage kidney disease, characteristics of
the study sample (using Indigenous terminologies as described by study authors),
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setting, study design, selection criteria used for the population, age and gender of
participants, participation rate, potential risk factors/confounders studied,
methodological characteristics of the study and reported outcomes. The quality of the
studies was assessed in accordance with the MOOSE guidelines C4). Quality criteria
included scrutiny of study design, ascertainment and types of end-stage kidney disease,
method of determination of Indigenous and non-Indigenous populations, sampling bias,
intention-to-treat analysis and losses to follow-up, outcome blinding and adjustment for
confounders. When data was missing or incomplete, the authors of the study were
contacted for clarification.
Statistical analysis: Dichotomous data were analysed using odds ratios for prevalence
studies, and relative risks for incidence studies, with 95% confidence intervals. Adjusted
risks were calculated if data were available to do so using SAS statistical package CS).
Results were expressed so that a relative risk or odds ratio more than 1 meant a greater
risk ESKD in Indigenous groups when compared to non-Indigenous groups.
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2.4: Results
Literature search: The search identified 525 articles, 350 from Medline and 175 from
EMBASE, from which 377 abstracts were excluded because they were not about ESKD,
and/or did not have a non-Indigenous comparator. Full text assessment of 148 papers
identified 19 studies. In addition, 5 studies were identified from reference lists to articles
(figure 2.4.1). Ineligible papers were excluded because they had no non-Indigenous
comparator (47%), had insufficient data to verify a relative risk (28%) or had duplicated
data (25%).
Included studies:
There were 24 studies describing prevalence and/or incidence of ESKD in Indigenous
compared with non-Indigenous people, and these were conducted from 1971 to 2003.
Studies grouped data within the categories of all-cause, diabetic and non-diabetic
ESKD. There were 14 papers with data on all-cause ESKD (table 2.4.1),3 papers with
data on non-diabetic ESKD C6,17,18) (table 2.4.1) and 16 papers with data on diabetic
ESKD (table 2.4.2). All tabulated data lists Indigenous and non-Indigenous groups by
the descriptions used in included studies. Besides two cross-sectional studies C9,20), all
of the study designs were retrospective cohort studies describing data from hospital and
health service records and renal failure database registries. Figure 2.4.1 shows there
were 6 studies including all American Indian/Alaskan Native people, 5 studies including
Native American Indians (all Native Americans, Wisconsin Native Americans, Navajo
Indians, Zuni Indians and Indigenous people of the Northern Mariana Islands), 4 studies
including Canadian Native people (all Canadian Native people and Saskatchewan
Indians), one study including all Goajiro Indians of Venezuela, 5 studies including
Indigenous Australians (all Indigenous Australians, Northern Territory Aboriginals, Tiwi
Islander Aboriginals and Western Australian Aboriginals) and 3 studies including all
Maori and Pacific Islander people.
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Prevalence and odds of all-cause, non-diabetic and diabetic end-stage kidney
disease in Indigenous people compared with non-Indigenous people
In table 2.4.1, five studies documented prevalence of all-cause ESKD e1,22,23,24,17),
and one of these included prevalence of non-diabetic ESKD (17). In table 2.4.2, three
studies documented prevalence of diabetic ESKD (19,20,17).
Odds of all-cause ESKD
The odds of all-cause ESKD were significantly greater in all Indigenous groups. The
odds varied from 1.5 to 3 times greater in all Native Americans and all Canadian Native
Indians over the period 1983 to 2001, with the exception of Zuni Indians, who had odds
of 11 times greater in 1983. In 1993, Western Australian and Northern Territory
Aboriginals had 7 to 8 times the odds of ESKD.
Odds of non-diabetic ESKD
In 2001, Navajo Indians had 1.5 times greater odds of non-diabetic ESKD. There were
no increased odds for all Native Americans and Native Indians in Arizona, New Mexico,
Utah and Colorado (excluding the Navajo Nation).
Odds of diabetic ESKD
In 1991, all Maori and Pacific Islander people had 10 to 14 times greater odds of
diabetic ESKD. In 1998, the odds were 1.5 times greater in all Native American
veterans. In 2000, the odds were 5 times greater for all Indigenous People of the
Mariana Islands. In 2001, odds were 2.5 times greater for all Native Indians, 4.5 times
greater for Navajo Indians, and almost 7 times greater for Native Indians in Arizona,
New Mexico, Utah and Colorado (excluding the Navajo Nation).
Incidence and relative risk of all-cause, non-diabetic and diabetic end-stage
kidney disease in Indigenous people compared with non-Indigenous people
All studies in table 2.4.1 describe incidence of all-cause ESKD, and three of these
studies included data on non-diabetic ESKD (16,17,18). All but 2 studies in table 2.4.2
(19,20) describe incidence of diabetic ESKD.
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Relative risk of all-cause ESKD
The relative risk of all-cause ESKD was significantly greater in all Indigenous groups.
From 1983 to 1986, the risk was 2 to 3 times greater in all American Indians/Alaskan
Native people, and in 1985 it was 1.2 to 4 times greater in all Native Americans, 9 times
greater in Zuni Indians and 18 times greater in Navajo Indians. From 1991 to 1998, the
risk was 1.7 times greater in Goajiro Indians. From 1981 to 2002, the risk was 2.5 to 4.5
times greater in all Canadian Native people. From 1992 to 2001, the risk was 4.5 times
greater for all Indigenous Australians, but was 16 times greater for the age group 45-54
years. In 1986, the risk was 2 times greater in Western Australian Indigenous
Australians, and 14 times greater in 1994. From 1988 to 1993, the risk was 8 times
greater in all Northern Territory Indigenous Australians, and four times greater in
Northern Territory Tiwi islanders. From 1992 to 2001, risk was 3.5 times greater in
Maori and Pacific Islander people, and from 1998 to 2002, the risk was 9 times greater.
Relative risk of non-diabetic ESKD
From 1981 to 1990, Saskatchewan females and males both had a 2.5 times increased
risk of non-diabetic ESKD. From 1998 to 2002, all Canadian Native people had a
significantly increased risk of 1.7 times. In 2001, all Native Americans and Navajo
Indians had a significantly reduced risk of 0.6 to 0.8. Native Americans in Arizona, New
Mexico, Utah and Colorado (excluding the Navajo Nation) had no difference in risk.
Relative risk of diabetic ESKD
From 1983 to 1987, the risk for all American Indians/Alaskan Native people was 2 to 7
times greater. From 1990 to 1994, it was 1.3 to 1.6 times greater. From 1994 to 2004, it
was 4.5 to 3.6 times greater. The greatest risk was within the 45 to 54 years age group,
where the risk was 16 times greater. From 1982 to 2003, Wisconsin Native Americans
had a 4 to 5 times greater risk. In 1985, Navajo Indians had a 26 times greater risk. In
2001, Navajo Indians had a 3 times greater risk, and Native Americans in Arizona, New
Mexico, Utah and Colorado (excluding the Navajo Nation) had a 4.6 times greater risk.
From 1981 to 2002, all Canadian Native people had a 4 to 7 times greater risk, although
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Saskatchewan Native people had a 7 to 9 times greater risk. From 1992 to 2002, within
the age group 45 to 64 years, all Indigenous Australians had a 45 times greater risk; all
Maori people 26 times greater risk; Pacific Islander people 43 times greater risk.
African Americans and Asian Americans were used as non-Indigenous comparators (in
addition to the comparators used in the studies above of Caucasians or aggregate
populations) for a number of diabetic studies (27,45,46). In 1994 and in 2004, American
Indians/Alaskan Natives had no difference in risk for diabetic ESKD compared to African
Americans. From 1983-1987 within the age group 45 to 54 years, the risk was 2 times
greater than African Americans, six times greater than Asian Americans (and 16 times
greater than Caucasian Americans). From 1997 to 2000 within the age group 45-54
years, the risk was 1.2 times greater than African Americans, 3 times greater than Asian
Americans (and 5 times greater than Caucasian Americans).
Quality of included studies
Table 2.4.3 describes the study quality. Of the 24 included studies, 4 had non-
Indigenous comparators from different study bases (17,25,26,19). Native American
Indians of the Navajo Nation and in Arizona, New Mexico, Utah and Colorado were
compared with the general US population (17). Navajo Indians of Ramah, Canoncito,
and Alamo Reservations were compared with the US white population (25). Gaojiro
Indians were compared with the total Venezuelan population (26). Indigenous people of
the Northern Mariana Islands were compared with the total US population (19). Most
studies determined Indigenous status by nomination at ESKD registration, on hospital
and Registered Indian records, census data and Indian Health Service records. Two
studies gave no method of determination for Indigenous status (23,26). Only one study
included all ESKD (untreated ESKD patients and deaths from ESKD) (23). Three
studies used tribal statistics and Indian Affairs departmental data in addition to national
census and registered Indian records so as to ascertain total Indigenous population
figures (25,24,27). Six studies had no information to allow adjustment or stratification by
confounders in estimates on prevalence and incidence (21,22,26,19,28,20). Seventeen
studies adjusted for age and/or sex in their own risk estimates. One study adjusted for
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other potential predictors in addition to age and sex, such as clinic visits, region,
remoteness, hypertension and cardiovascular disease (12).
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2.5: Discussion
This is the first study to summarise the risk for ESKD in Indigenous people compared to
non-Indigenous people. Besides two cross-sectional reports, all studies described risk
through retrospective review of registry, health service and hospital databases. Despite
a large number of studies describing ESKD in Indigenous populations (figure 2.4.1), a
disproportionate amount of the published literature originates from a handful of remote
communities by a few research groups e9,30,31). These studies may not represent the
interests of all Indigenous people in Australia, USA, Canada and New Zealand, where
the majority reside in urban areas alongside non-Indigenous countrymen (32,33,34,35). To
date there have been no prospective population-based studies of risk for ESKD that
include a non-Indigenous comparator group.
The prevalence, incidence and risk for all-cause and diabetic ESKD in Indigenous
people is universally greater when compared to Caucasian populations, and the
disparity appears to be widening over time. Most of the increased risk for all-cause
ESKD is attributable to high rates of diabetic ESKD. For those studies that stratified for
age, the age groups 45-54 years, and 45-64 years have the greatest disparity for
Indigenous people when compared to non-Indigenous people for both all-cause and
diabetic ESKD ee,1 ,37,18). Prevalence, incidence and risk for all-cause and diabetic
ESKD were consistently higher over time among the Zuni Indians, Indigenous
Australians, Maori and Pacific Islander people when compared to other Indigenous
groups. A slightly increased prevalence and odds for non-diabetic ESKD was seen in
Navajo Indians, although they had a significantly reduced relative risk of non-diabetic
ESKD. Canadian Native people and tribal groups had a slightly increased risk of non-
diabetic ESKD, but it was four times less than their risk for diabetic ESKD. In those
studies comparing Indigenous groups to other minority or disadvantaged groups, the
increased risk for ESKD was less, particularly in comparison with African Americans.
This suggests socio-demographic factors common to all disadvantaged groups (rather
than unique biological differences in Indigenous people) playa major part in the
development of ESKD.
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Some of the heterogeneity in risk between Indigenous groups can be accounted for by
classification bias and use of inappropriate non-Indigenous comparators. Because most
Indigenous populations are more youthful, have a higher proportion of females, and
have higher rates of diabetic ESKD in women, adjustment of analyses for age and sex
increases the risk in Indigenous people almost universally (36,38,39,17). Inconsistent
adjustment of estimates between studies for age and sex increases the heterogeneity of
these results, and makes meta-analysis or summary estimates of risk across
Indigenous groups difficult.
Most studies had some degree of ESKD ascertainment bias through accounting only
for treated cases of ESKD. All ESKD registries in included studies assessed the
prevalence and incidence by the number of patients either on treatment or beginning
treatment, but not accounting for those who refuse treatment, have no insurance to pay
for it, have limited access to it, or die before gaining access to treatment. These
disadvantages are likely to affect many more Indigenous than non-Indigenous people.
Despite the fact that Goajiro Indians have a twice higher risk of ESKD than the general
population and they make up 3% of the population, they represent only 3% of the
dialysis population (26). Because the absolute numbers of Indigenous cases of ESKD
are small, accounting for even one or two extra cases can make a large difference to
risk estimates. Only one study checked health service records and death certificates to
account for untreated renal failure patients, and found a 7% under-ascertainment of
Indigenous ESKD cases when using registry data only (23).
Only two papers lacked a description of how Indigenous status was determined (23,26).
Despite this, racial and ethnic misclassification on databases still accounts for a
significant underreporting of ESKD cases, and a reduction in real risk estimates.
Nomination of Indigenous status on hospital and registry data is usually performed by
medical or clerical staff, and is vulnerable to error (40,41). Underreporting of ethnicity on
population census counts or national registers will in contrast increase risk estimates,
however this increase is likely to be smaller than the decrease resulting from Indigenous
17
Chapter 2: Review of the literature - a systematic review of the prevalence, incidence and risk of ESKD in
Indigenous people
status and ESKD ascertainment bias (36).Odds for all-cause ESKD in all Canadian
Native people increased from 1.5 times to 2.5 times greater when only registered Native
Canadians were accounted for, and relative risk increased from 2.5 times to 4 times
greater.
Most of the excess risk in Indigenous people for ESKD is due to increased rates of
diabetic ESKD. Why diabetes behaves differently in Indigenous populations may in part
be explained by socio-demographic inequities that delay the diagnosis and adequate
treatment of diabetes and diabetic kidney disease. Only one paper adjusted for these
risk factors that affect Indigenous and other disadvantaged groups, such as remote
living, lack of access to health care and inadequate social capital (12). Measurement
and adjustment for potential socio-demographic confounders is essential in teasing out
the complex relationship between race, disadvantage and risk for ESKD. Without
appropriate adjustment, race becomes the proxy for the increased risk for ESKD. Well-
defined socio-demographic risk factors are amenable to generational change, and are
largely preventable (as opposed to biological variants, which are not). Future research
into ESKD needs to consider the early causal chain to these disease outcomes, and
include acceptable (local) non-Indigenous comparator groups as part of prospective
population-based research.
18
Chapter 2: Review of the literature - a systematic review of the prevalence, incidence and risk of ESKD in
Indigenous people
Figure 2.4.1: Flow chart showing the identification of studies
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Abbreviations: AI/AN, American Indian/Alaskan Native; CN, Canadian Native, ESKD, end-stage kidney
disease; lA, Indigenous Australian; IPNMA, Indigenous People of the Northern Mariana Islands; NA,
Native American; NT lA, Northern Territory Indigenous Australian; PI, Pacific Islander; WA lA, Western
Australian Indigenous Australian.
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Table 2.4.1: Characteristics of prevalence and incidence studies evaluating the effect of Indigenous status on end-stage
kidney disease'
Author Selling & study Design Age ESKD IndigenousW Non-lndigenousW ORIRR ESKD in
Date of period range type (P)revalence (P)revalence Indigenous vs
publication (years) (I)ncidence (I)ncidence Non-Indigenous
----------------- - - - -- - -
(95% el)
Megill D (25) Shiprock IHS Retrospective NS Treated Navajo Indians Ramah, US Whites RR
1988 records cohort study Canoncito,Alamo
ESRD Network VI reservations
Albuquerque (I) 2591170,000 (I) 24624/296670000 18.32 (16:22-20:71)
Navajo tribal
statistics
University New
Mexico databank
1985
Pasinski R (21) Zuni IHS records Retrospective 14-81 Treated a) Zuni Indians a) Whites Area VI
1987 Albuquerque cohort study (P) 1983 (P) 1983 a) OR 1983
Gallup Dialysis 20/6892 266 pmp 10:91 (6:92-17:20)
Centre
ESKD Network VI a) All races Area VI
Albuquerque Average (I) Average (I) a) RR
1973-1983 3:8/5263 83 pmp 8.70 (3: 11-24.33)
US census
1970 & 1980 b) Native Indians Area VI b) Whites Area VI
(P) 1983 (P) 1983 b) OR 1983
808 pmp 266pmp 3:04 (2:64-3.49)
Young T (24) Canadian National Retrospective 0-65+ Treated Canadian Native Peoples All Canadians RR
1989 Renal Failure cohort study Average (I) Average (I)
Register a) All registered Indians
DINA 305/1316017 8432/148975265 a) 4.09 (3.65-4:59)
Canadian census
1981-1986 b) All Native people b) 2.46 (2.19-2.75)
305/2193362
(P) 31 Dec 1986 (P) 31 Dec 1986 OR 1986
c}AII registered Indians
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702/1316017 33221/148975265 c) 2.39 (3.22-2.58)
d) All Native people
702/2193362 d) 1.44 (1.33-1.55)
Dyck R (16) Canadian Organ Retrospective 0-60+ Treated Saskatchewan Fi rst Saskatchewan non- RR
1998 Replacement cohort study non- Nation people Aboriginals
Register diabetic Average (I) Average (I) Females
1981-1990 17/20988 females 158/493750 females 2.53 (1.53-4.18)
22/16667 males 263/496226 males Males
2.49 (1.61-3.85)
Stolzmann K (42) US Upper Midwest Retrospective 0-75+ Treated Wisconsin Native Wisconsin Whites RR
2005 Renal Network 11 cohort study American
CDC-WONDER (I) 1982 (I) 1982 1982
1982 & 2003 6/21352 352/4455696 3.56 (1.59-7.97)
(I) 2003 (I) 2003 2003
27/27054 1276/5316667 4.16 (2.84-6.09)
HoyW (43) US HCFA data Retrospective 0-75+ Treated Native Americansl US Whites RR
1989 1983-1986 cohort study Alaskan Natives Native American!Alaskan
Average (I) Average (I) Natives
189 pmp 100 pmp 1.89 (1.48-2.41)
303 pmp adjusted 3.03 (2.14-4.21)
adjusted
(I) 1985
Arizona Indians Arizona Indians
382 pmp 3.82 (3.07-4.76)
New Mexico Indians New Mexico Indians
399pmp 3.99 (3.20-4.97)
Zuni Indians Zuni Indians
912 pmp 9.12 (7.42-11.21)
Navajo Indians Navajo Indians
176 pmp 1.76 (1.38-2.25)
Newman J (39) US HCFAdata Retrospective 0-75+ Treated Alaskan Natives! US Whites RR
1990 1983-1986 cohort study American Indians
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IHS records Average (I) Average (I) 1,76 (1 A6-2.13)
1985 108/642857 7529/79004197
US census
1980
Brameld K (23) Western Australian Retrospective NS All Aboriginals in Western Non- Aboriginals RR
1999 Health Services cohort study Australia Western Australia
Research Linked (I) (yr) pt yrs (I) (yr) pt yrs 1986
Data (1986) 6.8/100,000 (1986) 3.6/100,000 2.84 (1.19-28.14)
Health Department 1994
Western Australia (1994) 79/100,0000 (1994) 5.1/100,000 14.31 (6.26-57A9)
1986-1994
(P) Dec 31 1993 (P) Dec 31 1993 OR 1993
140/100,000 pt years 15.6/100,000 pt yrs 8.0 (4.60-41.58)
HoyW (22) Northern Territory Retrospective 0-60+ Treated Aboriginals Non-Aboriginals RR
1995 Australia Hospital cohort study Northern Territory Northern Territory
and dialysis files Average (I) Average (I)
1988-1993 a) All Aboriginals All Aboriginals
ABS 1991 83/25387 44/105405 7.83 (5A3-11.29)
b) Tiwi Islander Tiwi Islander
Aboriginals Aboriginals
1636 pmp 3.91 (2.90-5.29)
c) Non-Tiwi Aboriginals Non-Tiwi Aboriginals
358 pmp 3A2 (1.13-5.17)
(P) 1993 (P) 1993 OR 1993
All Aboriginals Non-Aboriginals
Northern Territory Northern Territory
40/25387 28/105405 7.83 (5A3-11.29)
Herrera J (26) Nth Western Retrospective NS Treated Goajiro Indians Whole population RR
2003 Venezuela cohort study Venezuela
University Hospital Average (I) Average (I)
records 7.3/184000 132 pmp 1.67 (1.34-2.07)
Annual records
public health
system
1991-1998
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Stewart J (36) ANZDATA Retrospective 0-65+ Treated Indigenous Australians Non-Indigenous RR
2004 ASS cohort study Australians
1992-2001 Average (I) (yrs) Average (I) (yrs)
(45-54) 387/260256 (45-54) 2106/23066813 16.29 (14.61-18.15)
(55-64) 289/137750 (55-64) 2900/15760870 8.74 (7.76-9.84)
Stewart J (1) ANZDATA Retrospective 0-65+ Treated a) Indigenous Australians a) Non-Indigenous RR
2004 ASS cohort study Australians
Stats NZ Average (I) (yrs) pmp Average (I) (yrs) pmp
1992-2001 (0-14) 7.9 (0-14) 6.4
(15-44) 282 (15-44) 34.5
(45-64) 1732 (45-64) 131 All
(65+) 1161 (65+) 250 Indigenous Australians
Total 12621372737 Total 13574/18040714 4.50 (4.25-4.77)
b) Maori b) Non-Indigenous New
Zealander
Average (I) (yrs) pmp Average (I) (yrs) pmp
(0-14) 4.3 (0-14) 8.5
(15-44) 85.3 (15-44) 33.5
(45-64) 1028 (45-64) 106
(65+) 920 (65+) 148 All Maori
Total 1037/554517 Total 1787/2949905 3.09 (2.86-3.33)
c) Pacific Islander c) as b) above
Average (I) (yrs) pmp
(0-14) 10.1
(15-44) 141
(45-64) 1087
(65+) 932 All Pacific Islanders
Total 421/204076 3.40 (3.06-3.79)
Stewart J (18) Multiple ESKD and Retrospective 45-74 Treated All ESKD All ESKD RR
2006 census databases cohort study Average (I) Average (I)
from different a) New Zealand a) New Zealand non- New Zealand
countries Maori/Pacific Islander Polynesian Maori/Pacific Islander
1998-2002 161/123851 28211880981 8.67 (7.14-10.52)
b1.9anadian Aboriginlll_ b) Canadian non- Canadian Aboriginal
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Hochman M (17)
2007
USRDS
2001
US census
2000
Aboriginal
1621160756 5056/17678042 3.52 (3.01-4.12)
All other non- All other non-
diabetic ESKD diabetic ESKD Non-diabetic
Average (I) Average (I) New Zealand
a) New Zealand a) New Zealand non- Maori/Pacific Islander
Maori/Pacific Islander Polynesian
321123851 166/1880981 2.93 (2.01-4.27)
b) Canadian Aboriginal b) Canadian non- Canadian Aboriginal
Aboriginal
35/160756 2280/17678042 1.69 (1.21-2.36)
Retrospective ;::.18 Treated All ESKD All ESKD All Native Americans
cohort study a) Native Americans a) General US Navajo Nation
Navajo Nation population OR
(P) 636/130907 (P) 400605/212673000 2.58 (2.39-2.79)
RR
(I) 109/130907 (I) 93886/212673000 1.89 (1.56-2.28)
All Native Americans
b) All Native Americans OR
(P) 5556/2023000 1.46 (1.42-1.50)
RR
(1) 1108/2023000 1.24 (1.17-1.32)
Native Americans in
c) Native Americans in AZ, NM, UT, CO
AZ, NM, UT CO (excludes (excludes Navajo
Navajo Nation) Nation)
(P) 1481/250820 OR
3.13 (2.98-3.30)
(I) 283/250820 RR
2.56 (2.27-2.87)
Non-diabetic ESKD Non-diabetic ESKD Non-diabetic
a) Native Americans a) General US Native Americans
Navajo Nation population Navajo Nation
(P) 223/130907 (P)255208/212673000 OR
1.42 (1.24-1.62)
(I) 24/130907 (I) 51042/212673000 RR
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Tareen N (38)
2005
USRDS
2001
US census
2000
Retrospective
cohort study
?18 Treated
b) All Native Americans
(P) 2023/2023000
(I) 28312023000
c) Native Americans in
AZ, NM, UT CO (excludes
Navajo Nation)
(P) 326/250820
(i) 531250820
Native Americans
(I) 1408/2023000
US Whites
(i) 254 pmp
0.83 (0.80-0.87)
Native Americans
OR
0.53 (0.51-0.55)
RR
0.59 (0.52-0.66)
Native Americans in
AZ., NM, UT, CO
(excludes Navajo
Nation)
OR
1.08 (0.97-1.21)
RR
0.88 (0.67-1.15)
RR
2.74 (2.40-3.13)
• Studies are arranged chronologically based on the initiation of sludy enrolmenl
mlndigenous and non-indigenous group descriptions are as given in the included studies
Abbreviations: ABS, Australian Bureau Statistics; ANZDATA, Australia and New Zealand Dialysis and Transplant Registry; AZ, Arizona; CDC-
WONDER, Centers for Disease Control and Prevention, Wide-Ranging Online Data for Epidemiological Research; CO, Colorado; DINA,
Department of Indian and Northern Affairs; ESKD, end-stage kidney disease; HCFA, The Health Care Financing Administration; ID, identification
number; IHS, indian Health Service; NM, New Mexico; OR, odds ratio; pmp, per million population; RR, relative risk; Stats NZ, Statistics New
Zealand; US, United States; USRDS, United States Renal Data System; UT, Utah.
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Table 2.4.2: Characteristics of prevalence and incidence studies evaluating the effect of Indigenous status on diabetic
end-stage kidney disease'
Author setting & Design Age Diabetic IndigenousID Non-lndigenousID ORIRR ESKD in
Date of study period range ESKD (P)revalence (P)revalence Indigenous vs
pUblication (years) type (I)ncidence (I)ncidence Non-Indigenous
(95% el)
Megill D (25) Shiprock IHS Retrospective NS Treated Navajo Indians Ramah, US Whites RR
1988 records cohort study Canoncito,Alamo
ESRD Network reservations
VI Albuquerque (I) 1021170000 (I) 6785/295000000 26.09 (21.45-31.72)
Navajo tribal
statistics
University New
Mexico
databank
1985
Young T (24) Canadian Retrospective 0-65+ Treated Canadian Native All Canadians RR
1989 National Renal cohort study Peoples
Failure Average (I) Average (I) All registered Indians
Register a) All registered Indians 4.05 (3.23-5.09)
DINA 78/337662 1492126175439
Canadian All Native people
census b) All Native people 2.43 (1.94-3.05)
1981-1986 78/562770
,J
Dyck R (28)
1994
Canadian
Organ
Replacement
Register
Registered
Native Peoples
Sasketchewan
1981-1990
Retrospective
cohort study
~20 Treated Saskatchewan Natives
Average (I)
a) 50/2107 diabetics
b) 50/28318 total
population
Non-Natives
Saskatchewans
Average (I)
a) 135/41646 diabetics
b) 135/668259 total
population
RR
a) 7.32 (5.28-10.16)
b) 8.74 (6.32-12.09)
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Stolzmann K (42) Renal Network Retrospective 0-75+ Treated
2005 Upper Midwest cohort study
Network 11
CDC-
WONDER
1982 & 2003
Teutsch S (37) US Medicare Retrospective All Treated
1989 database cohort study
1983-1985
Wisconsin Native
American
(I) 1982
3/35294
(I) 2003
23/49676
American Indians
Average (I) (yrs) pmp
(45-54) 310
(55-64) 600
Wisconsin Whites
(I) 1982
99/4500000
(I) 2003
483/4979381
US Whites
Average (I) (yrs) pmp
(45-54) 20
(55-64) 50
US Blacks
Average (I) (yrs) pmp
(45-54) 150
(55-64) 220
US Asians
Average (I) (yrs) pmp
(45-54) 50
(55-64) 130
RR
1982
3.86 (1.23-12.19)
2003
4.77 (3.14-7.25)
RR
15.50 (9.68-24.36)
12.00 (8.99-16.01)
2.07 (1.70-2.51)
2.73 (2.34-3.18)
6.20 (4.60-8.36)
4.61 (3.82-5.58)
Newman J (39) US Medicare Retrospective 0-75+ Treated Alaskan Natives US Whites RR
1990 USIHS cohort study American Indians
databases Average (I) Average (I)
US census 597/3553571 20253/212518363 1.76 (1.63-1.91)
1983-1986
Muneta B (27) US Medicare Retrospective All Treated American Indian a) US Whites RR
1993 database cohort study Alaskan Native
IHS data (I) 196 pmp (I) 29 pmp 6.76 (4.58-9.98)
1983-1987
US census b) US Blacks
1980 (I) 109 pmp 1.80 (1.42-2.27)
Simmons D (20) Sth Auckland Cross- 18-79 Treated Maori Europeans OR
1994 Middlemore sectional al.(P) diabetics (P) diabetics Maori
28
Hospital study 4/84 1/297 14.14 (1.56-128)
records
GP referrals Pacific Islanders Pacific Islanders
1991 b) (P) diabetics 9.66 (1.07-87.3)
4/123
CDC report (44) US Medicare Retrospective All Treated American Indian/ Total US population RR
1999 database cohort study Alaskan Native 1990
US census Average (I) diabetics Average (I) diabetics 1.25 (1.08-1.44)
1990& 1996 a) (1990) 394/83475 378/100000 1996
b) (1996) 719/123116 1.55 (1.36-1.75)
Stewart J (1) ANZDATA Retrospective 0-65+ Treated a) Indigenous a) Non-Indigenous RR
2004 ABS cohort study Australians Australians Indigenous Australians
Stats NZ Average (I) (45-64yrs) Average (I) (45-64yrs)
1992-2001 409/389524 879/37887931 45.26 (40.25-50.89)
b) Maori b) c) Other New
Zealander Maori
Average (I) (45-64yrs) Average (I) (45-64yrs)
475/1000000 122/6594595 25.68 (21.04-31.32)
c) Pacific Islander
Average (I) (45-64yrs) Pacific Islander
169/211514 43.19 (34.22-54.52)
Gilbertson D (45) USRDS Retrospective NS Treated American Indian/ a) US White RR
2007 1994-2004 cohort study Alaska Native b) US Black
US census (I) (yr) pmp (I) (yr) pmp 1994
2000 (1994) 360 (1994) a) 80 a) 4.50 (3.35-5.73)
b) 300 b) 1.20 (1.03-1.40)
2004
(2004) 360 (2004) a) 100 a) 3.60 (2.88-4.49)
b) 380 b) 0.95 (0.82-1.09)
Young B (12) US Dept Retrospective Mean Treated Native American a) US Caucasian OR
2003 Veterans cohort study 64.1 ± Veterans Veterans
Affairs health 11.4 (P) 105/222 diabetics (P) 9489/26212 a)Diabetics
database 105/1747 veterans diabetics 1.31 (1.03-1.65)
1998 9489/241548 veterans Veterans
29
1.53 (1.26-1.87)
Lopes A (46) USRDS Retrospective NS Treated Native American Indians RR
2004 1997-2000 cohort study Average (I) per 10mp Average (I) per 10mp
5233 a) US whites a) 5.11 (4.78-5.46)
1024
b) US Asians b) 2.85 (2.70-3.00)
1836
c) US Blacks c) 1.24 (1.19--1.30)
4208
Stewart J (18) Multiple ESKD Retrospective 45-74 Treated New Zealand New Zealand RR
2006 and census cohort study Maori/Pacific Islander non-Polynesian New Zealand
databases from Average (I) Average (I) Maori/Pacific Islander
different 117/123851 71/1880981 25.03 (18.64-33.01)
countries
1998-2002 Canadian Aboriginal Canadian non- Canadian Aboriginal
Aboriginal
Average (I) Average (I)
119/160756 1891/17678042 6.92 (5.75-8.33)
Abidi S (19) US Medicare Cross- All Treated Indigenous people Total US population OR
2005 database sectional Northern Mariana
Dec 312000 study Islands
US census (P) 57/23908 (P) 46/100000 5.18 (3.51-7.65)
2000
Hochman M (17) USRDS Retrospective ? 18 Treated a) Native Indians Navajo a) Generai US Native Indians Navajo
2007 2001 cohort study Reservation population Reservation
US census (P) 406/130907 (P) 146744/212673000 OR
2000 (I) 86/130907 (I) 42535/212673000 4.50 (4.08-4.96)
RR
b) All Native Americans 3.28 (2.66-4.06)
(P) 3439/2023000 All Native Americans
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(I) 829/2023000 OR
2.46 (2.38-2.55)
RR
2.05 (1.91-2.19)
c) Native Americans in All Native Americans in
AZ, NM, UT CO AZ, NM, UT, CO
(excludes Navajo OR
Nation) 6.67 (6.29-7.07)
(P) 1154/250820 RR
(I) 2311250820 4.60{4.05~ ..24)
• Studies are arranged chronologically based on the initiation of study enrolment
'" Indigenous and non-Indigenous group descriptions are as given in the included studies
Abbreviations: ABS, Australian Bureau Statistics; ANZDATA, Australia and New Zealand Dialysis and Transplant Registry; CDC, Centers for
Disease Control and Prevention; CDC-WONDER, Centers for Disease Control and Prevention, Wide-Ranging Online Data for Epidemiological
research; DINA, Department of Indian and Northern Affairs; ESKD, end-stage kidney disease; GP, general practitioner; IHS, Indian Health
Service; pmp, per million population; Stats NZ, Statistics New Zealand; US, United States; USRDS, United States Renal Data System.
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Table 2.4.3: Quality of included studies evaluating risk of Indigenous status on end-
stage kidney disease (n=24)
Characteristic Yes
Non-Indigenous comparator from 20
same study base
Indigenous status adequately 22'
determined
Sampling biases
Numerator (ESKD sample) 23'
Denominator (Indigenous population) 21
Adjustment/stratification for
confounders
Age and/or sex only 17
ah. l'
None 4
No
4
2'
l'
3'
7
23
20
Comment
Indigenous group vs non-Indigenous comparator:
• Navajo Indians vs US whites or total population
• Goajiro Indians vs total Venezuelan population
• Indigenous people of Northern Mariana Islands
vs total US population
'Indigenous status determined by:
• ESKD database
• Hospital record racial nomination
• IHS nomination
• Registered Indian records
• Census data collection
'No description of determination given
, Treated ESKD onIy
'Treated and untreated ESKD
Determined by:
• National census
• Registered Indian records
, Determined by:
• Indigenous census
• Tribal statistician
• Adjustment for registered Indian bias
• Indian health service records
'Age, sex, clinic visits, region, non-service connection,
hypertension, cardiovascular disease
Abbreviations: ESKD, End-stage kidney disease; lCD, International Classification Diseases; IHS, Indian
Health Service.
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3.1 : Abstract
Indigenous minorities have substantially higher rates of ESKD, especially Australian
Aboriginals. Previous work suggests a causal pathway beginning early in life. No
studies have shown the prevalence of early markers of chronic kidney disease in both
Indigenous and non-Indigenous children or the association of these markers with
environmental health determinants, such as geographic remoteness and socioeconomic
disadvantage.
Height, weight, blood pressure and urinary abnormalities were measured in age
and gender-matched Aboriginal and non-Aboriginal children from primary schools
across geographically diverse areas of New South Wales, Australia. Haematuria was
defined as ~25 RBC/uL (,?,1+), proteinuria ~0.30glL (~1+), and albuminuria (ACR)
~3.4mglmmoL. Remoteness of locality and socioeconomic status were assigned using
the Accessibility and Remoteness Index of Australia (ARIA++) and Socio-Economic
Indexes For Areas (SEIFA).
From 2002 to 2004, 2266 children (55% Aboriginal, mean age 8.9 years) were
enrolled from 37 primary schools. Overall prevalence of haematuria was 5.5%,
proteinuria 7.3%, and albuminuria 7.3%. Only haematuria was more common in
Aboriginal children (7.1 versus 3.6%; p = 0.002). Socioeconomic disadvantage and
geographical isolation were neither significant nor consistent risk factors for any marker
of CKD.
Aboriginal children have double the prevalence of hematuria compared with non-
Aboriginal children but no increase in albuminuria or proteinuria, which are more
important risk factors for CKD. Geographical isolation and socioeconomic disadvantage
are not risk factors for markers of CKD in children. This suggests the causal pathways
for ESKD in Aboriginal people are not established by childhood and are therefore
preventable.
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3.2: Introduction
Indigenous minorities have almost universally poorer health outcomes than non-
Indigenous majority populations worldwide and this is particularly true for kidney
disease c)e)e). Australian Aboriginal and Torres Strait Islander people (hereafter
referred to as Aboriginal) are eight-times more likely to develop end-stage kidney
disease (ESKD) than non-Aboriginal people, are 10 years younger on average, are only
half as likely to be listed for transplantation, and have almost 30% lower graft and 8%
lower patient survival 5-years post-transplantation (1). This pattern of excessive burden
due to increased prevalence and poorer outcomes once ESKD occurs is also found in
the Inuit and Native Canadians in Canada (2), Native Americans in the USA (3), and in
the Maori people of New Zealand (1).
Why Indigenous peoples have such an excess risk of ESKD is largely unknown. The
three main causes of ESKD in Aboriginal people are diabetic nephropathy, primary
glomerulonephritis, and hypertension (4). A much larger proportion of ESKD in
Aboriginal Australians is attributed to diabetic nephropathy (47%) as compared to non-
Aboriginal Australians (17%), however the ESKD excess is not explained solely by
differences in diabetic prevalence or co-morbidities (1). The causal chain contributing to
chronic kidney disease (CKD) may start at or before birth, with maternal factors (5), low
birth weight and reduced nephron mass (6) () rendering the kidney more vulnerable to
diabetes and hypertension. However marked regional differences in ESKD have been
noted between Aboriginal populations (8) and in ethnically homogeneous countries such
as Japan, suggesting sociodemographic influences rather than genetic predisposition
are responsible (9). Environmental factors such as isolated living and socioeconomic
disadvantage may play the more important role in the development of CKD (8).
Current knowledge about the risk factors for CKD in Aboriginal people in Australia is
mainly limited to adult-based research that comes from areas of high remoteness and
socioeconomic disadvantage in Northern Australia, and lacks non-Aboriginal control
groups or adjustment for variability in locality and sociodemographics Co). The aims of
our study were to determine whether the increased risk of CKD in Aboriginal adults is
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evident in childhood, and to determine whether environmental health determinants
could explain any difference in observed risk.
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3.3: Methods
Selection of participants: Government-run primary schools were approached for testing
from urban, coastal, rural and remote locations across the state of New South Wales
(Appendix 6). This state has the highest Aboriginal population in Australia. Non-
government schools (private and denominational) have very few Aboriginal enrolments,
and were not considered for recruitment. To maximise power, sampling was done to
obtain equal numbers of Aboriginal and non-Aboriginal children, and in similar
proportions from urban, coastal, rural and remote areas. All primary schools in remote
communities were approached and other areas were sampled if greater than twenty
Aboriginal children in the relevant age range attended.
Aboriginal status was determined using the Australian Bureau of Statistics best practice
.
recommendations, asking the Standard Indigenous Question on the consent form "Is
your child of Aboriginal or Torres Strait Islander origin?" C\ All Aboriginal children in
the participating primary schools were offered testing for height, weight, blood pressure
and urinary dipstick abnormalities. Non-aboriginal children were matched for gender
and age (nearest birthday) using class lists. We aimed to recruit equal numbers of boys
and girls, Aboriginal and non-Aboriginal children, and approximatelyequal numbers of
children from each 12 month age group.
Aboriginal community engagement: Consultation with local Aboriginal Medical Services
and consent from community leaders was undertaken prior to commencement of the
study. Approval was obtained from the Ethics Committees of the Children's Hospital at
Westmead, the University of Sydney, New South Wales Area Health Services and the
New South Wales Department of Education and Training. Informed consent was
obtained for each child and, in accordance with NHMRC Guidelines for Ethical Conduct
in Aboriginal and Torres Strait Islander Research C2), data was collected onto a
standardised form and de-identified for storage and analysis before being returned to
each community after the stUdy visit. Permission to publish data was also obtained from
each community.
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Measurement of markers of chronic kidney disease and associated risk factors: Markers
of chronic kidney disease measured were haematuria, proteinuria and albuminuria. Risk
factors known and thought to be associated with the development of CKD in Aboriginal
people were also recorded, including age, gender, growth parameters, birth weight,
blood pressure and environmental health determinants: categories of isolation,
disadvantage and region.
A morning clean catch specimen was collected from each child, with dipstick analysis
for haematuria, proteinuria and albuminuria performed at the survey site on fresh
specimens using a Bayer Clinitek 50 machine C3). Leukocytes and nitrites were also
recorded for later adjustment for abnormalities of presumed urinary tract infection. Girls
older than eight years who were found to have haematuria were questioned about
menses, and if appropriate, collection was performed at another time.
Haematuria was defined as greater than or equal to 25 RBC per microlitre (1+),
proteinuria as greater than or equal to 0.30 giL (1+) and albuminuria as
albumin:creatinine (ACR) greater than or equal to 3.4 mglmmol.
Standardisation of urban, coastal, rural and remote locality was made using the
Accessibility and Remoteness Index of Australia (ARIA++), with each subject given an
Index score according to their postcode of residence C4). Using geographical
information system (GIS) capabilities, distances, services and population density for
each locality are converted to a continuous variable with values ranging from zero for
high accessibility, to 18 for extreme remoteness C5). ARIA++ values for this NSW study
ranged from 0 to 14, and for categorical analysis the scores were grouped into quartiles.
Isolation categories (and ARIA++ score range) used were: Least isolation (0-1.1), low-
mid isolation (1.2-2.4), high-mid isolation (2.5-4.9) and highest isolation (5.0-14.0).
Locality was also classified by region (in order of increasing remoteness by ARIA
score); Urban, south coast, north coast, rural and remote.
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To determine the level of social and economic well being of areas studied, the Socio-
Economic Indexes for Areas 2001 Cl) Index of Disadvantage was applied to subjects at
the level of collection district of residence. This is the smallest geographic area for
which the Index is available. The Index of Disadvantage is a continuous score, and is
based upon characteristics such as low income, lower level of education, high
unemployment, and unskilled jobs. It has been standardised to a mean of 1000, and a
standard deviation of 100 across all collection districts in Australia, ie, 95% of scores
are between 800 and 1200. Higher scores indicate higher socio-economic status (SES)
and least disadvantage. For categorical analysis, the scores were grouped into
quartiles: Highest disadvantage (680-835), high-mid disadvantage (836-960), low-mid
disadvantage (961-988) and least disadvantage (989-1103).
Birth weight was provided by the parent/carer by recall or from the child's health record.
Height was measured in stocking feet to the nearest 0.1 cm with a SECA 220 telescopic
portable stadiometer C7 ) that was calibrated between screening visits. Weight was
measured in stocking feet and in school uniform on digital scales to the nearest 0.01 kg.
Body surface area (BSA), body mass index (BMI), height and weight standard deviation
z-scores were calculated using an age and sex-adjusted program CB). Blood pressure
was measured on the right arm with the child sitting, using an aneroid
sphygmomanometer and the largest cuff to encircle the arm and cover at least three-
quarters of the length of the upper arm C9). In children less than 13 years, diastolic
pressure was measured at the point of muffling (Korotkov 4). For older children the point
of disappearance was used (Korotkov 5) eo). For children with diastolic and/or systolic
blood pressure greater than the 90th centile for age and sex, two further blood pressures
were recorded after resting the child, and the lowest blood pressure according to the
systolic reading was recorded in mmHg el ).
Data analysis: Proportions of CKD markers (haematuria, proteinuria and albuminuria)
and associated risk factors (age, gender, birth weight, systolic and diastolic blood
pressure, height standard deviation (SD), weight SD, body mass index SD, and
category of isolation, disadvantage and region) were compared between Aboriginal and
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non-Aboriginal groups using the chi-squared or Fisher's exact test. The Mantel
extension test was used to determine linear trends across categories and quartiles.
Odds ratios for markers of chronic kidney disease by isolation category, disadvantage
category and region were determined using logistic regression, with 95% confidence
intervals. Analyses were adjusted for age, gender, diastolic and systolic blood pressure,
height SO, weight SO, body mass index SO and categories of isolation, disadvantage
and region. Where appropriate, analyses were then further adjusted for Aboriginal race.
Adjustment was made in all analyses for the effect of cluster sampling by school.
The Hosmer and Lemeshow test for goodness of fit was applied in the multivariate
models. Tests for interactions between race, gender, age, categories of isolation,
disadvantage and region and other significant variables in the final model were
performed. Significance was set at a p-value of <0.05 for main effects and for
interactions. Statistical analysis was completed using SAS e2) and SPSS software e3).
We planned to collect data from 1000 Aboriginal and 1000 non-Aboriginal children
which was sufficient to detect differences in prevalence of markers of CKO between the
two groups of 2.9 versus 1.1 %, 4.0 versus 1.8%, 5.5 versus 2.9% at 80% power for
haematuria, proteinuria and albuminuria respectively.
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3.4: Results
Baseline characteristics (table 3.4.1) From February 2001 to June 2004,2266 children
were enrolled from 37 primary schools across New South Wales. There were 1248
(55.1 %) Aboriginal and 1018 (44.9%) non-Aboriginal children, 51 % were male, and the
mean age was 8.9 years. There were proportionally more Aboriginal children in the
youngest age group (4-6 years), in the lowest weight SD quartile (both p<0.0001) and in
the lowest systolic (p<0.0001) and diastolic blood pressure quartiles (p=0.02).
Aboriginal children were more likely to live within the categories of highest isolation and
disadvantage, and in the most remote region (p<0.0001). There were no differences
between the groups for sex, birth weight, height SD and body mass index SD quartiles.
Design effect estimates for the impact of cluster sampling by school were small for all
markers of CKD: 1.10 for haematuria, 1.20 for proteinuria and 1.28 for albuminuria.
Prevalence of baseline markers of CKD: (table 3.4.2) The overall prevalence of
haematuria was 5.5%, proteinuria 7.3% and albuminuria 7.3%.
Risk factors for baseline markers of CKD:
Aboriginality (table 3.4.2) Aboriginal children were more likely to have haematuria than
non-Aboriginal children, and this association was more significant after adjustment for
environmental health determinants and other covariates (adjusted OR 2.25, 95% CI
1.37-3.69, p=0.001). Even after adjustment, there were no differences in the frequency
of proteinuria (adjusted OR 0.93,95% CI 0.68-1.27, p=0.65) or albuminuria (adjusted
OR 1.37, 95% CI 0.93-2.01, p=O.11) between the Aboriginal and non-Aboriginal
children.
Geographical isolation (table 3.4.3) Children from low-mid isolation areas had a
relatively low prevalence of haematuria (unadjusted OR 0.36, 95% CI 0.18-0.71,
p=0.002) compared with the least isolated-referent category, which did not change
appreciably with adjustment, but there was no evidence of a linear trend in the
association between isolation and frequency of haematuria (trend p=0.05, non-trend p
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<0.05). There was no association between prevalence of proteinuria and isolation
category. There appeared to be an inconsistent relationship between isolation category
and frequency of albuminuria detected, with the most isolated children having the lowest
prevalence of albuminuria, especially after adjustment for race and other environmental
health determinants (race adjusted OR 0.49, 95% CI 0.26-0.90, p=0.01). There was,
however, no evidence of a linear trend between isolation and frequency of albuminuria
(trend p=0.19).
Region (table 3.4.4) No association between regional categories and markers of CKD
was found. There was an increasing trend in risk for proteinuria from urban to remote
regions (p=0.04), however deviation from trend was also significant (p<0.05).
Social disadvantage (table 3.4.5) No association between social disadvantage
categories and markers of CKD was found. There was a decreasing trend in risk for
proteinuria from least to highest disadvantage categories (p=0.004).
There were no interactions found between environmental health determinants and race,
age, gender or other covariates in any model.
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3.5: Discussion
Aboriginal children are no more likely to have early urinary markers of CKD than non-
Aboriginal children, except for haematuria, and we were unable to show any consistent
clear association between proposed environmental determinants of health - social
disadvantage and isolation - and risk of early CKD. Race is often used incorrectly as a
proxy for many risk factors in health that are indicators of disadvantage, including
geographical remoteness and socioeconomic status e4 ). We measured all these
potential risk factors in our study and have shown that neither racial nor environmental
risk factors appear predictive of early chronic kidney disease. This is the first study
designed to differentiate the relative contributions of race and environmental health
determinants on early markers of CKD.
Our results are surprising, as we expected to find an increased prevalence of CKD,
especially albuminuria, in Aboriginal children and particularly in remote communities.
This hypothesis is largely based on studies of adult Aboriginal people. In remote
Aboriginal communities in the Northern Territory of Australia, where the incidence of
ESKD is the highest in Australia and the world (1000-2500 cases per million population
annually), microalbuminuria and overt albuminuria in Aboriginal adults are highly
prevalent (23% and 30% respectively). Over 1-8 years follow-up, albuminuria was
strongly predictive of chronic kidney disease, although this association was not followed
from childhood (10). The current prevalence of albuminuria (ACR > 3.4 mglmmol) in
those aged 5-19 years from this community is 7.6%, similar to the rate seen in our
Aboriginal (8.1 %) and non-Aboriginal participants (6.5%) es). However the lack of non-
Aboriginal control groups and the socioeconomic similarities in these remote settings
forces a presumption of race as the major contributor. This study has found no
significant differences in albuminuria or proteinuria between Aboriginal and non-
Aboriginal children across New South Wales, even when controlling for levels of
isolation, disadvantage and region. From a sociodemographic perspective, when
compared with lower risk determinants, areas of remoteness, high isolation and high
disadvantage carried no increased risk for CKD in this cohort.
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The higher prevalence of haematuria in the Aboriginal children, which was even more
significantly associated with race after adjustment for environmental confounders, has
been noted in other Indigenous populations. An excess of haematuria has been found in
Aboriginal children from remote communities with high rates of post-infectious
glomerulonephritis e6). In a population of Aboriginal children aged 5-19 years screened
from remote Northern Territory communities, the rate of asymptomatic haematuria
(7.7%) was similar to that in our Aboriginal cohort (7.1 %) (25). In non-diabetic
Indigenous adults a higher prevalence of haematuria has been associated with familial
factors e7) eel, mesangioproliferative glomerulonephritis e9) and IgA nephropathy (30).
In Aboriginal children with haematuria, ESKD outcomes have not yet been
demonstrated e') and prospective studies are needed. A two-fold increased risk of
haematuria in our Aboriginal cohort does not explain the almost nine-fold greater risk for
ESKD in Aboriginal Australians when compared to non-Aboriginal Australians.
What are the possible reasons in this study for the lack of differentiation in risk for CKD
between Aboriginal and non-Aboriginal children from sociodemographically diverse
environments? The study had an adequate sample size; even with larger numbers any
increase in risk would be small. The precision in risk for albuminuria is already narrowly
defined, with the upper limit of any 95% confidence interval being 2.3. Cluster sampling
bias appeared minimal and adjustment for this bias made little difference to the
summary estimates.
Measurement of the main predictors of risk (Aboriginal status and categories of
isolation, disadvantage and region) was performed using standardised systems (11)
(14) (16). There is no easy solution to the misclassification bias introduced when
spatially-aggregated measures are applied to individual data, and there is no method
available to identify and measure ecological bias. These standards, however, have
been used reliably in geographically and ethnically-similar population-based samples (8)
e2). High levels of disadvantage in some areas of lowest isolation demonstrate the
disparities between environmental determinants of health (33), emphasising the
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importance of using more than one measure, across urban to very remote regions as
we have done.
It is unlikely there was error in recording the outcome, as measurement of proteinuria
was performed using both standard machine dipstick analysis, but confirmed with a
more precise albumin:creatinine (ACR). Early morning protein:creatinine correlates well
with 24 hour urinary protein in children with normal renal function (34). Spot ACR has
been shown to have very good receiver operator characteristic curves for detecting
pathological albuminuria at the cut-off used in this study (35). Unfortunately, the test
performance for proteinuria screening tests in low prevalence populations has not been
validated. Semi-quantitative, one-off estimations of urinary protein in children vary
according to posture, exercise, illness and time of day (34), and repeat testing to
demonstrate persistent markers is likely to be of more importance. We look forward to
reporting the results of prospective testing over six years in this cohort.
Have we misclassified or omitted outcome measures for early CKD? Proteinuria was
found to be the strongest risk factor for ESKD in the largest community-based study of
mass screening, with an adjusted relative risk of 14.9 e6 ). With regards to recording
other possible outcomes, measuring creatinine or glomerular filtration rate in a healthy
paediatric sample is unlikely to be helpful in determining risk for CKD. Renal ultrasound
added little to the evaluation of high risk Aboriginal children and adults with
asymptomatic proteinuria or haematuria (25).
This study indicates that within NSW, there is no increased risk of early CKD in healthy
primary school-aged Aboriginal children when compared to non-Aboriginal children. In
addition, environmental determinants of health are not associated risk factors for CKD in
these children. Our findings suggest whilst the causal pathways for end-stage kidney
disease in Aboriginal people may exist in childhood or earlier, an increased risk for CKD
is not yet apparent. Therefore, preventative measures addressing and lifestyle factors
such as smoking, obesity, diet and alcohol abuse in Aboriginal children and young
adults are likely to make a significant impact on CKD development e7 ).
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Longitudinal data are currently being collected on this cohort, and will provide unique
and valuable information on the natural history of chronic kidney disease in Aboriginal
and non-Aboriginal children across different levels of sociodemographic risk.
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Table 3.4.1: Baseline sociodemographic and clinical characteristics
Variable AU Aboriginal Non-Aboriginal p
snbjects % % %
n = 2266 n=1248 n=IOI8
Gender
Male 1155 51.0 634 50.8 521 51.2 0.86
Female 1111 49.0 614 49.2 497 48.8
Age gronps (years)
4-5.9 211 9.3 142 11.3 69 6.8 <0.0001
6-6.9 281 12.4 170 13.6 III 10.9
7-7.9 329 14.5 189 15.2 140 13.7
8-8.9 337 14.9 185 14.8 152 14.9
9-9.9 351 15.5 168 13.5 183 18.0
10-10.9 361 15.9 172 13.8 189 18.6
11-14.8 396 17.5 222 17.8 174 17.1
Birth weight qnartiles (g)*
412-2920 217 25.7 119 29.6 98 22.1 0.08
2921-3316 210 24.9 92 23.1 118 26.4
3317-3685 210 24.9 98 24.4 112 25.3
3686-5272 208 24.6 92 22.9 116 26.2
Height SO qnartiles*
-4.8 to -0.7 563 25.1 334 26.9 229 22.8 0.12
-0.8 to 0.1 564 25.1 306 24.6 258 25.7
0.2 to 1.0 558 24.8 305 24.7 253 25.0
1.1 to 4.8 562 25.0 295 23.8 267 26.6
Weight SO quartiles*
-6.6 to -0.5 560 24.9 351 28.3 209 20.8 <0.0001
-0.4 to 0.3 560 24.9 301 24.3 259 25.7
0.4 to 1.2 567 25.2 269 21.7 298 29.7
1.3 to 13.3 559 24.9 319 25.7 240 23.9
BMI SO quartiles*
-4.8 to -0.8 560 24.9 333 26.9 227 22.5 0.08
-0.7 to 0.1 562 25.0 298 24.0 264 26.3
0.2 to 0.7 566 25.2 298 24.0 268 26.7
0.8 to 6.9 558 24.8 311 25.1 247 24.6
Isolation category (ARIA score)
Least isolation (0-1.1) 610 26.9 323 25.9 287 28.2 <0.0001
Low-mid isolation (1.2-2.4) 639 28.2 340 27.2 299 29.4
High-mid isolation (2.5-4.9) 521 23.0 242 19.4 279 27.4
Highest isolation (5.0-14.0) 496 21.9 343 27.5 153 15.0
Disadvantage category (SEIFA score)
Least disadvantage (989-1103) 548 24.2 273 21.9 275 27.0 <0.0001
Low-mid disadvantage (960-988) 585 25.8 287 23.0 298 29.3
High-mid disadvantage (836-960) 576 25.4 334 26.8 242 23.8
Highest disadvantage (680-835) 557 24.6 354 28.4 203 19.9
Region
Urban 370 16.3 201 16.1 169 16.6 <0.0001
South coast 364 16.1 192 15.4 172 16.9
North coast 497 21.9 260 20.8 237 23.3
Rural 599 26.4 304 24.4 295 29.0
Remote 436 19.2 291 23.3 145 14.2
Abbreviations: ARIA++, Accessibility and Remoteness Index of Australia; BMI, body mass index; BP, blood
pressure; SD, standard deviation; SElFA, Socio-Economic Indexes For Areas.
*Indicates where data does not total 2266.
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Table 3.4.1 cont: Baseline sociodemographic and clinical characteristics
Variable AIl Aboriginal Non-Aboriginal p
snbjects % % %
n = 2266 n~1248 n~1018
Systolic BP quartiles (mmHg)*
62-92 562 25.1 347 28.2 215 21.4 <0.0001
93-100 608 27.2 328 26.6 280 27.9
101-108 542 24.2 266 21.6 276 27.5
109-170 525 23.5 291 23.6 234 23.3
Diastolic BP quartiles (mmHg)*
28-53 522 23.2 316 25.6 206 20.5 0.02
54-58 618 27.6 344 27.9 274 27.3
59-64 585 26.2 303 24.6 282 28.1
65-98 512 22.9 269 21.8 243 24.2
Abbreviations: ARlA++, Accessibility and Remoteness Index of Australia; BMI, body mass index; BP, blood
pressure; SD, standard deviation; SElFA, Socia-Economic Indexes For Areas.
*Indicates where data does not total 2266.
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Table 3.4.2: Prevalence of baseline chronic kidney disease markers in Aboriginal and non-Aboriginal
children
Overall Non-Aboriginal Aboriginal p
(referent category)
Hematuria
Events (%) 122 (5.5) 36 (3.6) 86 (7.1)
Unadjusted OR 1.00 2.02 (1.30-3.13) 0.002
Adjusted OR " 1.00 2.25 (1.37-3.69) 0.001
Proteinuria
Events (%) 161 (7.3) 75 (7.6) 86 (7.0)
Unadjusted OR 1.00 0.93 (0.65-1.32) 0.67
Adjusted OR' 1.00 0.93 (0.68-1.27) 0.65
Albuminuria (ACR mg/mmol)
Events (%) 157 (7.3) 63 (6.5) 94 (8.1)
Unadjusted OR 1.00 1.27 (0.87-1.84) 0.22
Adjusted OR' 1.00 1.37 (0.93-2.01) 0.11
0/Adjusted for age, gender, birth weight, height SD, weight SD, BMI SD, systolic BP, diastolic
BP, isolation category, disadvantage category and region.
Definitions: Hematuria 2: 25 RBC per HPF (I +); proteinuria 2: 0.30 giL (I+); albuminuria,
albumin:creatinine (ACR) 2: 3.4 mg/mmol.
Abbreviations: ACR, albumin:creatinine; BMI, body mass index; BP, blood pressure; SD,
standard deviation.
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Table 3.4.3: Association between baseline chronic kidney disease markers and geographical
isolation
Lowest Low-mid High-mid Highest Trend
isolation isolation isolation isolation p
(referent
category)
Hematuria
Events (%) 34 (5.7) 15 (2.4) 40 (7.9) 33 (6.8)
Unadjusted OR 1.00 0.36 (0.18-0.71) 1.26 (0.75-2.10) 1.07 (0.49-2.37) 0.05-
Adjusted OR 0/ 1.00 0.31 (0.14-0.66) 1.26 (0.73-2.16) 0.99 (0.46-2.16)
Race adjusted OR' 1.00 0.29 (0.13-0.63) 1.31 (0.77-2.23) 0.84 (0.38-1.85)
Proteinuria
Events (%) 41 (6.9) 58 (9.3) 28 (5.5) 34 (7.0)
Unadjusted OR 1.00 1.78 (0.89-3.59) 0.96 (0.46-2.00) 1.24 (0.58-2.62) 0.48-
Adjusted OR 0/ 1.00 1.62 (0.78-3.39) 0.99 (0.46-2.14) 1.16 (0.53-2.55)
Race adjusted OR ' 1.00 1.63 (0.78-3.42) 0.99 (0.46-2.13) 1.17 (0.54-2.57)
Albuminuria
Events (%) 45 (7.9) 47 (7.5) 42 (8.3) 23 (5.2)
Unadjusted OR 1.00 0.82 (0.48-1.40) 0.96 (0.62-1.50) 0.59 (0.27-1.27) 0.19
Adjusted OR 0/ 1.00 0.63 (0.35-1.13) 0.87 (0.58-1.31) 0.52 (0.28-0.97)
Race adjusted OR ' 1.00 0.62 (0.35-1.11) 0.88 (0.59-1.32) 0.49 (0.26-0.90)
-Non-trend p<0.05
WAdjusted for age, gender, height SD, weight SD, BM! SD, systolic BP, diastolic BP,
disadvantage category and region.
~Adjusted for race, age, gender, height SD, weight SD, BM! SD, systolic BP, diastolic BP,
disadvantage category and region.
Definitions: Hematuria 2: 25 RBC per HPF (1 +); proteinuria 2: 0.30 giL (1+); albuminuria,
albumin:creatinine (ACR) 2: 3.4 mg/mmol.
Abbreviations: ACR, albumin:creatinine; BM!, body mass index; BP, blood pressure; SD,
standard deviation.
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Table 3.4.4. Association between baseline chronic kidney disease markers and region
Urban Coastal Rural Remote Trend
(referent p
category)
Hematuria
Events (%) 26 (7.3) 41 (4.8) 29 (4.9) 26 (6.2)
Unadjusted OR 1.00 0.64 (0.34-1.22) 0.66 (0.29-1.49) 0.83 (0.35-1.95) 0.68
Adjusted OR ' 1.00 0.67 (0.32-1.42) 0.56 (0.24-1.30) 1.02 (0.41-2.58)
Race adjusted OR ' 1.00 0.66 (0.31-1.40) 0.55 (0.22-1.37) 0.89 (0.36-2.24)
Proteinuria
Events (%) 14 (3.9) 61 (7.2) 55 (9.4) 31 (7.4)
Unadjustcd OR 1.00 1.89 (0.81-4.42) 2.53 (1.06-6.05) 1.94 (0.81-4.65) 0.04'
Adjusted OR ' 1.00 2.26 (0.68-7.53) 2.03 (0.78-5.32) 2.30 (0.71-7.41)
Race adjusted OR' 1.00 2.27 (0.68-7.57) 2.04 (0.78-5.33) 2.32 (0.72-7.51)
Albuminuria
Events (%) 20(6.1) 71 (8.4) 44 (7.5) 22 (5.9)
Unadjusted OR 1.00 1.41 (0.85-2.35) 1.25 (0.75-2.10) 0.96 (0.41-2.28) 0.60
Adjusted OR ' 1.00 1.33 (0.66-2.68) 1.0! (0.60-1.72) 0.95 (0.39-2.30)
Race adjusted OR • 1.00 1.32 (0.65-2.70) 1.01 (0.59-1.73) 0.91 (0.37-2.27)
nlon-trend p<0.05
• Adjusted for age, gender, height SD, weight SD, BMI SD, systolic BP, diastolic BP, isolation
category and Disadvantage category.
"Adjusted for race, age, gender, height SD, weight SD, BMI SD, systolic BP, diastolic BP,
isolation category and Disadvantage category.
Definitions: Hematuria ~ 25 RBC per HPF (I +); proteinuria > 0.30 gIL (1 +); albuminw'ia,
albumin:creatinine (ACR) > 3.4 mg/mmo1.
Abbreviations: ACR, albumin:creatinine; BMI, body mass index; BP, blood pressure; SO,
standard deviation.
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Table 3.4.5: Association between baseline chronic kidney disease markers and social
disadvantage
Least Low-mid High-mid Highest Trend
disadvantage disadvantage disadvantage disadvantage p
(referent
category)
Hematuria
Events (%) 32 (6.0) 25 (4.4) 32 (5.7) 33 (6.0)
Unadjusted OR 1.00 0.73 (0.28-1.91) 0.95 (0.40-2.24) 0.99 (0.47-2.12) 0.78
Adjusted OR • 1.00 0.55 (0.21-1.41) 0.82 (0.35-1.93) 0.76 (0.34-1.72)
Race adjusted OR ' 1.00 0.59 (0.22-1.57) 0.79 (0.33-1.91) 0.72 (0.30-1.73)
Proteinuria
Events (%) 53 (9.9) 43 (7.6) 34 (6.0) 31 (5.6)
Unadjusted OR 1.00 0.75 (0.41-1.39) 0.58 (0.32-1.05) 0.54 (0.27-1.06) 0.004
Adjusted OR • 1.00 0.57 (0.21-1.58) 0.53 (0.22-1.28) 0.57 (0.27-1.24)
Race adjusted 0 R • 1.00 0.57 (0.21-1.58) 0.53 (0.22-1.28) 0.58 (0.27-1.23)
Albuminuria
Eveots (%) 43 (8.1) 42 (7.5) 41 (8.2) 31 (5.6)
Unadjusted OR 1.00 0.93 (0.53-1.63) 1.02 (0.67-1.57) 0.68 (0.40-1.16) 0.18
Adjusted OR • 1.00 0.80 (0.39-1.68) 0.87 (0.46-1.65) 0.68 (0.42-1.11)
Race adjusted OR • 1.00 0.82 (0.38-1.74) 0.86 (0.45-1.66) 0.66 (0.40-1.10)
"'Adjusted for age, gender, height SO, weight SO, BMI SO, systolic BP, diastolic BP, isolation
category and region.
"Adjusted for race, age, gender, height SO, weight SO, BMI SO, systolic BP, diastolic BP,
isolation category and region.
Definitions: Hematuria > 25 RBC per HPF (1+); proteinuria > 0.30 gIL (1+); a1bwninuria,
alburnin:creatinine (ACR) > 3.4 rnglmmol.
Abbreviations: ACR, albumin:creatinine; BMI, body mass index; BP, blood pressure; SD,
standard deviation.
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4.1 : Abstract
Objective Indigenous people have a two to tenfold increased risk of premature
death from cardiovascular disease. We aimed to determine whether some key risk
factors for cardiovascular disease occur more commonly in Aboriginal than non-
Aboriginal Australian children.
Participants and Setting Children were enrolled from primary schools throughout
New South Wales, the state with the highest number of Aboriginal people.
Exposures and Outcome Measures Associations between ethnicity, gender, birth
weight, socio-demographic status and hypertension, obesity, baseline and persistent
albuminuria were determined.
Results 2266 children (55% Aboriginal) were enrolled. Mean age was 8.9 years C±
3.8 years). Obesity (body mass index.?: 2 standard deviations) was detected in 7.1 %,
systolic hypertension (blood pressure >901h percentile) in 7.2%, diastolic
hypertension in 5.9%, baseline albuminuria (albumin:creatinine .?: 3.4 mg/mmol) in
7.3%, and persistent albuminuria in 1.5% with no differences between Aboriginal and
non-Aboriginal children. Hypertension was less common with increasing social
disadvantage (trend p<O.02). Increasing 8MI SD was strongly associated with
systolic and diastolic hypertension (both p<O.0001).
Conclusions Many risk factors for cardiovascular disease are already common in
young children, but not more prevalent in Aboriginal than non-Aboriginal children. In
all children, overweight and obesity have the strongest association with hypertension
but social disadvantage appears protective for hypertension. Our findings suggest
that risk for cardiovascular health disparities seen in Indigenous adults manifests
beyond childhood, and that a window of opportunity exists to prevent some of these
outcomes.
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4.2: Introduction
Cardiovascular disease is the leading cause of premature death in Indigenous
people world-wide, and there is an increasing disparity in rates of cardiovascular
deaths between Indigenous and white populations that is pronounced by middle age.
Recent data for American Indian and Alaskan Natives shows the cardiovascular
death rate in 45-55 year olds is twice that of US whites with a 4.1 % annual increase,
compared with a 1.7% annual decrease in whites (\ By age 40, Aboriginal
Australians are 1°times more likely to die of ischaemic heart disease compared with
non-Aboriginal Australians e).
The causal pathways to these health disparities are poorly researched, and are likely
to be multi-determinant, due to differences in physiological and socio-economic risk
factors. Overall rates of obesity and hypertension in American Indian and Alaskan
Native adults are higher than US whites, and the disparity widens with age e).
Australian Aboriginals more than 15 years of age are 1.5 times more likely to be
overweight or hypertensive (4). Diabetes prevalence is twice the national rate in
American Indians and Alaskan Natives, and more than four times the national rate in
remote Aboriginal Australians (3) (5). Albuminuria presents early as part of the
metabolic syndrome complex in Aboriginal Australians and Native Americans (6) n,
and it robustly predicts cardiovascular morbidity and death (6). This increased
burden of risk factors found in Indigenous adults contributes to the widening gap in
cardiovascular health outcomes between Indigenous and non-Indigenous people,
and a tendency for disease at a much younger age (7) (7). The social and
environmental inequalities that Indigenous people are born and raised with, such as
the lack of access to healthcare, inadequate healthcare delivery and social
disadvantage, are also likely to contribute to these outcomes (8).
There are no popUlation-based studies in ethnically and socio-economically diverse
children evaluating the early prevalence of risk factors for cardiovascular disease.
This study aims to determine whether established risk factors for cardiovascular
disease (obesity, hypertension and albuminuria) are more prevalent in Aboriginal
than non-Aboriginal Australian children, and whether these risk factors are
associated with physiological determinants of ethnicity, gender and birth weight, and
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environmental health determinants of geographical isolation and social
disadvantage.
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4.3: Methods
Selection of participants Government-run primary schools were selected from urban,
coastal, rural and remote locations known for their high Aboriginal population across
the state of New South Wales. This state has the highest proportion of Aboriginal
people. To maximise power, sampling was done to obtain equal numbers of
Aboriginal and non-Aboriginal children, and in similar proportions from urban,
coastal, rural and remote areas. All primary schools in remote communities were
approached, and other areas were sampled if greater than twenty Aboriginal children
in the relevant age range attended.
Aboriginal status was determined using the Australian Bureau of Statistics best
practice recommendations, asking the Standard Indigenous Question on the consent
form "Is your child of Aboriginal or Torres Strait Islander origin?" (9). All Aboriginal
children in the participating primary schools were offered measurement of height,
weight, blood pressure and urinary dipstick abnormalities. We aimed to recruit equal
numbers of boys and girls, Aboriginal and non-Aboriginal children, and
approximately equal numbers of children from each 12 month age group.
Aboriginal community engagement Consultation with local Aboriginal Medical
Services and consent from community leaders was undertaken prior to
commencement of the study. Approval was obtained from the Ethics Committees of
the Children's Hospital at Westmead, the University of Sydney, New South Wales
Area Health Services and the New South Wales Department of Education and
Training. Informed consent was obtained for each child in accordance with NHMRC
Guidelines for Ethical Conduct in Aboriginal and Torres Strait Islander Research Co).
Data was collected onto a standardised form and de-identified for storage and
analysis before being returned to each community after the study visit. Permission to
publish data was also obtained from each community.
Measurement of birth weight, growth parameters and blood pressure Birth weight
was provided by the parent/carer by recall or from the child's health record. Height
was measured in stocking feet to the nearest 0.1 cm with a SECA 220 telescopic
portable stadiometer Cl ) that was calibrated between screening visits. Weight was
measured in stocking feet and in school uniform on digital scales to the nearest 0.01
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kg. Body mass index (BMI), height and weight standard deviation z-scores (SO)
were calculated using an age and gender adjusted program based upon international
normative data C2). Blood pressure was measured on the right arm with the child
sitting, using an aneroid sphygmomanometer and the largest cuff to encircle the arm
and cover at least three-quarters of the length of the upper arm C3). In children less
than 13 years, diastolic pressure was measured at the point of muffling (Korotkoff 4).
For older children the point of disappearance was used (Korotkoff 5) C4). For
children with diastolic and/or systolic blood pressure greater than the 90th percentile
for age and gender (using normative data from Australian children, including
Aboriginal children), two further blood pressures were recorded after resting the
child, and the lowest blood pressure according to the systolic reading was recorded
in mmHg C5).
Measurement of albuminuria A morning clean catch specimen of urine was collected
from each child, with dipstick analysis for albuminuria performed at the survey site on
fresh specimens using a Bayer Clinitek 50 machine and Albustix dipsticks C6).
Leukocytes and nitrites were also recorded for later adjustment for abnormalities of
presumed urinary tract infection. Girls older than eight years who were found to have
haematuria were questioned about menses, and if appropriate, collection was
performed at another time. Because albuminuria is often transient, follow-up
urinalysis was performed two years after baseline testing on all available children
and the frequency of persistent albuminuria (albuminuria detected at baseline and
follow-up) and non-persistent or transient albuminuria (albuminuria detected at either
baseline or follow-up) was also ascertained.
Measurement of environmental health determinants Standardisation of urban,
coastal, rural and remote locality was made using the Accessibility and Remoteness
Index of Australia (ARIA++), with each subject given an index score according to
their postcode of residence C7). Using geographical information system (GIS)
capabilities, distances, services and population density for each locality are
converted to a continuous variable with values ranging from zero for high
accessibility, to 18 for extreme remoteness C8). ARIA++ values for this NSW study
ranged from 0 to 14, and for categorical analysis the scores were grouped into
quartiles. Isolation categories (and ARIA++ score range) used were: Least isolation
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(0-1.1), low-mid isolation (1.2-2.4), high-mid isolation (2.5-4.9) and highest isolation
(5.0-14.0).
To determine the level of social and economic well being of areas studied, the Socio-
Economic Indexes for Areas 2001 C9) Index of Disadvantage was applied to subjects
at the level of collection district of residence. This is the smallest geographic area for
which the Index is available, and includes approximately 200 households. The Index
of Disadvantage is a continuous score, and is based upon characteristics such as
low income, lower level of education, high unemployment, and unskilled jobs. It has
been standardised to a mean of 1000 and a standard deviation of 100 across all
collection districts in Australia, ie, 95% of scores are between 800 and 1200. Higher
scores indicate higher socio-economic status (SES) and least disadvantage. For
categorical analysis the scores were grouped into quartiles: Highest disadvantage
(680-835), high-mid disadvantage (836-960), low-mid disadvantage (961-988) and
least disadvantage (989-1103).
Data analysis Cardiovascular risk factors considered were systolic and diastolic
hypertension (blood pressure greater than the 90th percentile for age and gender),
obesity (8MI SD greater than or equal to 2), albuminuria at baseline
(albumin:creatinine, ACR, greater than or equal to 3.4 mg/mmol) and persistent
albuminuria (albuminuria at both baseline and at 2 year follow-up). Potential
predictors of cardiovascular risk factors were Aboriginal status, female gender, low
birth weight (less than or equal to 2500g), higher isolation categories (ARIA score
1.2-14.0) and higher disadvantage categories (SEIFA score 680 to 988). Categories
of gender, age group, systolic and diastolic blood pressure percentiles, isolation and
disadvantage, quartiles of birth weight, height SD, weight SD, body mass index SD
and cardiovascular risk factors were compared between Aboriginal and non-
Aboriginal groups using the chi-squared test. The association between predictors
and cardiovascular risk factors was determined using odds ratios and 95%
confidence intervals with the presumed lowest risk category of predictor as the
referent group. Logistic regression was used to adjust for differences in ethnicity,
age, gender, diastolic and systolic blood pressure, body mass index SD and
categories of isolation and disadvantage. The Mantel extension test was used to
determine linear trends across categories and quartiles. Adjustment was made in all
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analyses for the effect of cluster sampling by school. Tests for interactions between
ethnicity, gender, age, categories of isolation and disadvantage and other significant
variables in the final model were performed. Significance was set at a p-value of
<0.05. Statistical analysis was completed using SAS (20) and SPSS software el ).
With data collection planned from1000 Aboriginal and 1000 non-Aboriginal children,
the study was adequately powered to detect differences in prevalence of
albuminuria, hypertension and obesity between the two groups of 5.5 versus 2.9%,
12.0 versus 10.0% and 9.0 versus 7.0% given a two-tailed significance of less than
0.05.
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4.4: Results
Baseline characteristics (table 4.4.1) From February 2002 to June 2004,2266
children were enrolled from 37 primary schools across New South Wales. There
were 1248 (55.1 %) Aboriginal and 1018 (44.9%) non-Aboriginal children, 51 % were
male, and the mean age was 8.9 years (± 3.8 years). There were proportionally more
Aboriginal children in the youngest age group (4 to 6 years), in the lowest weight SO
quartile, in the most isolated area and in the most disadvantaged category (all
p<0.0001). There were no differences between the groups for gender, birth weight,
height SO, body mass index SO quartiles, and blood pressure percentile categories.
At two year follow-up there were 1334 children available for urinalyses. Twenty
children (1.5%) had persistent albuminuria, and 157 children (11.8%) had transient
albuminuria (albuminuria at either baseline or at follow-up).
Prevalence of cardiovascular risk factors The observed frequencies of outcomes of
interest were systolic hypertension (7.2%), diastolic hypertension (5.9%), obesity
(7.1 %), baseline albuminuria (7.3%) and persistent albuminuria (1.5%).
Physiological predictors of cardiovascular risk factors (table 4.4.2) Aboriginal
children were no more likely to have cardiovascular risk factors than non-Aboriginal
children. At baseline testing, female children were at higher risk of albuminuria
compared with male children (adjusted OR 1.81, 95 % CI 1.46-2.15, p=0.001). There
were no differences in rates of persistent and transient albuminuria between males
and females (l2.12, p=0.15), nor between Aboriginal and non-Aboriginal children
(l 0.15, p=0.70). When compared with higher birth weight, low birth weight was not
associated with any cardiovascular risk factor. None of these physiological
determinants were associated with obesity or hypertension.
Environmental predictors of cardiovascular risk factors (table 4.4.2) There was a
trend for higher risk of systolic and diastolic hypertension in less disadvantaged
children (trend p=0.01 and 0.02 respectively). There were no significant trends
across isolation categories for any cardiovascular risk factor. None of these
environmental determinants were associated with albuminuria or obesity.
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Association between cardiovascular risk factors (table 4.4.3) Increasing systolic
blood pressure centiles were associated with diastolic hypertension, and increasing
diastolic blood pressure centiles were associated with systolic hypertension (both
trend p< 0.0001 ).There was a strong association between increasing BMI SO and
risk of systolic and diastolic hypertension (both trend p<0.0001). Compared with
children in the lowest BMI SO quartile, the adjusted risk of systolic and diastolic
hypertension for children in the highest BMI SO quartile was 12.37 (6.17-24.78) and
5.05 (2.74-9.32) respectively, both p<0.0001. Conversely, higher systolic and
diastolic blood pressure centiles were strongly associated with obesity (both trend p
< 0.0001). There was a trend for lower risk of albuminuria in children with higher BMI
SO (trend p=0.005). Compared with children in the lowest BMI SO quartile, the
adjusted risk of albuminuria for children in the highest BMI SO quartile was 0.51
(0.32-0.82), p=0.001.
There were no interactions found between ethnicity, age, gender, isolation and
disadvantage categories, or other covariates in any model.
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4.5: Discussion
Aboriginal children in New South Wales have no increased prevalence of traditional
cardiovascular risk factors (hypertension, albuminuria and obesity) when compared
with non-Aboriginal children. Ethnicity is prone to misuse as a proxy of disadvantage
e2)(23), though it is likely the socio-demographic factors associated with being
Aboriginal contribute cumulatively to the poor cardiovascular health of Aboriginal
adults. Such factors include lower income and education levels, geographic isolation,
limited access to health care and diseconomies of scale due to sparsely distributed
populations (24). This is one of the few studies that differentiate the contributions of
ethnicity and environmental health determinants towards risk of cardiovascular
disease in children. We have found that ethnicity is not associated with increased
cardiovascular risk, even after adjustment for differences in socio-demographic
status.
The lack of non-Indigenous control groups and the socio-economic similarities in
studies of Indigenous adults from non-population-based, remote community settings
forces the presumption that Indigenous status is the major contributor of disease e5).
However, in Aboriginal communities with the highest rates of cardiovascular death in
Australia es), a similar prevalence of albuminuria to our study findings has been
found on cross-sectional testing of the children. The frequency of albuminuria
(ACR>3.4 mglmmol) in those aged 5-19 years from such communities was 7.6%.
which is not different to the baseline rate seen in our Aboriginal (8.1 %) and non-
Aboriginal (6.5%) children. Accepting that much of this albuminuria is likely to be only
transient ell, at two-year follow-up we found no significant differences in transient or
persistent albuminuria between Aboriginal and non-Aboriginal children.
Study design issues are unlikely to explain the reasons for a lack of differentiation in
risk for cardiovascular disease between Aboriginal and non-Aboriginal children from
socio-demographically diverse environments. The study was adequately powered in
terms of sample size for the cardiovascular risk factors. Adjustment for cluster
sampling bias made little difference to the summary estimates. Measurement of the
ethnic and environmental predictors of risk was performed using standardised
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systems (9)(17)(19). We accept that unmeasured confounding from individual-level
socio-economic factors remains as a study bias. With further data collection, multi-
level analyses could be used to identify, measure and correct for ecological bias
when spatially-aggregated measures are applied to individual data e8). The
standards used in this study, however, have been applied reliably in geographically
and ethnically similar samples (29) eo). Parentally recalled birth weight has been
shown as a reliable proxy for recorded birth weight in population-based research e1)
e2 ).
It is unlikely there was error in recording the outcomes. Blood pressure was
measured using appropriate cuff sizes, particularly for obese and older children, and
repeat measures were performed in hypertensive children. Spot ACR has been
shown to have good receiver operator characteristic curves for detecting pathological
albuminuria at the cut-off used in this study e3). Obesity was determined using BMI
standard deviations, which has been validated for use in this age group of children
(34). Overall prevalence of obesity of 7.1 % in our cohort is comparable to 6% for
Australian children es). Waist circumference has been shown to be more predictive
of cardiovascular risk in Indigenous adults e\ and measurement of outcomes such
as central obesity, blood lipid, glucose, HbA1C and insulin levels would have been
desirable for evidence of metabolic syndrome e7 ). Measuring all possible
cardiovascular risk factors was beyond the practicalities of such a large school-
based screening study, and painful or embarrassing procedures would have been
counter-productive to the current success of our follow-up recruitment rates.
Overweight and obesity were most significantly associated with hypertension.
Without early intervention, these obese and hypertensive pre-pubertal children are at
high risk for diabetes and cardiovascular disease in adulthood, and they are likely to
have shorter life expectancies than their parents (38) e9). The increasing risk for
hypertension in socially advantaged children seems contradictory to other studies
(40) (41). Our study sampled children where Aboriginal populations reside, in areas of
the lowest socio-economic status (42). The highest SES quartile in our cohort
(indicating lesser disadvantage) correlates with mid-range SES categories in other
comparative studies (43) (44). Our findings are consistent with these studies that show
the prevalence of disease risk factors follow a bell shaped curve across different
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socio-economic environments. Lowest risk occurs at either extreme of socio-
economic status and highest risk in mid-range SES categories (43)(44).
Female children were found to be at increased risk of albuminuria at baseline, even
after adjustment for presumed urinary tract infection, and testing menstruating
females at another time. Transient proteinuria is a common cause of albuminuria in
this age group (27), and most of the albuminuria found in these children was
transient. At two year follow-up there was no difference in rates of persistent and
transient albuminuria between males and females.
Low birth weight was not associated with any cardiovascular disease risk factor. Low
birth weight has been associated with higher risk of hypertension in children from
observational studies with well and poorly defined study bases (45) (46). A systematic
review of 55 studies showed that birth weight had little association to blood pressure
levels in later life. Being currently overweight had a much more relevant and
significant association with hypertension (46), as we have shown in our study.
Microalbuminuria is an established marker with obesity as part of the metabolic
syndrome in adults (37), however our finding that children in higher BMI SO quartiles
have no increased risk for albuminuria is not novel, and has been found even in
children with insulin resistance (47). Measurement error may also contribute to a
spurious increase in risk for albuminuria in underweight children. An overestimation
of microalbuminuria by ACR may result in these children with low muscle mass due
to a combination of normal excretion of urinary albumin with a low urinary creatinine
excretion (48). Whether albuminuria is predictive of cardiovascular disease in youth,
as it is in adults, remains to be proven.
This study indicates that within New South Wales, there is no increase in prevalence
of these risk factors for cardiovascular disease in primary school aged Aboriginal
children when compared to non-Aboriginal children. Children who are obese and
children from areas of mid-range socio-economic status are at higher risk of
developing cardiovascular disease. This suggests that some of the difference in
cardiovascular risk for Indigenous people manifests beyond childhood, and may
therefore result from broader social inequalities. It also suggests that a window of
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opportunity exists to develop strategies for all children that deal with obesity and
underlying social disparities, which in turn may prevent some of the cardiovascular
disease inequality in Aboriginal adults.
70
Chapter 4: Cardiovascular risk factors in Australian Indigenous and non-Indigenous children: a
population-based study
Table 4.4.1: Baseline characteristics
lariJble All subjects Aboriginal Non-Aboriginal p
n = 2266 % n=1248 % n=1018 %
Gonder
\lale 1155 51.0 634 50.8 521 51.2 0.86
Female I I II 49.0 614 49.2 497 48.8
Ig'groups (years)
1-5.9 211 9.3 142 11.3 69 6.8 <0.0001
'-6.9 281 12.4 170 13.6 III 10.9
-·7.9 329 14.5 189 15.2 140 13.7
-8.9 337 14.9 185 14.8 152 14.9
;-9.9 351 15.5 168 13.5 183 18.0
10-10.9 36\ 15.9 172 13.8 189 18.6
11-14.8 396 17.5 222 17.8 174 17.1
Birth weight quartiles (g)*
:12-2920 217 25.7 119 29.6 98 22.1 0.08
~21-3316 210 24.9 92 23.1 118 26.4
J317-3685 210 24.9 98 24.4 112 25.3
3686-5272 208 24.6 92 22.9 116 26.2
Rogbl SD quartiles*
~.8 10 -0.7 563 25.1 334 26.9 229 22.8 0.12
-0.8 10 0.1 564 25.1 306 24.6 258 25.7
.210 1.0 558 24.8 305 24.7 253 25.0
: 1104.8 562 25.0 295 23.8 267 26.6
~,ight SD quartiles* I
-6.6 to -0.5 560 24.9 351 28.3 209 20.8 <0.0001 I
-0.4 10 0.3 560 24.9 301 24.3 259 25.7
'4 to 1.2 567 25.2 269 21.7 298 29.7
31013.3 559 24.9 319 25.7 240 23.9
8\11 SD quartiles*
~.8 10 -0.8 560 24.9 333 26.9 227 22.5 0.08
-0.7 to 0.1 562 25.0 298 24.0 264 26.3
0.2 to 0.7 566 25.2 298 24.0 268 26.7
1.8 to 6.9 558 24.8 311 25.1 247 24.6
1..lalion category (ARIA score)
least isolation (O-l.!) 610 26.9 323 25.9 287 28.2 <0.000 I
Low-mid isolation (1.2-2.4) 639 28.2 340 27.2 299 29.4
High-mid isolalion (2.5-4.9) 521 23.0 242 19.4 279 27.4 IHighest isolation (5.0-14.0) 496 21.9 343 27.5 153 15.0
Disadvantage category (SEIFA score)
Least disadvantage (989-1103) 548 24.2 273 21.9 275 27.0 <0.0001
low-mid disadvantage (960-988) 585 25.8 287 23.0 298 29.3
High-mid disadvantage (836-959) 576 25.4 334 26.8 242 23.8
Highesl disadvantage (680-835) 557 24.6 354 28.4 203 19.9
Sl,tolic BP perceutiles*
<50th 1258 56.2 711 57.7 547 54.4 0.09
50· to 90th 817 36.5 426 34.6 391 38.9
90th 162 7.2 95 7.7 67 6.7
Ililslolic BP percenliles*
< 50th 1410 63.0 793 64.4 617 61.4 0.34
50· to 90th 696 31.2 370 30.0 326 32.4
>90th 131 5.9 69 5.6 62 6.2
Abbreviations: ARIA, Accessibility and Remoteness Index of Australia; BMI, body mass
index; BP, blood pressure; SO, standard deviation; SElfA, Socio-Economic Index For Areas.
*Indicates where data does not total 2266
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Table 4.4.2: Physiological and environmental predictors of cardiovascular risk factors
Systolic H~pertension Diastolic Hypertension Albuminuria Obesity
N (%) AORI N (%) •
• AORI
Predictor AOR' N (%) AOR- N (%)
195% Cil 195%Cn 195% CIl 195% CI)
Aboriginality
Non-Aboriginal" 67 (6.7) 1.00 62 (6.2) 1.00 63 (6.5) 1.00 63 (6.7) 1.00
Aboriginal 95 (7.7) 1.22 (0.87-1.57) 69 (5.6) 0.94 (0.57-1.31) 94 (8. I) 1.37 (0.93-2.01) 82 (7.4) 1.10 (0.76-1.44)
Gender
Male" 76 (6.7) 1.00 70(6.\) 1.00 59 (5.4) 1.00 72 (7.0) 1.00
Female 86 (7.8) 1.34 (0.99-1.69) 61 (5.6) 0.88 (0.50-1.25) 98 (9.4)
t 73 (7.2) 1.03 (0.69-1.37)1.8\(1.46-2.\5)
Birth weight
> 2500 " 100 (7.8) 1.00 80 (6.3) 1.00 94 (7.7) 1.00 86 (7.3) 1.00
< 2500g \1 (8.7) 1.1 0 (0.43-1.76) 5 (4.0) 0.63 (0.33-1.63) 6 (5.0) 0.58 (0.25-1.53) 7 (6.0) 0.77 (0.32-1.81)
Isolation
Least isolation* 34 (5.6) 1.00 19 (3. \) 1.00 45 (7.9) 1.00 44 (7.8) 1.00
Low-mid isolation 71 (\1.3) 2.20 (1.38·3.5\) 62 (9.9) 3.75 (2.14-6.55) 47 (7.5) 0.9\ (0.58-1.42) 45 (7.9) 1.01 (0.66·1.56)
High-mid isolation 25 (4.9) 0.89 (0.50·1.49) 34 (6.7) 2.24 (1.23-4.01) 42 (8.3) 1.04 (0.67-1.64) 27 (5.7) 0.70 (0.41.1.17)
Highest isolation 32 (6.5) 1.20 (0.72·1.95) \6 (3.2) 1.04 (0.52-2.06) 23 (5.2) 0.6\ (0.36-1.09) 29 (6.5) 0.83 (0.50·1.36)
Social disadvantage
Least disadvantage" 55 (10.2) 1.00 33(6.1) 1.00 43 (8.\) 1.00 34 (6.9) 1.00
,
Low-mid disadvantage 43 (7.4) 0.70 (0.46-1.10) 47 (8.\) 1.37 (0.84-2.23) 42 (7.5) 0.87 (0.66-1.37) 27 (5.0) 0.89 (0.57-1.39)
High-mid disadvantage 30 (5.3) 0.51 (0.30-0.83) 31 (5.5) 0.96 (0.59-1.54) 41 (8.2) 1.00 (0.70-1.62) 44 (8.5) \.22 (0.76-2.00)
Highest disadvantage 34 (6.2) t 20 (3.6) t 3\ (5.6) 0.70 (0.46-1.11) 40 (8.1) 1.20 (0.72-1.89)0.59 (0.35-0.95) 0.62 (0.36-1.05)
*Referent category
t Trend p < 0.05
IAdjusted for ethnicity, age, gender, body mass index, birth weight, blood pressure and categories of isolation and disadvantage.
Abbreviations: ACR, albumin:creatinine; AOR, adjusted odds ratio; ARIA, Accessibility and Remoteness Index of Australia; 8Ml, body mass index; SO, standard
deviation; SEIFA, Socio-Economic Indexes For Areas.
Definitions: Systolic hypertension, systolic blood pressure> 90th percentile; diastolic hypertension, diastolic blood pressure> 90
th
percentile; albuminuria,
albumin:creatinine (ACR) > 3.4 mglmmol; obesity, 8M! ? 2 SO; least isolation, ARIA score 0-1.1; low-mid isolation, ARIA score \ .2-2.4; high-mid isolation,
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ARIA score 2.5-4.9; highest isolation, ARIA score 5.0-14.0; least disadvantage, SEI FA score 989-1 103; low-mid disadvantage, S EI FA score 960-988; high-mid
disadvantage, SElFA score 836-959; highest disadvantage, SElFA score 680-835.
-----
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Table 4.4.3: Association between cardiovascular risk factors
'ovascular risk factors
alie BP centiles
iQlh'
';I'_90th
~
minuria (ACR mglmmol)
'.4
'.4
•
lIII SD quartiles
JS to -0.8
7to 0.1
2toO.7
.8 to 6.9
Systolic
hypertension
AOR (95% CI':
1.00
3.95 (2.65-5.87)
54.80 (34.0-88.0) t
1.00
0.61 (0.27-1.35)
1.00
2.50 (1.14-5.49)
4.26 (2.04-8.91)
12.37(6.17-24.78) t
Diastolic
hypertension
AOR (95% CI':
1.00
5.36 (3.18-9.02)
29.11 16.59-51.09) t
1.00
1.06 (0.52-2.16)
1.00
1.88 (0.95-3.74)
2.67 (1.40-5.12)
5.05 (2.74-9.32) t
Albuminuria
AOR (95% CI':
1.00
0.98 (0.70-1.38)
0.55 (0.25-1.22)
1.00
0.65 (0.44-0.95)
0.73(0.35-1.53) t
1.00
0.67 (0.44-1.04)
0.65 (0.42-1.02)
0.51 (0.32-0.82) t
Obesity
AOR (95% cn:.
1.00
3.65 (2.36-5.66)
15.41(9.32-25.49) t
1.00
3.0 I (2.05-4.43)
8.75 (5.31-14.44) t
1.00
0.45 (0.18-1.11)
-
• Referent category
t Trend p < 0.05
: Adjusted for ethnicily, age, gender, body mass index, birth weight, blood pressure and categories
of isolation, disadvantage and region.
Abbreviations: ACR, albumin:creatinine; AOR, adjusted odds ratio; BMI, body mass index; BP,
blood pressure; SO, standard deviation.
Definitions: Systolic hypertension, systolic blood pressure> 90th percentile; diastolic
hypertension, diastolic blood pressure> 90th percentile; albuminuria, albumin:creatinine (ACR)
> 3.4 mg/mmol; obesity, BMI > 2 SO.
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5.1 : Abstract
Background Albuminuria predicts cardiovascular and end-stage kidney disease in
Indigenous populations. Early detection in Indigenous children may identify those who
could benefit from early treatment. Community-based detection of albuminuria needs to
be performed using a reliable, inexpensive and widely available test, such as a
proteinuria dipstick. Dipstick accuracy for detecting albuminuria in a community setting
has not been evaluated.
Aims We assessed the accuracy of Multistix 10 SG dipsticks to detect baseline
albuminuria and predict for persistent albuminuria at two-year follow up in a population-
based cohort of Australian Aboriginal and non-Aboriginal elementary school-aged
children. Variability in the accuracy of dipsticks in subgroups of higher risk children was
analysed using the relative diagnostic odds ratio (RDOR).
Using Multistix 10 SG dipsticks, index test positive cases were defined as greater
than or equal to 0.30g/L (1+) proteinuria, and index test negative cases as less than
0.30g/L (negative or trace) proteinuria. Referent test positive cases were defined as
spot albumin:creatinine (ACR) greater than or equal to 3.4 mg/mmoL, and referent test
negative cases as ACR less than 3.4 mg/mmoL.
Results 2266 children (55.1 % Aboriginal, 51.0% male, mean age 8.9 years) were
enrolled. At two-year follow-up, 1432 (63.0%) children were retested (54.0% Aboriginal,
50.5% male, mean age 10.5 years). Prevalence of baseline albuminuria was 7.3%, and
persistent albuminuria was 1.5%. Dipsticks had a sensitivity of 62%, specificity of 97%
at baseline. In predicting persistent albuminuria, sensitivity was 75%, specificity 93%.
Accuracy did not vary with ethnicity, gender or body mass index. Accuracy was less in
younger children (4.0-7.9 years), and in those with haematuria.
Conclusions The performance characteristics of Multistix dipsticks make them suitable
for albuminuria detection in Aboriginal and other higher risk groups of children. More
than two-thirds of children detected at a single test will have transient rather than
persistent albuminuria. Multistix dipsticks are particularly useful for detecting children
who will have persistent albuminuria.
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5.2: Introduction
Morbidity and premature mortality from chronic disease are a much greater burden for
Indigenous than for non-Indigenous populations. Cardiovascular disease is the leading
cause of premature death in Indigenous people from 45 years of age, which is 20 years
earlier than in non-Indigenous populations. Death rates from cardiovascular disease in
Indigenous people are two to tenfold higher than in non-Indigenous people (\ In 2005,
there were record numbers of new cases of kidney failure patients entering dialysis or
transplant programs across the world e) (\ and Indigenous people were vastly over
represented in this group (4) (2). Indigenous Australians are, on average, eight times
more likely than non-Indigenous Australians of the same age and sex to develop end-
stage kidney disease (5). End-stage kidney disease occurs almost 10 years earlier in
Indigenous people, at a median age of 51 versus 60 years in non-Indigenous people (6).
With treatments now available to reduce the rate of progression of these chronic
diseases, health interest groups have called for governments to commence national
programs for the early identification of those at greatest risk (2) (3) () (8).
Albuminuria presents early in Indigenous populations with high background rates of
cardiovascular and kidney disease (9) CO). Even after adjustment for other traditional
risk factors, albuminuria strongly predicts all-cause mortality, cardiovascular morbidity,
cardiovascular mortality and end-stage kidney disease (8). In Australian Aboriginal
communities, an albuminuria secondary prevention program has demonstrated
significant reduction in mortality and morbidity from cardiovascular and chronic kidney
disease C\ A program aimed at early detection and monitoring of albuminuria in
Aboriginal children should provide an inexpensive, portable, point-of-care diagnostic
service given the remoteness of many Indigenous communities C2). Urine dipsticks for
spot albumin:creatinine have been shown to be accurate in diagnosing albuminuria C3),
however their cost prohibits them as a screening instrument C4 ). Inexpensive urine
dipsticks for proteinuria could serve this purpose, but there are currently no data on their
accuracy to detect albuminuria in children in community-based settings.
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The aims of our study were to evaluate the accuracy of Multistix proteinuria dipsticks for
detecting albuminuria in Aboriginal children, to determine whether accuracy varies with
subject characteristics, and to determine the predictive ability of dipsticks to identify
those children with persistent albuminuria over two years of follow-up, who are at
greatest risk of chronic disease.
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5.3: Methods
The Standards for Reporting of Diagnostic Accuracy (STARD) checklist was adopted for
the reporting of these data C\
Selection of participants: Government-run elementary schools were approached for
testing from urban, coastal, rural and remote locations across the state of New South
Wales. This state has the highest Aboriginal population in Australia C6). Non-
government schools (private and denominational) have very few Aboriginal enrolments,
and were not considered for recruitment. To maximise power and generalisability,
consecutive sampling was done to obtain equal numbers of Aboriginal and non-
Aboriginal children, males and females, and in similar proportions from urban, coastal,
rural and remote areas. All elementary schools in remote communities were
approached and other areas were sampled if greater than twenty Aboriginal children in
the relevant age range attended.
Aboriginal status was determined using the Australian Bureau of Statistics best practice
recommendations, asking the Standard Indigenous Question on the consent form "Is
your child of Aboriginal or Torres Strait Islander origin?" (16). All Aboriginal children in
the participating elementary schools were offered testing. Non-Aboriginal children were
matched for gender and age from the same class. We aimed to recruit equal numbers
of boys and girls, Aboriginal and non-Aboriginal children, and equal numbers of children
from each 12 month age group.
Approval was obtained from the Ethics Committees of the Children's Hospital at
Westmead, the University of Sydney, New South Wales Area Health Services and the
New South Wales Department of Education and Training. Informed consent was
obtained for each child and, in accordance with NHMRC Guidelines for Ethical Conduct
in Aboriginal and Torres Strait Islander Research C\ data was collected onto a
standardised form and de-identified for storage and analysis before being returned to
each community after the study visit. Permission to publish data was also obtained from
each community.
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Multistix proteinuria dipstick (index test): The Multistix-10 SG reagent dipstick costs
approximately $ US 0.80 per stick, and detects urinary protein by the protein-error-of-
indicators principle eB). At a constant pH, the development of any green colour is due to
the presence of protein. The colour is then read spectrophotometrically by the Bayer
Clinitek 50 urinalysis machine within four proteinuria categories: negativeltrace (protein
<0.30 giL), 1+ (protein 0.30 gIL), 2+ (protein 1gIL), 3+ (protein 3 gIL) and 4+ ~ 20 gIL)
C9).
Spot urine albumin:creatinine dipstick (referent test): The Clinitek dipstick detects urine
albumin and creatinine concentrations, at an approximate cost of $ US 3.80 per stick
(14). Urine albumin is measured by dye-binding of albumin with sulphonephthalein dye
resulting in a colour shift at a constant pH. This is referred to as the protein error of pH
indicators. Urine creatinine complexes with copper and the copper-creatinine complex
reacts with hydroperoxide and a dye to produce a colour change. Colour changes are
then read spectrophotometrically by the Bayer Clinitek 50 urinalysis machine as a ratio
of albumin:creatinine concentration within three categories: normallno pathological
albuminuria (ACR < 3.4 mglmmoL), microalbuminuria (ACR 3.4-33.9 mglmmoL) and
macroalbuminuria (ACR > 33.9 mglmmoL). This method has been validated as a
referent standard test for verifying albuminuria in children (20).
Sample collection and handling: All children were given verbal instructions by the study
nurse about the method of urine collection. Parent/carer assistance was provided in the
younger age group. A morning clean catch urine specimen was collected from each
child into a sterile container and analysed immediately with the index and referent tests
by the nurse at the survey site. Girls older than eight years who were found to have
haematuria were questioned about menses, and if this was present, collection was
performed at another time.
Definition of positivity: All samples were tested according to the manufacturer's
instructions by the index and referent tests at the same time point by the study nurse
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e1). A computer print-out of results at the following cut-oils was produced by the
urinalysis machine at the end of each test. Kidney Disease Outcomes Quality Initiative
(KDOQI) recommendations for cut-off values were used to define proteinuria,
albuminuria and haematuria (20). Test positive cases were defined as greater than or
equal to 0.30g/L proteinuria (Multistix dipstick 1+), and test negative cases were defined
as less than 0.30g/L proteinuria (Multistix dipstick negative or trace). Referent test
positive cases were defined as albumin:creatinine (ACR) greater than or equal to 3.4
mg/mmoL at initial testing (baseline albuminuria present), and referent test negative
cases as ACR less than 3.4 mg/mmoL at initial testing (no baseline albuminuria).
Because albuminuria can be a benign transient phenomenon in the paediatric age
group ez), we also assessed test performance of Multistix dipsticks in predicting
persistent albuminuria, with referent test positive cases classified as those children with
spot urine ACR greater than or equal to 3.4 mg/mmoL at both initial testing and two-
year follow-up. Referent test negative cases were then defined as ACR less than 3.4
mg/mmoL at both initial testing and two year follow-up, or a combination of positive and
negative tests at baseline and follow-up (none or transient albuminuria). Haematuria
was defined as greater than or equal to 25 RBC/uL (Multistix dipstick 1+) at baseline
testing, and no haematuria as less than 25 RBC/uL (Multistix dipstick negative or trace)
at baseline testing. Albuminuria in association with suspected urinary tract infection
(Ieucocytes and/or nitrites on Multistix dipstick testing), and macroalbuminuria (ACR
greater than or equal to 34 mg/mmoL) were found in less than 1% of children. These
children were included in the analyses.
Precision of the referent and index tests was assessed by the study nurse using quality
control calibration materials at each screening centre prior to testing any samples. All
positive and negative control calibrations fell within the acceptable cut-offs designated
by the manufacturer e\ based upon national and international precision goals derived
from biological variation and international concensus data on performance criteria e4)
e5).
83
Chapter 5: Diagnostic accuracy of urine dipsticks for detecting albuminuria in Indigenous and non-
Indigenous children in a community setting
Statistical Methods:
For albuminuria at baseline and for persistent albuminuria, comparisons between the
index and referent tests for the entire cohort and sub-groups were represented in two-
by-two contingency tables. Indicators of test performance derived from these tables
were sensitivity, specificity and relative diagnostic odds ratios with 95% confidence
intervals. The diagnostic odds ratio is the ratio of the odds of albuminuria in proteinuria
dipstick positives relative to the odds of albuminuria in proteinuria dipstick negatives.
The value of the diagnostic odds ratio ranges from zero to infinity, with higher values
indicating better discriminatory test performance eel. The relative diagnostic odds ratio
compares this ratio of test performance in at risk sub-groups (Aboriginal children, males,
older children, children with haematuria and normal weight and overweight! obese
children) against the presumed lower risk referent group (non-Aboriginal children,
females, younger children, children without haematuria and underweight children) with
95% confidence intervals for proportions calculated using exact binomial methods. Age
was divided into tertiles, with younger children defined as 4.0 to 7.7 years at baseline,
and 6.0 to 9.4 years at two year follow-up. Older children were defined as 7.8 to 14.8
years at baseline, and 9.5 to 15.4 at two year follow-up. Underweight was defined as
body mass index (BMI) standard deviation (SO) less than 1, overweight and obese as
BMI SO greater than 1, and normal weight as BMI SO -1 to +1 e\ Statistical analyses
were completed using SAS ee) and SPSS e9).
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5.4: Results
Participants: From February 2002 to September 2004, 2266 healthy children were
enrolled from 37 elementary schools across New South Wales, and included 1248
(55.1 %) Aboriginal children. Overall, 51.0% were male, and the mean age was 8.9
years It 2.0 years). There were proportionally more Aboriginal children in the youngest
age terti Ie (37.4% versus 28.5%, >f 20.01, 2df, P < 0.0001), with no significant
differences between Aboriginal and non-Aboriginal children for gender and BMI
categories. There were significantly more Aboriginal children with haematuria at
baseline testing compared with non-Aboriginal children (7.1 % versus 3.6%, >f 12.31,
ldf, p=0.002). A more detailed description of sUbject characteristics at baseline is
available elsewhere eO).At two-year follow-up from March 2004 to December 2006,
there were 1432 (63.0%) children available for re-testing; 773 (54.0%) were Aboriginal,
50.4% were male, and the mean age was 10.5 years It 2.0 years). When comparing
the overall group at follow-up to those children lost-to-follow-up, there were significantly
more children from the oldest age group who were lost-to-follow-up compared with
younger age groups (p<O.OOOl). There were no differences in ethnicity, gender or BMI
SO between children at follow-up and those children lost-to-follow-up.
Figures 5.4.1 and 5.4.2 show the process of patient recruitment, order of tests and the
crude test results. Of the 2266 children enrolled at baseline, 53 (2.3%) children would
not provide a urine sample on the test day and 78 children (3.4%) did not receive an
ACR due to equipment failure at the study site. Of the 1432 (63%) children available for
two-year follow-up testing, 74 (5.2%) did not have both an initial Multistix dipstick test
and initial ACR, and 17 (1.2%) did not receive a follow-up ACR.
The prevalence of baseline albuminuria was 7.3%, and persistent albuminuria (at two
year follow-up) was 1.5%. There was no significant difference in the prevalence of
baseline or persistent albuminuria between Aboriginal and non-Aboriginal children
(8.1 % versus 6.5%, X2 1.97, 1df, p=0.16 and 1.4% versus 1.5%, >f 0.03, 1 df, p=0.86).
Baseline and follow-up data for the cohort have been described in more detail
elsewhere (30).
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Accuracy for baseline albuminuria: Table 5.4.1 shows the accuracy of the Multistix
dipstick for the diagnosis of albuminuria at baseline. Overall sensitivity was 62% (55-
70%) and overall specificity was 97% (96-98%). There were no significant differences in
the accuracy of Multistix dipsticks in detecting baseline albuminuria in Aboriginal
compared with non-Aboriginal children (ROOR 0.97, 95% CI 0.42-2.25, p=0.62),
females compared with males (ROOR 0.53, 95% CI 0.23-1.23, p=0.56), and
overweight/obese and normal weight children compared with underweight children
(ROOR<0.5), although there was a trend towards lower accuracy with increasing 8MI
(trend p=0.01). Multistix dipsticks were more accurate in diagnosing baseline
albuminuria in older children (8.0-15.0 years) compared with the youngest age tertile
(4.0-7.9 years), ROOR>4, trend p=0.01, and in children with haematuria compared to
children without haematuria (ROOR 7.51, 95% CI 2.27-24.82, p=0.01).
Accuracy for persistent albuminuria: Table 5.4.2 shows the results of Multistix dipsticks
in predicting persistent albuminuria. Overall sensitivity was 75% (53-89%), and overall
specificity was 93% (92-94%). There were no significant differences in the accuracy of
Multistix dipsticks in predicting persistent albuminuria in Aboriginal compared with non-
Aboriginal children (ROOR 0.81, 95% CI 0.10-6.60, p=0.82), females compared with
males (ROOR 1.05, 95% CI 0.13-8.55, p=0.36), older children (8.0-15.0 years)
compared with the youngest age tertile (4.0-7.9 years), ROOR<0.9, trend p=0.31, and
overweight/obese and normal weight children compared with underweight children,
although there was a trend towards better accuracy with increasing 8MI (ROOR>1.6,
trend p=0.01). Multistix dipsticks were substantially less accurate in predicting persistent
albuminuria in children with haematuria compared to children without haematuria
(ROOR 0.03, 95% CI 0.001-0.93, p=0.02).
Absolute accuracy: Table 5.4.3 shows the absolute accuracy per 1000 children tested
using ACR and Multistix dipsticks. Out of a hypothetical cohort of 1000 children, with 73
having baseline albuminuria (a prevalence of 7.3%), Multistix dipsticks would correctly
identify 45 children with albuminuria at the expense of 20 false positives and 28 false
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negatives. At two-year follow-up, 15 children will have persistent albuminuria. Multistix
dipsticks would identify 11, at the expense of 60 false positives (including those with
transient albuminuria) and 4 false negatives.
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5.5: Discussion
In this first large-scale community-based cohort study of the test performance of urine
dipsticks in detection of albuminuria in Indigenous children, we have shown that
Multistix dipsticks are accurate for cross-sectional detection, and more accurate for
detecting children with persistent albuminuria. We have also shown that accuracy does
not vary with ethnicity. Multistix dipsticks are a cheap, convenient and portable
diagnostic method for albuminuria detection.
Many of the design features of this study suggest the results are valid and
generalisable. This was a prospective evaluation of dipstick urinalysis testing for
albuminuria in a consecutive series of children from a clinically relevant and
generalisable population. The children tested at follow-up were similar in demographic
characteristics to the original population-based cohort at baseline. Many previous
studies have used diseased cases with controls for dipstick evaluation, which leads to
an over estimate of the true test performance (spectrum bias) (31) (32) e3). There was no
verification bias because all children received both the dipstick and referent tests. The
study nurse was not blinded to the results of either test; however interpretation of each
was quantitative. The nurse had no information on the previous referent test result at
the follow-up testing, and therefore, no significant effect from unblinding is expected (34)
es). A single referent test was used, and there was no time interval or treatment
between the dipstick and baseline referent tests. We accept that because some of the
samples were collected at a time other than first-morning, some of the proteinuria
detected will be orthostatic, particUlarly for the adolescents. Persistence of proteinuria in
these children at first-morning follow-up testing would make orthostatic proteinuria less
likely.
Twenty four-hour proteinuria is conventionally considered the gold standard for
diagnosing albuminuria, but this method is unreliable due to collection errors and
inconvenience es) (37). These problems are compounded in the paediatric population
and in highly mobile, remote populations with limited access to health services, as seen
in Aboriginal communities (12). For these reasons we used spot urine ACR as our
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surrogate referent test in this study. Replacement of 24-hour urine protein by spot urine
ACR for follow-up diagnostic purposes has been justified by substantial agreement
between the two methods for all age groups with a wide spectrum of renal function, and
over the entire proteinuria range (38) (39) CO) (13). There was no specific treatment for
any child with albuminuria found at baseline before the follow-up referent test was
performed, and we used predefined, standard cut-off values for index and referent test
positives and negatives (20).
We found that test performance varied with a number of subject characteristics. Multistix
dipsticks were more accurate in detecting albuminuria in older children at baseline, due
to a low sensitivity, but this finding was not confirmed for the more important outcome of
persistent albuminuria. However, this result may have been influenced by the
disproportionate losses at follow-up between the oldest age group and the younger age
groups. Dipsticks were less accurate for detecting albuminuria in children with higher
8MI at baseline, but more accurate in predicting persistent albuminuria in children with
higher 8MI at follow-up (again due to differences in sensitivity). Dipsticks were better at
detection of albuminuria in the presence of haematuria, although haematuria worsened
the prediction of persistent albuminuria at follow-up. These inconsistent findings in
children with haematuria need to be interpreted cautiously. There are no comparable
data from other studies, and these results are largely influenced by the continuity
correction of 0.5, resulting in unstable estimates.
Long-term prospective studies are needed to determine the risk of ESKD in Aboriginal
children and young adults with albuminuria, and how the risks change in association
with other co-morbidities such as hypertension and diabetes. Compared with the cost of
relocation, dialysis and other treatments for sustaining an Aboriginal Australian on
dialysis for an average survival period of 20 years (41), it may eventuate that health
dollars and much psychological suffering could be saved through a primary prevention
program, as has been proposed for other high risk populations (42) (43). Point-of-care
testing for community risk assessment is culturally appropriate and Widely accepted
within Aboriginal communities (12) (11). Our results support the use of Multistix
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dipsticks as a reliable, low-cost diagnostic instrument for albuminuria in Aboriginal and
other children.
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Figure 5.4.1: Flow diagram of recruitment and testing of children at baseline
Eligible children, n = 2266
Excluded, n-53* •
Multistix dipstick test, n=2213
Multistix proteinuria dipstick +ve, n= 161
IN.A~_- I~1
ACR, n=157
Multistix proteinuria dipstick -ve, n=2052
•No ACR, n=74**
ACR, n=1978
ACR +ve, n=98
'Child refused to void
"Equipment failure
ACR -ve, n=59 IACR +ve, n=59 I ACR -ve, n=1919
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Figure 5.4.2: Flow diagram of recruitment and testing of children at two-year follow-up.
Eligible children at baseline, n=2266
Away during screen week, n=80
Refused or no consent, n=33
Unknown or moved to schools
outside of screening area, n=721
•
Eligible children at two year follow-up, n= 1432
Excluded, n=74* I •
Initial ACR and Multistix dipstick test, n=1358
Initial Multistix proteinuria dipstick test -ve, n=1253Initial Multistix proteinuria dipstick test +ve, n=105
No follow-up ~ j
ACR, n=1 **
No follow-up
ACR, n=16**
• j
FOllow-up ACR, n=104 [ Follow-up ACR, n=1237
ACR +ve, n=15 ACR -ve, n=89 I ACR +ve, 0=5 1 ACR -ve, 0=1232
'No initial Multistix dipstick test, and/or no initial ACR
" Equipment failure
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Table 5.4.1: Accuracy of Multistix dipsticks in detecting albuminuria at baseline (prevalence 7.3%)
teristics Prevalence TP TN FP FN Sensitivity % Specificity % Relative Diagnostic
albuminuria 0/. 95% CI 95%C Odds Ratio 95% C
cohort 7.3 98 1919 59 59 62 (55-70) 97 (96-98) NA
tityAboriginal' 6.5 42 877 31 21 67 (54-77) 97 (95-98) 1.00
<lriginal
r
ti"
l.aJe
Itrtiles (years)-1.9'
-9.9
1~15.0
sediment
tuna absent·
aturia present
SO
'fweight·
,31 weighl
""eight/obese
8.1
5.4
9.4
6.0
7.2
8.8
6.8
16.5
11.1
7.2
4.8
56 1042 28 38
38 1014 24 21
60 905 35 38
12 633 14 29
37 658 20 16
49 628 25 14
83 1823 58 55
15 95 1 4
31 299 13 8
57 1237 36 42
10 364 10 9
60 (49-69)
64 (52-75)
61 (51-70)
29 (19-40)
70 (59-79)
78 (68-85)
60 (52-68)
79 (57-91)
80 (68-88)
58 (50-65)
53 (34-69)
97 (96-98)
98 (97-98)
96 (95-97)
98 (97-99)
97 (96-98)
98 (97-99)
97 (96-98)
99 (94-100)
96 (94-97)
97 (96-98)
97 (96-98)
0.97 (0.42-2.25)
1.00
0.53 (0.23- 1.23)
1.00
4.07 (1.31-12.68)
4.70 (1.54-14.36)
1.00
7.51 (2.27-24.82)
1.00
0.52 (0.18-1.53)
0.45 (0.11-1.92)
c
*Referent group
Abbreviations: 8Ml, body mass index; FN, false negative; FP, false positive; SO, standard
deviation; TN, true negative; TP, true positive.
Definitions: Albuminuria, ACR > 3.4 mg/mlTIol; haematuria > 25 RBC per HPF (1+);
undelweight, 8M] SO < -I; nonnal weight, 8M! SO -I to +!; overweight and obese, 8Ml SO>
+1.
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• Table 5.4.2: Accuracy of Multistix dipsticks in detecting persistent albuminuria (prevalence 1.5%)
I{uracteristics Prevalence TP TN FP FN Sensitivity e;. Specificity 0/0 Relative Diagnostic
albuminuria % (95% CT) (95% CI) Odds Ratio (95% CI)
Whole cohort 1.5 15 1232 89 5 75 (53-89) 93 (92-94) NA
£Ihnicity
.ion·Aboriginal* 1.4 7 576 43 2 78 (45-94) 93 (91-95) 1.00
Aboriginal
Gtnder
\1,leO
female
Ii' tertiles (years)
6.0-9.4°
9.5·11.4
11.5-15.4
1.5
1.5
1.5
0.9
1.1
2.4
8
7
8
3
4
8
656 46
640 35
592 54
412 20
415 31
405 38
3
3
2
I
I
3
73 (43-90)
70 (40-89)
80 (49-94)
75 (31-95)
80 (38-96)
73 (44-90)
93 (91-95)
95 (93-96)
92 (89-94)
95 (94-96)
93 (92-94)
91 (90-92)
0.81 (0.10-6.60)
1.00
1.05 (0.13-8.55)
1.00
0.87 (0.04-21.23)
0.46 (0.03-6.74)
Other sediment'·
Haematuria absent· 1.5
•
15 1190 77 4 78 (56-90) 94 (93-95) 1.00
Haematuria present
B\II SD
Underweight·
.~ormal weight
Overweight/obese
1.9
1.8
1.9
0.3
o
3
I I
I
4 I 12
204 21
740 53
281 15
I
I
4
o
25 (21-27)
70 (31-93)
72 (48-88)
75 (20-97)
77 (76-79)
91 (90-92)
93 (93-94)
95 (94-96)
0.03 (0.001-0.93)
1.00
1.59(0.17-15.15)
2.46 (0.10-108.09)
·Referent group
t o.5 was added to all cells to obtain an estimate that deals with the zero cell.
• Haematuria absent or present at baseline
Abbreviations: BMI, body mass index; FN, false negative; FP, false positive; TN, true negative; TP, true
positive; SO, slandard deviation.
Definitions: Albuminuria, ACR > 3.4 mglmmol; baematuria > 25 RBC per HPF (1+); underweight, BMI
SO < -1 ;nonnal weight, BMI SO -1 to +I;overweight and obese, BM! SD>+ I.
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Table 5.4.3: Absolute accuracy per 1000 children screened by Multistix dipsticks (assuming a
point prevalence of7.3% for albuminuria at baseline and 1.5% for persistent albuminuria)
Target
condition
Baseline
albuminuria
Persistent
albuminuria
Number Number Difference Number Number Difference
detected detected excluded excluded
withACR with withACR with
dipstick dipstick
73 45 28 927 899 28
15 11 4 985 916 69
Abbreviations: ACR, albumin:creatinine
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6.1 : Abstract
Background Aboriginal Australians have a nine-fold increased risk for end-stage renal disease.
There is no information on the natural history and risk for chronic kidney disease (CKD) in
Aboriginal and non-Aboriginal children.
Study Design Using a prospective study design, we aimed to determine the prevalence of
persistent markers and risk factors for CKD in Australian Aboriginal and non-Aboriginal children,
and whether Aboriginal children are at increased risk for persistent markers of CKD after
accounting for socio-demographic differences.
Setting and Participants Children were enrolled from elementary schools throughout New
South Wales.
Predictors, Outcomes, Measurements Urine analysis, height, weight, blood pressure, birth
weight and socio-demographic status were measured at baseline and two-year follow up.
Albuminuria was defined as ACR > 3.4 mglmmol, haematuria as >25 RBC/uL ~1+), obesity as
8MI ~ 2 standard deviations, and systolic and diastolic hypertension as blood pressure >90lh
percentile.
Results 2266 children (55.1 % Aboriginal, 51.0% male, mean age 8.9 years + SD 2.0 years)
were enrolled at baseline. Early markers and predictors of CKD at baseline were frequent:
•
haematuria (5.5%), albuminuria (7.3%), obesity (7.1 %), systolic hypertension (7.2%) and
diastolic hypertension (5.8%). There were 1432 children (63%) available for re-testing at two-
year follow up (54.0% Aboriginal, 50.5% male, mean age 10.5 years + SD 2.0 years).
Persistent obesity (5.3%) was frequent, but persistent markers of CKD were infrequent (systolic
hypertension 1.1 %, diastolic hypertension 0.2%, haematuria 1.1 % and albuminuria 1.5%). While
there were more Aboriginal than non-Aboriginal children with baseline haematuria (7.1 % versus
3.6%, p=0.001), after adjustment for age, gender, birth weight and socio-demographic status,
there was no increased risk for persistent haematuria, albuminuria, obesity or hypertension in
Aboriginal children.
Limitations Persistent markers of CKD were much less frequent than anticipated, which may
have affected study power. The group lost at follow-up were older children which may have
biased the results.
Conclusions Overall only 20% of children found to have markers of early CKD have persistent
abnormalities (diastolic and systolic hypertension, albuminuria, hematuria) 2 years later,
equivalent to a population point prevalence of 1-2% in children with a mean age of 10 years.
Aboriginal children have higher rates of baseline and transient haematuria, but no increased risk
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for persistent markers of CKD, suggesting that adolescence and young adulthood is a critical
time for preventative strategies.
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6.2: Introduction
Morbidity and premature mortality from chronic kidney disease are a much greater burden for
Indigenous than for non-Indigenous populations. Native American Indians have a twice higher
incidence of end-stage kidney disease compared with non-Indigenous Americans, although the
disparity is almost four times higher for South Western Native Americans (\ Canadian Indians
have two-and-a-half times higher incidence of end-stage kidney disease compared with the total
Canadian population (2). Aboriginal and Torres Strait Islander Australians (hereafter referred to
as Aboriginal) are nine times more likely than non-Aboriginal Australians to develop end-stage
kidney disease (3). End-stage kidney disease occurs almost 10 years earlier in Australian
Aboriginal people, at a median age of 51 versus 60 years in non-Aboriginal Australians (4).
A much larger proportion of end-stage kidney disease in Aboriginal Australians is attributed to
diabetic nephropathy (47%) as compared to non-Aboriginal Australians (17%), but little is known
about the early causal pathways leading to these health disparities (4). Most research to date
has documented disease end-points in high-risk communities (1,2,4), with few studies
measuring or adjusting for environmental risk factors that will also affect non-Indigenous people,
such as lack of access to health care, remote and lower standards of living (5). There are
several studies from high risk Indigenous communities describing the prevalence of early
chronic kidney disease markers (6) () (8), but there are no population-based studies that
documeht the persistence of early chronic kidney disease markers in Indigenous children
compared with non-Indigenous children.
Our aim was to determine the prevalence of persistent markers and risk factors for chronic
kidney disease (CKD) in Australian Aboriginal and non-Aboriginal children, and whether
Aboriginal children are at increased risk for chronic kidney disease after accounting for socio-
demographic differences.
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6.3: Methods
Selection of participants: Government-run elementary schools were approached for testing from
urban, coastal, rural and remote locations across the state of New South Wales. This state has
the highest Aboriginal population in Australia, and Aboriginal people within New South Wales
have three times the risk of ESKD than non-Aboriginals (3). To maximise power, sampling was
done to obtain equal numbers of Aboriginal and non-Aboriginal children, and in similar
proportions from urban, coastal, rural and remote areas. All elementary schools in remote
communities were approached and other areas were sampled if greater than twenty Aboriginal
children in the relevant age range attended. We attempted to enrol all Aboriginal students from
participating schools, and to age and gender match them with a random sample of non-
Aboriginal students.
Aboriginal status was determined using the Australian Bureau of Statistics best practice
recommendations, asking the Standard Indigenous Question on the consent form "Is your child
of Aboriginal or Torres Strait Islander origin?" (9) . All Aboriginal children in the participating
elementary schools were offered testing for height, weight, blood pressure and urinary dipstick
abnormalities. We aimed to recruit equal numbers of boys and girls, Aboriginal and non-
Aboriginal children, and approximately equal numbers of children from each 12 month age
group.
Aboriginal community engagement: Consultation with local Aboriginal Medical Services and
consent from community leaders was undertaken prior to commencement of the study.
Approval was obtained from the Ethics Committees of the Children's Hospital at Westmead, the
University of Sydney, New South Wales Area Health Services and the New South Wales
Department of Education and Training. Informed consent was obtained for each child and, in
accordance with NHMRC Guidelines for Ethical Conduct in Aboriginal and Torres Strait Islander
Research Co), data were collected onto a standardised form and de-identified for storage and
analysis before being returned to each community after the study visit. Permission to publish
data was also obtained from each community.
Measurement of markers of chronic kidney disease: Markers and predictors of CKD measured
were haematuria, albuminuria, systolic and diastolic hypertension, and obesity. Risk factors
known and thought to be associated with the development of these markers in Aboriginal and
102
Chapter 6: Risk for chronic kidney disease in Australian Indigenous and non-Indigenous children: a population-
based follow-up study
non-Aboriginal people were also recorded, including age, gender, growth parameters, birth
weight and environmental health determinants: measures of geographic isolation and social
disadvantage.
Amorning clean catch specimen was collected from each child, with dipstick analysis for
haematuria, and albuminuria performed at the survey site on fresh specimens using a Bayer
Clinitek 50 machine C'). Leukocytes and nitrites were also recorded for later adjustment for
abnormalities of presumed urinary tract infection. Girls older than eight years who were found to
have haematuria were questioned about menses, and if appropriate, collection was performed
at another time. According to Kidney Disease Outcomes Quality Initiative (K/DOQI) definitions,
haematuria was defined as greater than or equal to dipstick 1+ (equivalent to 25 RBC per
microlitre 1+), and albuminuria as albumin:creatinine (ACR) greater than or equal to 3.4
mg/mmol C2).
Birth weight was provided by the parent/carer by recall or from the child's health record. Height
was measured in stocking feet to the nearest 0.1 cm with a SECA 220 telescopic portable
stadiometer C3 ) that was calibrated between screening visits. Weight was measured in stocking
feet and in school uniform on digital scales to the nearest 0.01 kg. Body mass index (BMI)
standard deviation z-scores (SO) were calculated using an age and sex-adjusted program C4).
Blood pressure was measured on the right arm with the child sitting, using an aneroid
sphygmomanometer and the largest cuff to encircle the arm and cover at least three-quarters of
the length of the upper arm CS). In children less than 13 years, diastolic pressure was measured
at the point of muffling (Korotkov 4). For older children the point of disappearance was used
(Korotkov 5) C6 ). Systolic and diastolic hypertensions were defined as blood pressure greater
than the 90th percentile for age and gender.
Follow-up measurements were performed two years after baseline testing at the elementary or
new high school on all available children, and the frequency of persistent chronic kidney
disease markers (markers detected at baseline and follow-up) was ascertained.
Standardisation of urban, coastal, rural and remote locality was made using the Accessibility
and Remoteness Index of Australia (ARIA++), with each subject given an Index score according
to their postcode of residence C\ Using geographical information system capabilities,
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distances, services and population density for each locality are converted to a continuous
variable with values ranging from zero for high accessibility, to 18 for extreme remoteness.
ARIA++ values for this NSW study ranged from 0 to 14, and for categorical analysis the scores
were grouped into quartiles. Isolation categories (and ARIAH score range) used were: Least
isolation (0-1.1), low-mid isolation (1.2-2.4), high-mid isolation (2.5-4.9) and highest isolation
(5.0-14.0).
To determine the level of social and economic well being of areas studied, the Socio-Economic
Indexes for Areas 2001 CB) Index of Disadvantage was applied to subjects at the level of
collection district of residence. This is the smallest geographic area for which the Index is
available, and includes approximately 200 households. The Index of Disadvantage is a
continuous score, and is based upon characteristics such as low income, lower level of
education, high unemployment, and unskilled jobs. It has been standardised to a mean of 1000,
and a standard deviation of 100 across all collection districts in Australia, ie, 95% of scores are
between 800 and 1200. Higher scores indicate higher socio-economic status (SES) and least
disadvantage. For categorical analysis, the scores were grouped into quartiles: Highest
disadvantage (680-835), high-mid disadvantage (836-960), low-mid disadvantage (961-988)
and least disadvantage (989-1103).
Data analysis: Comparisons between children followed-up and those with only baseline data
were made by ethnicity, gender, age groups, birth weight quartiles, body mass index SD
quartiles, and categories of isolation and disadvantage using the chi-squared test. Odds ratios
and relative risks for baseline and persistent markers of CKD in Aboriginal compared with non-
Aboriginal children (referent group) were determined using logistic regression with 95%
confidence intervals. The relative risk between other potential predictors (gender, age, birth
weight, body mass index, geographic isolation and social disadvantage) and persistent markers
of CKD was determined using logistic regression with 95% confidence intervals. The presumed
lowest risk category of each predictor was used as the referent group. The mantel extension
test was used to determine linear trends across categories. Analyses were adjusted for age,
gender, body mass index SD, birth weight, categories of isolation and disadvantage and school
using a random effects model.
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Tests for interactions between ethnicity, gender, age, categories of isolation, disadvantage and
other significant variables in the final model were performed. Significance was set at a p-value
of <0.05 for main effects and interactions. Statistical analysis was completed using SAS C9) and
SPSS software (20).
We planned to collect data at baseline from 1000 Aboriginal and 1000 non-Aboriginal children
which were sufficient to detect differences in prevalence of markers of CKD between the two
groups of 2.9 versus 1.1 %, 5.5 versus 2.9%, 8.2 versus 6.0%, and 9.4 versus 7.2% at 80%
power for haematuria, albuminuria, obesity and systolic hypertension respectively. We
anticipated a 60-70% follow-up rate which would allow detection of differences in persistent
markers between Aboriginal and non-Aboriginal children of 3.8 versus 1.5%, 3.2 versus 1.0%,
7.6 versus 5.3% and 7.3 versus 5.0% at 80% power for haematuria, albuminuria, obesity and
systolic hypertension respectively.
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6.4: Results
From February 2001 to June 2004, 2266 children were enrolled from 37 primary schools across
New South Wales. Participation rates for both Aboriginal and non-Aboriginal students were 85-
100%. There were 1248 (55.1%) Aboriginal children, 51% were male, and the mean age was
8.9 years (± SO 2.0 years). A more detailed description of baseline characteristics has been
reported elsewhere (21).
Characteristics at two-year follow-up (table 6.4.1) At two-year follow-up from March 2004 to
December 2006, there were 1432 (63.0%) children available for re-testing; 773 (54.0%) were
Aboriginal, 50.4% were male, and the mean age was 10.5 years li SO 2.0 years). When
comparing the overall group at follow-up to those children with only baseline data, there were
significantly more children from the older age groups and from urban areas who had no follow-
up data (p<0.0001). There were no differences in ethnicity, gender, birth weight, BMI SO and
social disadvantage category between children at follow-up and those children with only
baseline data.
Prevalence of baseline markers of chronic kidney disease in Aboriginal and non-Aboriginal
children (table 6.4.2) Obesity (7.1 %) and early markers of CKO at baseline were common:
haematuria (5.5%), albuminuria (7.3%), systolic hypertension (7.2%) and diastolic hypertension
(5.8%). There was no increased risk for these early markers of chronic kidney disease in
Aboriginal compared with non-Aboriginal children, with the exception of haematuria, 7.1 %
versus 3.6% (adjusted odds ratio 2.25,95% CI 1.37-3.69, p=0.001).
Prevalence of persistent markers of chronic kidney disease in Aboriginal and non-Aboriginal
children (table 6.4.2) At two-year follow-up, the overall prevalence of persistent markers of CKO
was much less frequent. Haematuria (1.1 %), albuminuria (1.5%), systolic hypertension (1.0%)
and diastolic hypertension (0.1 %). Obesity remained relatively frequent at 5.3%. There was no
increased risk for any persistent marker in Aboriginal when compared to non-Aboriginal
children.
Physiological and socia-demographic predictors for persistent markers of chronic kidney
disease (table 6.4.3) There was no increased risk of any persistent marker of CKO for females
compared with males, nor for lower birth weight compared with higher birth weight. Risk of
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persistent haematuria increased with increasing age (trend p=0.004). Increasing age was not a
risk factor for any other persistent marker of CKO. Risk of persistent systolic hypertension
increased with increasing BMI SO (trend p= 0.001), and the highest BMI SO quartile was
significantly associated with risk for persistent systolic hypertension (adjusted RR 5.78, 95% CI
1.24-26.73, p=0.03). There was a decreasing risk for persistent systolic hypertension and
persistent albuminuria with increasing social disadvantage (both trend p<0.02). The quartile with
the highest social disadvantage had a significantly lower risk of persistent albuminuria (adjusted
RR 0.17, 95% CI 0.05-0.57, p=0.004). There were no physiological or socio-geographic
predictors of persistent obesity found.
There were no interactions found between environmental health determinants of geographic
isolation and social disadvantage and ethnicity, age, gender or other covariates in any model.
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6.5: Discussion
This is the first population-based cohort study describing the natural history of early CKD in
Indigenous children that includes a non-Indigenous comparator group, and measures and
adjusts for social disadvantage and geographic isolation. Non-Indigenous comparators are
essential in deciding the level of increased risk for Indigenous children against the background
population rates, and measurement of socio-demographic factors is important in adjusting for
the potentially confounded relationship between health, isolated living and social disadvantage.
In our prospective study of 2266 children, 50% of whom are Aboriginal, over two years of follow-
up we have shown that persistent markers of CKD are infrequent, and there is no increased risk
for persistent markers in Aboriginal children when compared to non-Aboriginal children, even
after adjustment for social disadvantage and geographic isolation.
The follow up data showed that while baseline markers are frequent in Aboriginal and non-
Aboriginal elementary school-aged children, most of these abnormalities are transient. At a
single test, Aboriginal children have twice the risk of haematuria as non-Aboriginal children, but
no increased risk for persistent haematuria. Other Australian Indigenous studies have a similarly
high cross-sectional prevalence of haematuria and albuminuria in children (22,6). These studies
are from extremely disadvantaged communities with the highest rates of end-stage kidney and
cardiovascular disease in the world. Without follow-up testing, or comparative data from a non-
Indigenous group, the assumption is that these frequent one-off markers lead to the high states
of disease seen in adulthood, and that ethnically-based biological effects are causative (23). Our
baseline results show that almost 80% of baseline urinary abnormalities are transient. Semi-
quantitative single estimations of urinary blood and protein in children vary according to posture,
illness, exercise and time of day (24). A twice higher rate of transient haematuria may reflect the
higher incidence of transient disease seen in Indigenous children, such as post-infectious
glomerulonephritis (8). The persistence of these markers are infrequent in our cohort, and do
not occur more frequently in Aboriginal children.
Obesity is a frequent predictor of CKD in these children, although no more so in Aboriginal
children. Rates of persistent obesity of 5.3% found in our study are similar to national rates of
obesity in Australian elementary school-aged children of 6% (25). Increasing BMI was predictive
of persistent systolic hypertension, and these children are at risk for early onset diabetes,
108
Chapter 6: Risk for chronic kidney disease in Australian Indigenous and non-Indigenous children: a population-
:laSed follow-up study
cardiovascular disease ea, 27) and most likely chronic kidney disease. They will be closely
lollowed-up over the final two-years of the study.
There was a decreasing risk for persistent systolic hypertension and persistent albuminuria in
!he most disadvantaged children. These associations seem contradictory to other studies
15,28,29). Our study sampled children in areas where Aboriginal children reside, in areas of
greatest disadvantage for the state of New South Wales (30). Therefore, the highest socio-
economic quartile in our cohort (indicating lesser disadvantage) correlates with mid-range socio-
economic categories in other comparative studies (31,32). Our findings are consistent with these
studies showing risk factors for chronic disease following a bell-shaped curve across different
socio-economic environments - lowest risk occurs at either extreme of socio-economic status,
with highest risk occurring in mid-range socio-economic categories.
Apotential limitation of our study was the 37% lost-to-follow-up, but we have shown that this
group is not significantly different to the children followed-up, apart from their age and
geographic location. There were proportionally more children followed-up in the remote areas,
when compared to urban areas. This reflects the close relationships originally established
between Area Health Workers in remote communities, and shows a higher degree of
disengagement among urban children. The higher proportion of older children lost-to-follow-up
results from older children absent or no longer at school, and we accept that they are likely to
be the children most at risk of chronic disease. We are attempting to address these differences
at our final four year follow-up. Even though these issues are a concern in terms of sampling
bias, the regression analyses for risk of CKD markers in Aboriginal children were adjusted for
age and location in an attempt to account for these imbalances.
The study was adequately powered to find relatively small differences in risk for persistent
markers of CKD if they existed between Aboriginal and non-Aboriginal children. However,
persistent markers were much less frequent than anticipated which may have affected the study
power. Measurement of the main predictor of risk, Aboriginal status, was performed using best
practise recommendations (9). Measurement of social disadvantage and geographic isolation
was made using standardised systems that have been applied reliably in geographically and
ethnically similar population-based samples (33,3). We accept that unmeasured confounding
from individual-level socio-economic factors remains as a study bias (34). With further data
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collection, multi-level analyses could be used to identify, measure and correct for ecological
bias when spatially-aggregated measures are applied to individual data, an approach we will
use for future follow-up (35). Parentally recalled birth weight has been shown as a reliable proxy
for recorded birth weight in population-based research (36).
Albuminuria is the strongest predictor of death, cardiovascular disease and end-stage renal
disease in Aboriginal adults which is why it was used in our study (37,36). Spot ACR, at the cut-
off used in this study, has good receiver operator curve characteristics for detecting pathological
albuminuria e9). Blood pressure was measured using appropriate cuff sizes, with repeat
measures performed in hypertensive children. A 90th percentile cut-off was used to classify
hypertension because we anticipated insufficient outcomes to perform analyses at a 95th
percentile cut-off. Obesity was determined using BMI standard deviations, which has been
validated for use in this age group of children (40), and our prevalence of obesity is comparable
to national surveys (25). Measurement of outcomes such as central obesity, blood lipid, glucose
and insulin levels would have been desirable for evidence of pre-diabetes and the metabolic
syndrome (41), however measuring all possible risk factors was beyond the practicalities of such
a large school-based screening study. Painful and embarrassing procedures would have been
counter-productive to the current success of our follow-up recruitment rates.
Within New South Wales, there is no increased risk for persistent markers of CKD in Aboriginal
children compared with non-Aboriginal children, and the three-fold increased risk for CKD
experienced by Aboriginal adults in New South Wales and nine-fold increased risk for all
Indigenous Australians is not yet established in this age group. This suggests that adolescence
and young adulthood are likely to be critical times for preventative strategies. These results also
show that a single measurement of markers of CKD in children is misleading as almost 80% of
all abnormalities are transient. Increasing BMI is the strongest risk factor for persistent
hypertension and persistent haematuria in these children, and obesity remains the most
concerning and persistent predictor of CKD in this age group. This suggests overweight and
obesity in children should be addressed from an elementary school age. These results provide
useful information for primary health care practitioners, paediatricians, nephrologists, policy-
makers and families.
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We look forward to reporting the four-year follow-up of these children and adolescents. This
study highlights a need for long-term prospective observational studies of risk for CKD in
Aboriginal and non-Aboriginal young adults over a range of socio-geographic areas. We plan to
follow this cohort of children for a further eight years into young adulthood (42) .
•
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Table 6.4.1: Characteristics of children at baseline stratified by follow-up status
Variable FOllow-up % Baseline % p
data available data only
available
(n = 1432) (n=834)
Etbnicity
Aboriginal 773 54.0 475 57.0 0.18
Non-Aboriginal 659 46.0 359 43.0
Gender
Male 723 50.5 432 51.8 0.54
Female 709 49.5 402 48.2
Age groups (years)
4-5.9 144 10.1 67 8.0 <0.0001
6-6.9 192 13.4 89 10.7
7-7.9 237 16.6 93 11.2
8-8.9 221 15.4 I 12 13.4
9-9.9 231 16.1 120 14.4
10-10.9 196 13.7 165 19.8
11-14.8 211 14.7 188 22.5
Birtb weigbt quartiles (g)*
412-2920 259 25.6 86 21.1 0.31
2921-3316 255 25.2 107 26.2
3317-3685 246 24.4 III 27.2
3686-5272 250 24.8 104 29.4
BMJ SD quartllcs*
-4.8 to -0.8 355 25.0 205 24.9 0.96
-0.7toO.1 352 24.8 210 25.5
0.2 to 0.7 363 25.5 203 24.6
0.8 to 6.9 3") ?4.8 206 25.0,-
Geographic Isolation (ARIA score)
Least isolation (0-1 .1) 358 25.0 252 30.2 <0.0001
Low-mid isolation (1.2-2.4) 453 31.6 186 22.3
High-mid isolation (2.5-4.9) 261 18.2 260 31.2
Highest isolation (5.0-14.0) 360 25.2 136 16.3
Social Disadvantage (SElFA score)
Least disadvantage (989-1103) 342 23.9 206 24.7 0.34
Low-mid disadvantage (960-988) 385 26.9 200 24.0
High-mid disadvantage (836-960) 370 25.8 206 24.7
Highest disadvantage (680-835) 335 23.4 222 26.6
Abbreviations: ARfA, Accessibility and Remoteness Index of Australia; BM!, body mass index; SD, standard
deviation; SErfA, Socio-Economic Indexes For Areas.
'Indicates where data does not equal column totals.
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Table 6.4.2: Prevalence of baseline and persistent markers of chronic kidney disease in Aboriginal and non-Aboriginal children at two year follow-up
Baseline Markers Persistent Markers
Marker of chronic kidney disease Overall Non-Aboriginal Aboriginal p Overall Non-Aboriginal Aboriginal p
(referent catcgory) (referent category)
Hematuria (dipstick ~ 2S RBC per HPF)
Events (%) J22 (5.5) 36 (3.6) 86 (71) IS (1.\) 6 (0.9) 9 (1.2)
Adjusted OR • 1.00 2.25 (1.37-3.69) 0.001 1.00 1.36 (0.29-6.36) 0.88
Albnminuria (ACR ~ 3.4 mg/mmol)
Events (%) 157(7.3) 63 (6.5) 94(8.1) 20 (1.5) 9 (1.4) II (1.5)
Adjusted OR' 1.00 1.37 (0.93-2.01) O. I I 1.00 1.80 (0.70-4.65) 0.60
Obesity (BMI ~ 2 SO)
Events (%) 145 (7.1) 63 (6.7) 82 (7.4) 74 (5.3) 33(5.1) 41 (5.4)
Adjusted OR' 1.00 1.10 (0.76-1.44) 0.52 1.00 1.09 (0.67-1.78) 0.20
Systolic hypertension (SBP > 90 th centile)
Events (%) 162 (7.2) 67(6.7) 95 (7.7) 14(1.0) 6 (0.9) 8(1.1)
Adjusted OR' 1.00 1.22 (0.87-1.57) 0.34 1.00 1.25 (0.45-3.47) 0.66
Diastolic hypertension (DBP > 90'h centile)
Events (%) 13\ (5.8) 62 (6.2) 69 (5.6) 2 (0.\) I (0.2) 1 (0.1)
Adjusted OR' 1.00 0.94 (0.57-1.31) 0.57 1.00
'Adjusted where appropriate for age, gender, birth weight, BMI SD, systolic BP, diastolic BP, isolation category and disadvantage category.
Abbreviations: ACR, albumin:creatinine; BMI, body mass index; DBP, diastolic blood pressure; HPF, lligh power field; OR, odds ratio; RBC, red blood cell; SBP,
systolic blood pressure; SD, standard deviation.
Definitions: Persistent marker = marker found at both baseline and follow-up.
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Table 6.4.3: Physiological and cnvironmental predictors of persistent markers of chronic kidney disease
HacJ11sturia Albuminuria Obesity Systolie Hypertension
(dillstick :: 25 RBC lIer HPF) (ACR > 3.4 mglmmol) (BMI > 2 SD) (SBP > 90'h centile)
Predietor N (%) AOR' N (%) AOR' N (%) AOR' N (%) AOR'
195% CI) 195% Cl) 195% Cl) 195% Cl)
Gender
Male" 5 (0.7) 1.00 10 (1.5) 1.00 41 (5.8) 1.00 6 (0.8) 1.00
Female 10(1.5) 1.37 (0.50-3.79) 10 (1.5) 1.12 (0.47-2.70) 33 (4.7) 0.89 (0.51-1.55) 8(1.1) 1.18 (0.31-4.45)
Age tertiles (years)
4.0-7.9" 3 (0.7) 1.00 4 (0.9) 1.00 25 (5.3) 1.00 4 (0.9) 1.00
8.0-9.9 5(1.1) 1.50 (0.21-10.50) 5 (1.1) 1.07 (0.17-5.66) 25 (5.3) 1.00 (0.51-1.96) 4 (0.9) 0.92 (0.28-3.08)
10.0-15.0 7 (1.5) 3.21 (0.62-16.56)' II (2.4) 2.95 (0.76-11.48) 24 (5.1) 1.00 (0.55-2.26) 6 (1.3) 1.36 (0.50-3.71)
Birth weight
> 2500g" 11 (1.2) 1.00 19(2.1) 1.00 48 (5.1) 1.00 9 (1.0) 1.00
~2500g 0(0) § 0.43 (0.02-7.31) 0(0) § 0.24 (0.01-4.05) 6 (5.9) 1.17 (0.50-2.85) I (1.0) 1.03 (0.13-8.21)
BMI SD qnartiles
-4.8 to -0.8" 4 (1.2) 1.00 6 (1.8) 1.00 0(0) 1.00 1 (0.3) 1.00
-0.7 to 0.1 I (0.3) 0.44 (0.04-5.27) 6 (1.8) 0.83 (0.24-2.96) 0(0) - 2 (0.6) 1.45 (0.01-3.94)
0.2 to 0.7 6 (1.7) 1.81 (0.25-13.10) 7 (2.1) 1.31 (0.31-5.57) 0(0) - 4 (1.1) 2.35 (0.31-5.90)
0.8 to 6.9 4 (1.2) 1.00 (0.89-3.59) 1 (0.3) 0.15 (0.01-2.05) 74 (5.3) - 7 (2.0) 5.78 (1.24-26.73) t
Isolation
Least isolation· I (0.3) 1.00 7 (2.1) 1.00 22 (6.2) 1.00 I (0.3) 1.00
Low-mid isolation 6 (1.4) 1.77 (0.16-19.18) 5 (1.1) 0.20 (0.05-0.87) 27 (6.0) 0.81 (0.27-2.42) 10(2.2) 4.00 (0.81-19.77)
High-mid isolation 6 (2.3) 5.90 (0.74-47.32) 4 (1.6) 0.49 (0.11-2.24) 6 (2.4) 0.35 (0.11-1.09) 2 (0.8) 2.20 (0.19-25.40)
Highest isolation 2 (0.6) 2.42 (0.22-26.58) 4 (1.3) 0.44 (0.11-1.82) 19(5.4) 0.60 (0.17-2.13) I (0.3) 0.95 (0.07-4.62)
Social disadvantage
Least disadvantage" 2 (0.6) 1.00 7(2.1) 1.00 20 (5.9) 1.00 7(2.1) 1.00
Low-mid disadvantage 6 (1.7) 1.79 (0.06-9.65) 6 (1.6) 0.95 (0.26-3.40) 20 (5.2) 0.75 (0.34-1.67) 4 (1.0) 0.66 (0.25-1.72)
High-mid disadvantage 4(1.1) 1.19 (0.30-4.73) 5 (1.6) 0.95 (0.08-2.43) 13 (3.7) 0.62 (0.22-1.71) 2 (0.6) 0.32 (0.09-1.08)
Highest disadvantage 3 (0.9) 1.00 (0.21-4.69) 2 (0.6) 0.17 (0.05-0.57) 21 (6.4) 1.38 (0.26-3.67) I (0.3) 0.16 (0.05-2.52)'
• Referent group
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t Trend p < 0.05
§ 0.5 added to cells to allow analysis
• Adjusted where appropriate for ethnicity, age, gender, birth weight, BMl SD, systolic BP, diastolic BP, isolation category and disadvantage category.
Abbreviations: ACR, albumin:creatinine; ARIA, Accessibility and Remoteness Index of Australia; AOR, adjusted odds ratio; BMI, body mass index; HPF, high
power field; RBC, red blood cell; SBP, systolic blood pressure; SO, standard deviation; SEIFA, Socio-Economic Indexes For Areas.
Definitions: Persistent marker =marker found at both baseline and follow-up; least isolation, ARIA score 0-1.1; low-mid isolation, ARIA score 1.2-2.4; high-mid
isolation, ARIA score 2.5-4.9; highest isolation, ARIA score 5.0-14.0; least disadvantage, SEIFA score 989-1103; low-mid disadvantage, SErFA score 960-988;
high-mid disadvantage, SEIFA score 836-959; highest disadvantage, SElFA score 680-835.
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7.1 : Abstract
Background: Indigenous people world-wide have a two to fifty-fold increased risk for end-stage
kidney disease (ESKO), but there is a paucity of data on the natural history and risk for early
chronic kidney disease (CKO) in Indigenous populations.
Methods: Aboriginal and non-Aboriginal children were enrolled from primary schools
throughout New South Wales, Australia. Urinalysis, height, weight, blood pressure, birth weight
and socio-demographic status were measured at baseline and two and four-year follow up.
Markers of CKO were albuminuria, ACR > 3.4 mg/mmol, haematuria >25 RBC/uL ~1+),
obesity, BMI ~ 2 standard deviations, and systolic and diastolic hypertension, blood pressure
~951h percentile.
Findings: 2266 children (55.1 % Aboriginal, 51.0% male, mean age 8.9 years ± SO 2.0 years)
were enrolled at baseline. There were 1432 children (63%) re-tested at two-year follow up, and
1506 children (67%) re-tested at four year follow-up. Prevalence of baseline CKO markers was
frequent (5-7%), but most abnormalities at baseline were transient. Besides persistent obesity
(5.0%), persistence of CKO markers at final follow-up were infrequent; haematuria (1.9%),
albuminuria (2.4%), systolic hypertension (1.5%) and diastolic hypertension (0.2%). There was
no difference in prevalence of persistent markers of CKO between Aboriginal and non-
Aboriginal children.
Interpretation: Over four year follow-up, Australian Indigenous children have no increased risk
for early evidence of CKO. More than 70% of baseline markers are transient, with persistent
markers being uncommon. Our findings suggest the increased risk for ESKO in Indigenous
adults is not manifest until young adulthood, and so is potentially preventable.
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7.2: Introduction
Chronic and end-stage kidney disease (ESKD) is of epidemic proportions in Indigenous
populations. Native American Indians, Canadian Indians and Indigenous Australians have a two
to nine times increased risk of end-stage kidney disease when compared to their non-
Indigenous countrymen, although the disparity is much greater within subgroups of Indigenous
populations C)(2)(3). ESKD occurs up to 10 years earlier in Indigenous people, who also have
an excess of co-morbid illness resulting in decreased survival. Particularly among diabetic
patients, Indigenous people have an accelerated course to ESKD once CKD occurs. Indigenous
people are less likely to be listed for transplantation, and wait longer for grafts, also resulting in
poorer survival (4).
Little is known about the early causal pathways leading to these health disparities. Other studies
have documented disease end-points in high-risk, geographically isolated, and disadvantaged
communities (1,2,4), but have not accounted for the likely multi-determinant causes, including
socio-demographic confounders. There are no studies describing the natural history of early
chronic kidney disease markers in Indigenous children compared with non-Indigenous children.
The aim of our study was to determine the prevalence of persistent markers of chronic kidney
disease in Australian Aboriginal and non-Aboriginal children, and whether ethnicity, geographic
remoteness and social disadvantage predict for persistent markers of chronic kidney disease.
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7.3: Methods
Selection of participants: Government-run primary schools were approached for testing from
urban, coastal, rural and remote locations in areas where Aboriginal people are known to live
across the state of New South Wales. This state has the highest Aboriginal population in
Australia. To maximise power, sampling was done to obtain equal numbers of Aboriginal and
non-Aboriginal children, and in similar proportions from urban, coastal, rural and remote areas.
All primary schools in remote communities were approached and other areas were sampled if
greater than twenty Aboriginal children in the relevant age range attended. We attempted to
enrol all Aboriginal students from participating schools, and to age and gender match them with
arandom sample of non-Aboriginal students. Participation rates for both Aboriginal and non-
Aboriginal students from each school were 85-100%.
Aboriginal status was determined using the Australian Bureau of Statistics best practice
recommendations, asking the Standard Indigenous Question on the consent form "Is your child
of Aboriginal or Torres Strait Islander origin?" (5). All Aboriginal children in the participating
primary schools were offered testing for height, weight, blood pressure and urinary dipstick
abnormalities. We aimed to recruit equal numbers of boys and girls, Aboriginal and non-
Aboriginal children, and approximately equal numbers of children from each 12 month age
group.
Aboriginal community engagement: Consultation with local Aboriginal Medical Services and
consent from community leaders was undertaken prior to commencement of the study.
Approval was obtained from the Ethics Committees of the Children's Hospital at Westmead, the
University of Sydney, New South Wales Area Health Services and the New South Wales
Department of Education and Training. Informed consent was obtained for each child and, in
accordance with NHMRC Guidelines for Ethical Conduct in Aboriginal and Torres Strait Islander
Research (6), data were collected onto a standardised form and de-identified for storage and
analysis before being returned to each community after the study visit. Permission to publish
data was also obtained from each community.
Measurement of markers of chronic kidney disease: Markers of chronic kidney disease
measured were haematuria, albuminuria, obesity and systolic and diastolic hypertension. Risk
factors known and thought to be associated with the development of these markers in
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Aboriginal and non-Aboriginal people were also recorded, including age, gender, growth
parameters, birth weight and environmental health determinants: measures of geographic
isolation and social disadvantage.
Amorning clean catch specimen was collected from each child, with dipstick analysis for
haematuria, and albuminuria performed at the survey site on fresh specimens using a Bayer
Clinitek 50 machine n. Leukocytes and nitrites were also recorded for later adjustment for
abnormalities of presumed urinary tract infection. Girls older than eight years who were found to
have haematuria were questioned about menses, and if appropriate, collection was performed
at another time. According to Kidney Disease Outcomes Quality Initiative (K100QI) definitions,
haematuria was defined as greater than or equal to 25 RBC per microlitre (1 +), and albuminuria
as albumin:creatinine (ACR) greater than or equal to 3.4 mg/mmol (8).
Birth weight was provided by the parent/carer by recall or from the child's health record. Height
was measured in stocking feet to the nearest 0.1 em with a SECA 220 telescopic portable
stadiometer (9) that was calibrated between screening visits. Weight was measured in stocking
feet and in school uniform on digital scales to the nearest 0.01 kg. Body mass index (BMI)
standard deviation z-scores (SO) were calculated using an age and sex-adjusted program Co).
Blood pressure was measured on the right arm with the child sitting, using an aneroid
sphygmomanometer and the largest cuff to encircle the arm and cover at least three-quarters of
the length of the upper arm C1). In children less than 13 years, diastolic pressure was measured
at the point of muffling (Korotkov 4). For older children the point of disappearance was used
(Korotkov 5) C2). Systolic and diastolic hypertensions were defined as blood pressure greater
than the 95th percentile for age and gender (12).
Follow-up measurements were performed two and four years after baseline testing at the
primary or new high school on all available children, and the frequency of persistent chronic
kidney disease markers (markers detected at baseline, at two-year and at four-year follow-up,
or in children with only a baseline and final test, markers detected at both baseline and follow-
up) was ascertained.
Standardisation of urban, coastal, rural and remote locality was made using the Accessibility
and Remoteness Index of Australia (ARIA++), with each subject given an Index score according
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to their postcode of residence C3). Using geographical information system (GIS) capabilities,
distances, services and population density for each locality are converted to a continuous
variable with values ranging from zero for high accessibility, to 18 for extreme remoteness C4).
ARIA++ values for this NSW study ranged from 0 to 14, and for categorical analysis the scores
were grouped into quartiles. Isolation categories (and ARIA++ score range) used were: Least
ISolation (0-1.1), low-mid isolation (1.2-2.4), high-mid isolation (2.5-4.9) and highest isolation
(5.0-14.0).
To determine the level of social and economic well being of areas studied, the Socio-Economic
Indexes for Areas 2001 C5) Index of Disadvantage was applied to subjects at the level of
collection district of residence. This is the smallest geographic area for which the Index is
available, and includes approximately 200 households. The Index of Disadvantage is a
continuous score, and is based upon characteristics such as low income, lower level of
education, high unemployment, and unskilled jobs. It has been standardised to a mean of 1000,
and a standard deviation of 100 across all collection districts in Australia, ie, 95% of scores are
between 800 and 1200. Higher scores indicate higher socio-economic status (SES) and least
disadvantage. For categorical analysis, the scores were grouped into quartiles: Highest
disadvantage (680-835), high-mid disadvantage (836-960), low-mid disadvantage (961-988)
and least disadvantage (989-1103).
I
Data analysis: Comparisons between Aboriginal and non-Aboriginal children at final follow-up
were made by gender, age groups, birth weight quartiles, body mass index SO quartiles, and
categories of isolation and disadvantage using the chi-squared test. Comparisons between
children at final follow-up and children with only baseline or baseline and two-year follow-up
were also made according to these categories using the chi-squared test. Adjusted relative risks
for baseline and persistent markers of chronic kidney disease in Aboriginal compared with non-
Aboriginal children (referent group) were determined using logistic regression, with 95%
confidence intervals. Adjusted relative risks for other potential predictors of persistent chronic
kidney disease markers (gender, age, birth weight, body mass index, geographic isolation and
social disadvantage) were determined using logistic regression, with the lowest risk category for
I each predictor being the referent group, with 95% confidence intervals. Analyses were adjusted
where appropriate for ethnicity, age, gender, body mass index SO, birth weight and categories
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of isolation and disadvantage. Adjustment was made in all analyses for the effect of cluster
sampling by school.
Tests for interactions between ethnicity, gender, age, categories of isolation, disadvantage and
other significant variables in the final model were performed. Significance was set at a p-value
of <0.05 for main effects and interactions. Statistical analysis was completed using SAS C6 ) and
SPSS software C7 ).
I We planned to collect data at baseline from 1000 Aboriginal and 1000 non-Aboriginal children
which were sufficient to detect differences in prevalence of markers of chronic kidney disease
between the two groups of 2.9 versus 1.1 %, 5.5 versus 2.9%, 8.2 versus 6.0%, and 9.4 versus
7.2% at 80% power for haematuria, albuminuria, obesity and systolic hypertension respectively.
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7.4: Results
Baseline recruitment and follow-up (figure 7.4.1) From February 2002 to June 2004,2266
children were enrolled from 37 primary schools across New South Wales. There were 1248
(55.1%) Aboriginal children, 51% were male, and the mean age was 8.9 years <± SD 2.0 years).
Amore detailed description of baseline characteristics has been reported elsewhere C8). At two-
year follow-up from March 2004 to December 2006, there were 1432 (63.0%) children available
lor re-testing; 773 (54.0%) were Aboriginal, 50.4% were male, and the mean age was 10.5
years <± SD 2.0 years). At four year follow-up from February 2006 to December 2007, 1506
children (66.5%) were re-tested, 1248 (55.1 %) were Aboriginal, 51.0% were male, and the
mean age was 13.3 years <± SD 3.2 years).
Characteristics of the Aboriginal and non-Aboriginal children at final follow-up (table 7.4.1) At
final follow-up, there were proportionally more Aboriginal children in the youngest age groups
and from the areas of highest isolation and disadvantage (all p<0.0001). This was also the case
at baseline (18). There were more Aboriginal children with lower birth weights at final follow-up
(p=0.001). When comparing the overall group at final follow-up to those children without a final
follow-up, there were significantly more children from the older age groups who had no final
follow-up (p<0.0001). There were no differences in ethnicity, gender, birth weight, 8Ml SD and
isolation and disadvantage categories between children at final follow-up and those children
without a final follow-up.
Prevalence of baseline and persistent markers of chronic kidney disease in Aboriginal and non-
Aboriginal children (table 7.4.2) Markers of chronic kidney disease at baseline were frequent;
haematuria (5.5%), albuminuria (7.3%), obesity (7.1 %), systolic hypertension (3.0%) and
diastolic hypertension (1.9%). There was no increased risk of baseline markers in Aboriginal
children as compared with non-Aboriginal children, with the exception of haematuria, 7.1 %
versus 3.6% (adjusted OR 2.25, 95% CI 1.37-3.69, p=0.001).
At four-year follow-up, the overall prevalence of persistent markers was much less frequent;
haematuria (1.9%), albuminuria (2.4%), obesity (5.0%), systolic hypertension (1.5%) and
diastolic hypertension (0.2%). There was no increased risk for any persistent marker in
Aboriginal children when compared to non-Aboriginal children, even after adjustment for
geographic remoteness and social disadvantage.
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Physiological and environmental predictors of persistent markers of chronic kidney disease
(table 7.4.3)
Females had a four times increased risk of persistent haematuria when compared to males
(adjusted RR 4.31, 95% CI 1.61-11.63, p=0.001). There was an increasing risk for persistent
systolic hypertension with increasing 8MI SO (trend p<0.0001), and the highest 8MI SO quartile
had a 19 times increased risk for persistent systolic hypertension when compared to the lowest
8MI SO quartile (adjusted RR 19.05, 95% CI 2.54-43.09, p<0.0001). There were no other
predictors for persistent markers of chronic kidney disease in these children, in particular,
persistent markers were not predicted by lower birth weight, geographic remoteness or social
disadvantage.
Association between persistent markers of chronic kidney disease (figure 7.4.2) This figure
demonstrates the clustered association between persistent CKO markers, systolic hypertension,
diastolic hypertension and obesity. All children with persistent diastolic hypertension had
persistent obesity, and most had persistent systolic hypertension. Half the children with
persistent systolic hypertension had persistent obesity.
There were no interactions found between environmental health determinants of geographic
isolation and social disadvantage and ethnicity, age, gender or other covariates in any model.
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7.5: Discussion
This study is the first population-based follow-up of risk for chronic disease in Indigenous
children and youth. It also includes a non-Indigenous comparator group, and measures and
adjusts for social disadvantage and geographic isolation. Non-Indigenous comparators are
essential in eliciting the magnitude of increased risk for Indigenous children against the
background population rates, and measurement of socio-demographic factors is important in
adjusting for the potentially confounded relationship between health, isolated living and social
disadvantage. This four-year follow-up study has shown that persistent markers of chronic
kidney disease are infrequent, and there is no increased risk for persistent markers in Aboriginal
children when compared to non-Aboriginal children, even after adjustment for social
disadvantage and geographic isolation.
Our cross-sectional survey of this cohort showed that baseline markers of chronic disease were
frequent in Aboriginal and non-Aboriginal elementary school-aged children, and that at a single
test, Aboriginal children have twice the risk of haematuria as non-Aboriginal children. Other
Indigenous studies have a similarly high cross-sectional prevalence of haematuria and
albuminuria in children C9) (20). These studies are from extremely disadvantaged communities
with high rates of end-stage kidney and cardiovascular disease. Without follow-up testing, or
comparative data from a non-Indigenous group, the assumption has been that these frequent
one-off markers lead to the high states of disease seen in adulthood, and that ethnically-based
biological effects are causative (21). Our follow-up results show that more than 70% of baseline
urinary and blood pressure abnormalities in Australian Aboriginal and non-Aboriginal children
and youth are transient. Semi-quantitative single estimations of urinary blood and protein in
children vary according to posture, illness, exercise and time of day (22). A higher rate of
transient haematuria may reflect the higher incidence of transient disease seen in Indigenous
children, such as post-infectious glomerulonephritis (23). The persistence of these markers are
infrequent in our cohort, and do not occur more frequently in Aboriginal children. The finding
that young females are more at risk of persistent haematuria is novel, and may be influenced by
a growing percentage of menstruating females within the cohort, although we attempted to test
these young women at a different time. Further investigation and longer-term follow-up of these
children is underway to determine the underlying cause of this association.
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Obesity is the only frequent persistent marker of chronic kidney disease in these children,
although no more so in Aboriginal children. Persistent obesity of 5.0% found in our study is
similar to national rates of obesity in Australian elementary school-aged children of 6% (24).
Increasing BMI and persistent obesity were significantly associated with persistent systolic and
diastolic hypertension. These children with clustering of CKD markers are also particularly at
risk for early onset diabetes and cardiovascular disease (25)(26).
This follow-up study was challenging because of high rates of school absenteeism and family
mobility, however our follow-up rate at four years improved upon our two-year follow-up rate
due to better community liaison and engagement with Aboriginal Area Health Workers. The
group lost to follow-up was not significantly different to those who we were able to follow, apart
from a higher proportion of older children lost who were absent or no longer at school. This may
have introduced ascertainment bias, but our follow-up rate of 70% is high, given the nature and
setting of the cohort. The regression analyses for risk of chronic kidney disease markers in
Aboriginal children were adjusted for age to account for these imbalances.
The study was adequately powered to find small differences in risk for markers of chronic
kidney disease if they existed between Aboriginal and non-Aboriginal children. Measurement of
the main predictor of risk, Aboriginal status, was performed using best practice
recommendations (5). Measurement of social disadvantage and geographic isolation was made
using standardised systems that have been applied reliably in geographically and ethnically
similar population-based samples (27). We accept that unmeasured confounding from individual-
level socio-economic factors remains as a study bias (28). With further data collection, multi-level
analyses could be used to identify, measure and correct for ecological bias when spatially-
aggregated measures are applied to individual data, an approach we will use for future follow-
up (29). Parentally recalled birth weight has been shown as a reliable proxy for recorded birth
weight in population-based research (30).
Have we omitted or misclassified outcome measures of early chronic kidney disease in these
children? Albuminuria is the strongest predictor of death, cardiovascular disease and end-stage
renal disease in Aboriginal adults (31)(32). Spot ACR, at the cut-off used in this study, has good
receiver operator curve characteristics for detecting pathological albuminuria (33). Blood
pressure was measured using appropriate cuff sizes, with repeat measures performed in
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hypertensive children. Obesity was determined using 8MI standard deviations, which has been
validated for use in this age group of children (34), and our prevalence of obesity is comparable
to national surveys (24). Measurement of outcomes such as central obesity, blood lipid, glucose
and insulin levels would have been desirable for evidence of pre-diabetes and the metabolic
syndrome es), however measuring all possible risk factors was beyond the practicalities and
community acceptance for such a large school-based screening study. Painful and
embarrassing procedures would have been counter-productive to the success of our follow-up
recruitment rates.
Within New South Wales, Australia, there is no increased risk for persistent markers of chronic
kidney disease in Aboriginal children. This suggests that the increased risk for chronic kidney
disease experienced by Aboriginal adults in Australia is not yet established in this age group,
and social health determinants are likely to be influential in the later development of this
increased risk. These results also show that a one-off measurement of markers of chronic
kidney disease in children is misleading as most abnormalities are transient. Persistent obesity
clusters closely with persistent hypertension, and its frequency suggests it should be addressed
from a primary school age. These results proVide useful information for primary health care
practitioners, paediatricians, nephrologists, policy-makers and families.
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Figure 7.4.1: Flow diagram of subjects and CKD markers at baseline, two-year and four-year follow-up
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Table 7.4.1: Baseline characteristics of children at four-year follow-up stratified by ethnicity
All % Aboriginal % Non- % P
,riable Subjects Aboriginal
N=1506 N=807 N=699
;ender
\lale 775 51.5 410 50.8 365 52.2 0.59
Female 731 48.5 397 49.2 334 47.8
IgC groups (years)
1-5.9 211 9.3 95 11.8 47 6.7 <0.0001
~.9 281 12.4 119 14.7 83 11.9
'·7.9 330 14.6 138 17.1 100 14.3
8·8.9 336 14.8 134 16.6 101 14.4
9-9.9 351 15.5 103 12.8 140 20.0
10-10.9 361 15.9 104 12.9 112 16.0
11-14.8 396 17.5 114 14.1 116 16.6
Birth weight quartiles (g)*
412-2920 258 25.0 138 30.1 120 20.9 0.001
1921-3316 266 25.8 120 26.2 146 25.4
J317-3685 255 24.7 108 23.6 147 25.6
3686-5272 253 24.5 92 20.1 161 28.0
!m SD quartiJes*
·4.8 to -0.8 357 23.9 207 25.8 150 21.8 0.30
-0.7 to 0.1 369 24.7 195 24.3 174 25.3
0.2 to 0.7 390 26.2 200 24.9 190 27.6
0.8 to 6.9 375 25.2 200 24.9 175 25.4
:;eographic Isolation (ARIA score)
Least isolation (0-1.1) 410 27.2 206 25.5 204 29.2 <0.0001
Low-mid isolation (1.2-2.4) 424 28.2 220 27.3 204 29.2
High-mid isolation (2.5-4.9) 329 21.8 149 18.5 180 25.8
Highest isolation (5.0-14.0) 343 22.8 232 28.7 1I 1 15.9
lO(ial Disadvantage (SElFA score)
Least disadvantage (989-1103) 548 24.2 273 21.9 275 27.0 <0.0001
Low-mid disadvantage (960-988) 585 25.8 287 23.0 298 29.3
High-mid disadvantage (836-960) 576 25.4 334 26.8 242 23.8
Highest disadvantage (680-835) 557 24.6 354 28.4 203 19.9
Abbreviations: ARIA, Accessibility and Remoteness Index of Australia; BMI, body mass index; SO,
standard deviation; SElFA, Socio-Economic Indexes For Areas.
·Indicates where data does not equal column totals.
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Table 7.4.2: Prevalence of baseline and persistent markers of chronic kidney disease in Aboriginal and
non-Aboriginal children
Baseline Persistent
ic kidney disease markers All Non- Aboriginal p All Non- Aboriginal p
Aboriginal Aboriginal
(referent (referent
category) category)
'fUria ~ 2S RBC per OPF,H)
,L, ('Vo) J?2 36 (3.6) 86(7.1) 25 12 (2.0) 13 (1.8)
,'ted RR • •(5.5) 1.00 2.25 (1.37-3.69) 0.00 I (1.9) 1.00 0.92 (0.50-2.45) 0.81
•nuria (ACR mglmmol)
(%) 157 63 (6.5) 94 (8.1) 36 17 (2.4) 19 (2.4)
,led RR' (7.3) 1.00 1.37 (0.93-2.0 I) 0.11 (2.4) 1.00 0.97 (0.53-2.01) 0.92
Iy (BMI~2SD)
('!o) 145 63 (6.7) 82 (7.4) 75 30 (4.3) 45 (5.6)
ed RR' (7.1 ) 1.00 1.10 (0.76-1.44) 0.52 (5.0) 1.00 1.32 (0.82-2.11) 0.25
'ie hypertension (SBP>9S"
)
,('Vo) 66 26 (2.6) 40 (3.2) 23 7 (1.0) 16 (2.0)
dRR' (3.0) 1.00 1.26 (0.77-2.09) 0.36 (1.5) 1.00 2.00 (0.82-5.00) 0.12
~e hypertension (DBP>9S"
,)
('Vo) 42 15(1.5) 27 (2.2) 3 1 (0.1) 2 (0.2)
."Ied RR'f' (1.9) 1.00 1.47 (0.78-2.80) 0.23 (0.2) 1.00 1.74 (0.15-19.2) 0.65
• p<O.OS
'Adjusted for age, gender, birth weight, BMI SO, systolic BP, diastolic BP, isolation category and
disadvantage category.
Definitions: Persistent marker, marker found at both baseline and follow-up.
Abbreviations: ACR, albumin:creatinine; BMl, body mass index; OBP, diastolic blood pressure; RR,
relative risk; SBP, systolic blood pressure; SO, standard deviation.
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Ilaematuria Albuminuria Obesity Systolic H~eertensiou
t ARR!Predictor N (%) ARR' N (%) ARR' N (%) N (%) ARR
{95% CI) {95% CI) {95% CI) {95% CI)
Gender
Male· 5 (0.7) 1.00 14 (1.8) 1.00 43 (5.5) 1.00 10 (1.3) 1.00
Female 20(3.1) 4.31 (1.61-11.63) 22 (3.0) 1.69 (0.86-3.33) 32 (4.4) 0.78 (0.49-1.25) 13(1.8) 1.39 (0.61-3.18)
Birth weight
> 2500· 15(1.7) 1.00 24 (2.4) 1.00 46 (4.6) 1.00 19(1.9) 1.00
< 2500g 2 (2.4) 1.39 (0.31-6.16) 2 (2.0) 0.83 (0.19-3.54) 6 (5.9) 1.32 (0.55-3.17) I (1.0) 0.52 (0.07-3.92)
BMI SO quartiles
4.8 to -0.8· 8 (2.6) 1.00 10 (2.8) 1.00 -
-
I (0.3) 1.00
-0.7 to 0.1 3 (0.9) 0.34 (0.09-1.34) II (3.0) 1.07 (0.45-2.54) -
-
o(0.0) 0.49 (0.02-14.50)
0.2 to 0.7 8 (2.3) 0.89 (0.33-2.39) 8 (2.1) 0.73 (0.28-1.87) -
-
3 (0.8) 2.77 (0.29-26.72)
0.8 to 6.9 6 (1.9) 0.71 (0.24-2.06) 7 (1.9) 0.66 (0.25-1.75)
- -
19(5.1) 19.05 (2.5443.09)t
Isolation
Least isolation· 9 (2.4) 1.00 12 (2.9) 1.00 19(4.6) 1.00 7 (1.7) 1.00
Low-mid isolation 11 (2.6) 1.07 (0.44-2.61) 7 (1.7) 0.56 (0.22-1.43) 26(6.1) 1.35 (0.73-2.48) 12 (2.8) 1.67 (0.654.28)
High-mid isolation 2 (1.1) 0.46 (0.10-2.16) 7 (2.1) 0.72 (0.28-1.86) 9 (2.7) 0.58 (0.26-1.32) 2 (0.6) 0.35 (0.07-1.70)
Highest isolation 3 (0.9) 0.36 (0.10-1.32) 10 (2.9) 0.99 (0.42-2.33) 21 (6.1) 1.35 (0.71-2.55) 23 (1.5) 0.34 (0.07-1.63)
Social disadvantage
Least disadvantage· 8 (2.3) 1.00 9 (2.6) 1.00 19 (5.5) 1.00 7 (2.0) 1.00
Low-mid disadvantage 4 (0.9) 0.40 (0.12-1.33) II (2.6) 0.98 (0.40-2.40) 19 (4.4) 0.79 (0.41-1.53) 9 (2.1) 1.04 (0.38-2.81)
High-mid disadvantage 8 (2.7) 1.17 (0.43-3.16) 6 (1.6) 0.60 (0.21-1.70) 18 (4.8) 0.86 (0.44-1.66) 3 (0.8) 0.39 (0.10-1.51)
Highest disadvantage 5 (2.0) 0.86 (0.28-2.65) 10 (2.8) 1.08 (0.43-2.68) 19 (5.4) 0.97 (0.50-1.86) 4 (1.1) 0.55 (0.16-1.90)
*Referent category
t Trend p < 0.05
'Adjusted for ethnicity, age, gender, body mass index, birth weight, blood pressure and categories of isolation and disadvantage.
Abbreviations: ARR, adjusted relative risk; 8Ml, body mass index; SO, standard deviation.
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Figure 7.4.2: Association between persistent markers of chronic kidney disease - systolic
hypertension, diastolic hypertension, obesity.
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8.1 : Discussion
The literature describing ESKD in Indigenous people is plentiful; however the vast
majority concentrates on a few remote groups and lacks non-Indigenous comparators.
When compared to Caucasians and national populations, the risk for all-cause ESKD is
universally greater among the Indigenous groups of the USA, Canada, Australia, New
Zealand and Venezuela. Most of this excess risk is due to a higher incidence of diabetic
ESKD. The reasons for this interaction between diabetes and risk for ESKD in
Indigenous populations has not yet been properly explored through examination of
physiological as well as environmental differences. Other non-Indigenous,
disadvantaged groups with higher rates of ESKD, such as African Americans, share
these socio-demographic risk factors, and have comparable rates of ESKD to
Indigenous people.
Of the few comparative studies describing risk for ESKD in Indigenous people
compared to non-Indigenous people, there are no observational or prospective studies
available, resulting in a lack of information on the early causal chain to these disease
outcomes. Most comparative studies are retrospective registry and hospital record
reviews, with the inherent bias of misclassification of Indigenous status, under-
ascertainment of ESKD through recording of treated cases only, and lack of
measurement of socio-demographic risk factors for chronic and end-stage kidney
disease. Many community-based or tribal studies lack an adequate non-Indigenous
comparator who shares the socio-demographic risk for the area. The results of these
studies are not readily applied to the broader Indigenous community. For all of the
countries included in this review, the majority of Indigenous people reside in urban
areas, where local non-Indigenous comparators are available and population-based
prospective studies are possible.
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What this study adds
The cross-sectional studies reported in this thesis are the first to describe the
prevalence of early markers of chronic kidney and cardiovascular disease in a
population-based sample of Aboriginal children as compared with non-Aboriginal
children. They also describe the association between risk for markers of chronic disease
and socio-demographic determinants of health. This research is the first to describe the
natural history of chronic kidney disease in Indigenous people, and to define important
risk factors so that preventative measures and better research may be developed.
The study on the diagnostic test accuracy is the first to assess the validity of proteinuria
dipsticks in detecting baseline and persistent albuminuria in Aboriginal and non-
Aboriginal children, and in subsets of children at higher risk of chronic kidney disease.
This is important research for informing primary-care, paediatric and other physicians
who work in remote Indigenous and other communities.
The prospective results are the first to describe the prevalence of more important
persistent markers of chronic kidney disease in Aboriginal and non-Aboriginal children,
and the risk for disease after accounting for socio-demographic differences.
Results - baseline (cross-sectional data, chapters 3 & 4)
Early markers of chronic kidney disease
The overall prevalence of baseline abnormalities was frequent; haematuria was 5.5%,
proteinuria 7.3%, and albuminuria 7.3%. Only haematuria was more frequent in
Aboriginal children (7.1 % versus 3.6%, p=O.002). Socio-economic disadvantage and
geographic isolation were neither significant nor consistent risk factors for any marker of
chronic kidney disease.
Early markers of cardiovascular disease
Risk factors measured for cardiovascular disease (obesity, albuminuria and systolic and
diastolic hypertension) are already common in young children. Obesity was detected in
7.1 %, albuminuria in 7.3%, systolic hypertension in 7.2% and diastolic hypertension in
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5.9%, with no differences in the prevalence of these risk factors between Aboriginal and
non-Aboriginal children. Hypertension was less common with increasing social
disadvantage, even after adjustment for body mass index (trend p<0.02). Increasing
body mass index standard deviation was strongly associated with systolic and diastolic
hypertension (both p<0.0001).
Results - prospective (two-year follow-up data, chapters 5 & 6)
Dipstick detection of albuminuria
Proteinuria dipsticks had a sensitivity of 62% and specificity of 97% at baseline. In
predicting persistent albuminuria, sensitivity was 75%, specificity 93%. Accuracy of
dipsticks did not vary with ethnicity, gender or body mass index. Accuracy was less in
younger children (4.0-7.9 years), and in children with haematuria.
Persistent markers of chronic kidney disease at first follow-up
Besides persistent obesity (5.3%), overall persistence of risk factors for chronic kidney
disease was low (systolic hypertension 1.1 %, diastolic hypertension 0.2%, haematuria
1.1 %, and albuminuria 1.5%). While there were more Aboriginal than non-Aboriginal
children with baseline haematuria (7.1% versus 3.6%, p=0.002), after adjustment for
age, gender, birth weight and socio-demographic status, there were no differences in
risk for the more important persistent chronic kidney disease markers between
Aboriginal and non-Aboriginal children.
Results - prospective (four-year follow-up data, chapter 7)
Persistent markers of chronic kidney disease at final follow-up
Prevalence of baseline CKD markers was frequent, but most abnormalities found at
baseline were transient. Besides persistent obesity (5.0%), persistence of CKD markers
at final follow-up were infrequent; haematuria (1.9%), albuminuria (2.4%), systolic
hypertension (1.5%) and diastolic hypertension (0.2%). After adjustment for socio-
demographic inequities, there was no difference in prevalence of persistent markers of
CKD between Aboriginal and non-Aboriginal children.
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Conclusions
The frequency of early markers of chronic kidney and cardiovascular disease at a single
test in New South Wales primary-school aged Aboriginal and non-Aboriginal children is
high. The frequency of the more important persistent markers of chronic disease is low,
besides obesity, which remains high. This highlights the importance of follow-up testing
in the detection of chronic disease markers, as 70-80% of abnormalities at a single test
will not persist. It also highlights the importance of intervening early in young obese
children, who are likely to remain obese without intervention.
At a single test, Aboriginal children from New South Wales, Australia have a higher
prevalence of haematuria, however they have no higher risk of any other marker. This
may reflect the higher rates of certain transient diseases in Aboriginal children, such as
post-infectious glomerulonephritis. These Aboriginal children have no higher risk of the
more important persistent markers of chronic kidney disease when compared to non-
Aboriginal children. Social disadvantage and geographic isolation carried no higher risk
of chronic disease in these children.
The performance characteristics of proteinuria dipsticks make them suitable for
albuminuria screening in Aboriginal and other higher risk groups of children, and they
are particularly useful for detecting children who will have persistent albuminuria.
Future directions
This work has established the natural history of early markers of chronic kidney and
cardiovascular disease in primary-school aged Aboriginal and non-Aboriginal children
from New South Wales, Australia, and shown that Aboriginal children and youth have
no increased risk for chronic disease when compared to non-Aboriginal children. Most
abnormalities are transient, and follow-up testing is important. Proteinuria dipsticks are
a cheap, portable and reliable method of detecting baseline and persistent albuminuria
in all children.
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This is important information in determining the causal chain of events towards
development of end-stage kidney disease. These findings suggest that these Aboriginal
children are not 'born into' a higher risk of chronic kidney disease, and that the three-
fold higher risk for end-stage disease experienced by New South Wales Aboriginal
adults is not yet manifest in Aboriginal children. This implies that higher risk of chronic
kidney disease develops in early adulthood, and that ongoing comparative studies are
needed to determine the contribution made by socio-demographic disadvantage to risk
of disease. The ARDAC Second Phase Study will follow this cohort of children for a
further six years (2008-2013), with additional anthropometric, laboratory and individual-
level socio-demographic data in order to document the natural history of chronic kidney
disease in Aboriginal young adults.
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APPENDIX 1: PARENT INFORMATION SHEET
Centre for Kidney Research
NHMRC Centre for Clinical Research Excellence in Renal Medicine
Phone: + 61 2 9845 3037
Fax: + 61 298453038
Email: ckr@chw.edu.au
Website:www.kidney-research.ora
Parent information sheet
The History of Renal Disease in Aboriginal Children in NSW (ARDAC study)
Investigators
Dr Jonathan C Craig
Dr Elisabeth Hodson
Dr Leigh Haysom
Ms Rita Williams
Ms Rhonda Sharples
Prof L Paul Roy
(Centre for Kidney Research)
Phone: 9845 3431
Phone: 9845 3430
Phone: 9845 3041
Phone: 9845 3019
Phone: 9845 3019
Phone: 9845 3037
Phone: 9845 3037
We know that many Aboriginal people develop complete kidney failure and require kidney
dialysis treatment or a kidney transplant. Research in the Northern Territory has shown that
many Aboriginal children have blood in their urine, suggesting that they could develop kidney
problems when they get older. In addition research in Aboriginal adults suggests that, if kidney
disease is detected early, treatment can be offered that may prevent kidney failure.
In NSW we do not know whether many Aboriginal children have blood in their urine or whether
Aboriginal children are more likely than non-Aboriginal children to have blood in their urine.
We believe it is important to find this out so we would like to carry out a research project to test
urine specimens from Aboriginal and non-Aboriginal children in different areas in New South
Wales. We hope the information we obtain from this study will help to determine how common
such early signs of kidney problems are in Aboriginal children and in non-Aboriginal children in
NSW.
We would like to ask you if you will let your child take part in the kidney testing study at your
school. This will involve a urine test, measuring blood pressure and recording your child's height
and weight. No blood tests will be taken as part of this study. We will send the results of the tests
to you. We can also send the results of the tests, if they are abnormal, to your own doctor if you
give us permission to do this.
If you would like your child to take part in the study, please fill out the consent form and
Sections A and B on the data collection form and give it to your child to bring back to the school.
We may not be able to test all those who have agreed to take part in the study as we are only able
to test about 200 children from each of the areas, where we are doing the study.
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We will make sure that all the infonnation collected in this study is kept confidential. All
infonnation will be entered into a database, which is accessed only by the staff at the Centre for
Kidney Research at The Children's Hospital at Westmead. Also it is a Hospital rule that
confidential infonnation kept on computer databases will be deleted and paper copies will be
shredded after 15 years. The results of the study will be provided to the Aboriginal communities
and will not be published without their pennission.
Please remember that, if you don't want to, you do not have to let your child take part in the
kidney testing study at your school.
If you have any concerns about how this study will be carried out, please do not hesitate to
discuss them with Rita Williams, one of the investigators (Tel: 02 9845 3019) or with Anne
O'Neill (Tel: 02 9845 1316), the Secretary of the Ethics Committee of the Children's Hospital at
Westmead, that has approved this project.
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APPENDIX 2: SCHOOL PRINCIPAL INFORMATION SHEET
Centre for Kidney Research
NHMRC Centre for Clinical Research Excellence in Renal Medicine
Phone:+ 61 298453037
Fax: + 61 2 98453038
Email: ckr@chw.edu.au
Website:
Dear Principal
www.kidney-research.org
Research Project: Antecedents of Renal Disease in Aboriginal Children
It is now widely recognised that there is an epidemic of renal disease among Aboriginal people
throughout Australia. Aboriginal people are 8 to 13 times more likely to develop renal failure, and
they do so at an earlier age than other Australians. Recent evidence from the Northern Territory and
elsewhere suggests that if renal disease is diagnosed early, effective prevention strategies can be
introduced to delay or in some cases prevent progression to the need for dialysis. In surveys
performed in the Northern Territory, it is clear that a significant number of Aboriginal children
already have evidence of renal disease.
Currently the extent to which this problem also affects children in New South Wales remains
unclear. In 2002 the staff of the Centre for Kidney Research at the Children's Hospital at Westrnead
surveyed 1000 children (500 Aboriginal children with 500 non-Aboriginal children as a comparison
group) in urban, rural and coastal settings to determine how many Aboriginal children had abnormal
urine tests, that could indicate a risk of kidney disease, and to find out how frequently these
abnormalities were found in Aboriginal children compared with non-Aboriginal children.
Preliminary analysis of the data suggests that the number of Aboriginal children with abnormalities
on urine testing is higher than the number of non Aboriginal children. However we need further
data to confirm this. We have received funding through an NHMRC Centre for dinical Research
Excellence grant to continue the survey in New South Wales schools. We hope that we can also
restudy children initially studied in 2002 and 2003 during the following 4 years to determine what
happens to these children in the short term.
We would like to invite students in your school to take part in the survey.
If you agree that your school can participate, the process will be as follows:
1. An explanation sheet and consent form will be sent home for parents or guardians of
Aboriginal and non-Aboriginal children.
2. If they agree to participate, a urine container will be sent home with the child.
3. On the screen day, the child will bring a sample of urine in the container provided. If
they forget, the sample can be collected at the school if the child is old enough to do this
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without help. The child will have their blood pressure taken and their height and weight
recorded. For statistical purposes the name, date of birth and address of the child will
also be recorded This information will be entered into a secure database with strict
privacyconsiderations and only aggregated data will be reported.
4. In the event that a child does show early signs of kidney disease, the information will be
sent to the child's parent or guardian so that the child can be taken to the family's doctor
of choice. Other families will be notified that the study revealed normal results.
We hope that your school will be able to join our survey. We ask that this proposal be discussed
with the Aboriginal Education Assistant and teachers in your school and a copy of this letter be
given to them For further information please don't hesitate to contact the undersigned
With kind regards
Yours sincerely
Dr Elisabeth Hodson
Head, Department of Nephrology
Dr Leigh Haysom
PhDFellow
Rita Williams
Senior Aboriginal Health Education Officer
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APPENDIX 3: CONSENT FORM
Centre for Kidney Research
NHMRC Centre for Clinical Research Excellence in Renal Medicine
Phone:+ 61 298453037
Fax: + 61 2 9845 3038
Email: ckr@chw.edu.au
Websife:www.kidney-research.orq
Investigators: Dr Jonathan C Craig, Dr Elisabeth Hodson, Ms Rita Williams, Dr Leigh Haysom, Prof L Paul Roy
CONSENT FORM
Antecedents of Renal Disease in Aboriginal Children in NSW (ARDAC study)
I have read and understood the Information Sheet, and give my consent for
............................ to participate in this research study.
I understand that I am free to withdraw from the study at any time and this decision will
not otherwise affect my child's care.
I give permission for the results of the tests, if abnormal:-
I. to be sent to my doctor, _
(insert name & address)
2. to be sent to the Aboriginal Medical Service
3. to be sent to my local Aboriginal Health Education Officer
(please circle your choices)
NAME OF CHILD: (Please print)
NAME OF PARENT OR CARER: (Please print)
RELATIONSHIP TO CHILD: (Please print)
SIGNATURE OF PARENT OR GUARDIAN .
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APPENDIX 4: DATA FORM
A. Child's details
1. Child's name: _
2. DateofBirth: __/~__
3. Sex: Male I Female (please circle)
4. Birth weight(ifknown): grams OR
Ibs oz
5. Address: _
_____ Post code _
6. Aboriginal or Torres Strait Islander / Non-Aboriginal
(please circle)
B Parent's Carer's/Guardian's details:
5. Mother/Father/Carer/Guardian: _
6. Contact phone No (optional): ( ) ---------------------:c
(The parents of any child whose results are abnormal and needs immediate action will be notified via phone)
7. Mobile phone number (optional):: _
C. Clinical details
8. Date screened: _/_/
9. Screened by:
10. Height: (em)
11. Weight: (kg)
12. Urine test result: Blood:
Protein:
13. Blood pressure:
14. Action taken:
Negative / Positive / trace + ++ +++ ++++
Negative / Positive I trace + ++ +++ ++++
IS. Other notes: _
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APPENDIX 5: SUPPORTING DATA FOR CHAPTER 2
Search strategy
The following search strategy was used to identify all epidemiological studies for
inclusion in the literature review "Epidemiology of end-stage renal disease in Indigenous
people" from these databases:
1. Medline and Premedline (1966 - present)
2. EMBASE (1980 - present)
3. All EBM Reviews including Cochrane databases
4. CINAHUATSI!Rural Health databases (1988 - present)
The fol/owing MESH and text terms were used to identify Indigenous people
Exp Oceanic ancestry group! or exp American native continental ancestry group! or exp
Alaskan native! or exp inuits
Aborigin$.tw
Koori$.tw
Torres Strait Islander$.tw
Maori$.tw
Pacific Islander$.tw
Manitoba.tw
James Bay Cree$.tw
Pima$.tw
Navajo$.tw
Gila River$.tw
Eskimo$.tw
Yanomami$.tw
Metis$.tw
First Nation$.tw
The fol/owing MESH and text terms were used to identify studies of end-stage
kidney disease
Exp Renal Replacement Therapy! or exp Renal Dialysis! or exp peritoneal dialysis! or
exp kidney failure! or kidney failure, chronic!
(Haemodialysis or hemodialysis).tw
peritoneal dialysis.tw
dialysis.tw
(haemofiltrat$ or hemofiltrat$).tw
(CAPD or CCPD or APD).tw
(ESRD or ESRF or ESKD or ESKF).tw
kidney graft$.tw
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renal graft$.tw
kidney transplant$.tw
renal transplant$.tw
renal insufficienc$.tw
chronic kidney disease$.tw
chronic renal disease$.tw
end stage renal disease$.tw
(end stage kidney failure or end stage renal failure or chronic renal failure).tw
The following MESH and text terms were combined with the above to identify
studies of frequency and aetiology
Review.pt
Meta analysis.pt
Systematic$ and (review$ or overview$).tw
Exp cohort-studies!
Exp case control studies!
Exp risk! or exp risk factors!
Odds.tw and ratio$.tw
Relative.twand risk.tw
Case.tw and control$.tw
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Early chronic kidney disease in Aboriginal and
non-Aboriginal Australian children: remoteness,
socioeconomic disadvantage or race?
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Indigenous people suffer substantially more end-stage kidney
disease (ESKD), especially Australian Aboriginals. Previous work
suggests causal pathways beginning early in life. No studies
have shown the prevalence of early markers of chronic kidney
disease (CKD) in both Indigenous and non-Indigenous children
or the association with environmental health determinants -
geographic remoteness and socioeconomic disadvantage.
Height weight, blood pressure, and urinary abnorrnal~ies were
measured in age- and gender-matched Aboriginal and
non-Aboriginal children from elementary schools across diverse
areas of New South Wales, Australia. Hematuria was defined as
;;> 2S red blood celis/pi (;;> 1 + ), proteinuria ;;> 0.30 gA (;;> 1+ ),
and albuminuria (by albumin:creatinine) ~ 3.4 mg/mmol.
Remoteness and socioeconomic status were assigned using the
Accessibility and Remoteness Index of Australia and Socie>-
Economic Indexes For Areas. From 2002 to 2004, 2266 children
(SS% Aboriginal, mean age 8.9 years) were enrolled from 37
elementary schools. Overall prevalence of hematuria was S.5%,
proteinuria 7.3%, and albuminuria 7.30/0. Only baseine
hematuria was more common in Aboriginal children (7.1 versus
3.6%; P = 0.002). At 2-year follow-up, 1.2% of Aboriginal children
had persistent hematuria that was no different from
non-Aboriginal children (P = 0.60). Socioeconomic disadvantage
and geographical isolation were neither significant nor
consistent risk factors for any marker of CKD. Aboriginal children
have no increase in albuminuria, proteinuria, or persistent
hematuria, which are more important markers for CKD. This
suggests ESKD in Aboriginal people may be preventable during
early adult life.
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Indigenous minorities have almost universally poorer health
outcomes than non-Indigenous majority populations world-
wide. This is particularly true for kidney disease. l -3 Australian
Aboriginal and Torres Strait Islander people (hereafter
referred to as Aboriginal) are eight times more likely to
develop end-stage kidney disease (ESKD) than non-Abori-
ginal people and are 10 years younger on average. They are
only half as likely to be listed for transplantation and have
almost 30% lower graft and 8% lower patient survival 5 years
post-transplantation. 1 This pattern of excessive burden due
to increased prevalence and poorer outcomes once ESKD
occurs is also found in the Inuit and Native Canadians in
Canada,2 Native Americans in the USA,3 and in the Maori
people of New Zealand.'
Why Indigenous peoples have such an excess risk of ESKD
is largely unknown. The three main causes of ESKD in
Aboriginal people are diabetic nephropathy, primary glomer-
ulonephritis, and hypertension.4 A much larger proportion of
ESKD in Aboriginal Australians is attributed to diabetic
nephropathy (47%) as compared with non-Aboriginal
Australians (17%); however, the ESKD excess is not explained
solely by differences in diabetic prevalence or comorbidities. 1
The causal chain contributing to chronic kidney disease
(CKD) may start at or before birth, with maternal factors':'
low birth weight and reduced nephron mass6 ,7 rendering the
kidney more vulnerable to diabetes and hypertension.
Marked regional differences in ESKD have been noted
between Aboriginal populations' and in ethnically homo-
geneous countries such as Japan, suggesting socio-demo-
graphic influences rather than genetic predisposition are
responsible.9 Environmental factors such as isolated living
and socioeconomic disadvantage may play the more
important role in the development of CKD.8
Current knowledge about the risk factors for CKD in
Aboriginal people in Australia is mainly limited to adult-
based research that comes from areas of high remoteness
and socioeconomic disadvantage in Northern Australia. This
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lacks non-Aboriginal control groups or adjustment for
variability in locality and sociodemographics. lo The aims of
our study were to determine whether the increased risk of
CKD in Aboriginal adults is evident in childhood, and to
determine whether environmental health determinants could
explain any difference in observed risk.
RESULTS
Baseline characteristics
From February 2002 to June 2004, 2266 children were
enrolled from 37 elementary schools across New South Wales
(Table I). There were 1248 (55.1%) Aboriginal and 1018
(44.9%) non-Aboriginal children; 51% were thale subjects,
and the mean age was 8.9 years (±3.8 years). There were
proportionally more Aboriginal children in the youngest age
group (4-6 years), in the lowest weight s.d. quartile (both
P<O.OOOI) and in the lowest systolic (P<O.OOOI) and
diastolic blood pressure quartiles (P = 0.02). Aboriginal
children were more likely to live within the categories of
highest isolation and disadvantage, and in the most remote
region (P<O.OOOI). There were no differences between the
groups for gender, birth weight, height s.d., and body mass
index s.d. quartiles.
Design effect estimates for the impact of cluster sampling
by school were small for all markers of CKD: 1.10 for
hematuria, 1.20 for proteinuria, and 1.28 for albuminuria.
Background prevalence of ESKD from the areas sampled
was 1170 cases per million Aboriginal population compared
with 740 cases per million non-Aboriginal population, with a
relative risk of ESKD in Aboriginal people of 1.58 (1.21-2.00),
P=O.OO1.
Prevalence of markers of CKD
The overall prevalence of hematuria was 5.5%, proteinuria
7.3%, and albuminuria 7.3% (Table 2).
Risk factors for markers of CKD
Aboriginolity. Aboriginal children were more likely to have
hematuria at baseline testing than non-Aboriginal children,
and this association was more significant after adjustment for
environmental health determinants and other covariates
(adjusted odds ratios (OR) 2.25, 95% confidence interval
(CI) 1.37-3.69, P = 0.001) (Table 2). Even after adjustment,
there were no differences in the frequency of proteinuria
(adjusted OR 0.93, 95% CI 0.68-1.27, P=0.65) or albumi-
nuria (adjusted OR 1.37, 95% CI 0.93-2.01, P= 0.11)
between the Aboriginal and non-Aboriginal children.
Persistent and non-persistent hematuria. At 2-year follow-up,
the overall prevalence of hematuria was 5.4%. At follow-up,
9/731 (1.2%) Aboriginal children had persistent hematuria,
compared with 6/643 (0.9%) non-Aboriginal children
(P= 0.60). There was also no difference in the frequency of
persistent and non-persistent hematuria between the Abori-
ginal and non-Aboriginal children (P=0.51).
Geographical isolation. Children from low-mid isolation areas
had a relatively low prevalence of hematuria (unadjusted OR
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0.36, 95% CI 0.18-{).71, P= 0.002) compared with the least
isolated-referent category, which did not change appreciably
with adjustmenti however, there was no evidence of a linear
trend in the association between isolation and frequency of
hematuria (trend P=0.05, non-trend P<0.05) (Table 3).
There was no association between prevalence of proteinuria
and isolation category. There appeared to be an inconsistent
relationship between isolation category and frequency of
albuminuria detected, with the most isolated children having
the lowest prevalence of albuminuria, especially after
adjustment for race and other environmental health deter-
minants (race adjusted OR 0.49, 95% CI 0.26-0.90, P = 0.01).
There was, however, no evidence of a linear trend between
isolation and frequency of albuminuria (trend P= 0.19).
Social disadvantage. No association between social disad-
vantage categories and markers of CKD was found (Table 4).
There was a trend for higher risk of proteinuria in less
disadvantaged children (P= 0.004).
Region. No association between regional categories and
markers of CKD was found. There was an increasing trend in
risk for proteinuria from urban to remote regions (P = 0.04),
but deviation from trend was also significant (P<0.05).
There were no interactions found between environmental
health determinants and race, age, gender, or other covariates
in any model.
DISCUSSION
Aboriginal children are no more likely to have early urinary
markers of CKD than non-Aboriginal children. There was a
higher prevalence of hematuria at baseline testing in
Aboriginal children, but there were no differences in the
rates of persistent hematuria between Aboriginal and non-
Aboriginal children. We were unable to show any consistent
clear association between proposed environmental determi-
nants of health - social disadvantage and isolation - and
markers of early CKD. Race is often used incorrectly as a
proxy for many risk factors in health that are indicators of
disadvantage, including geographical remoteness and socio-
economic status." We measured all these potential risk
factors in our study and have shown that neither racial nor
environmental risk factors appear predictive of early CKD.
Importantly, the association between environment and
markers of CKD was not altered by adjustment for Aboriginal
status. This is the first study designed to differentiate the
relative contributions of race and environmental health
determinants on early markers of CKD.
Our results are surprising as we expected to find an
increased prevalence of CKD, especially albuminuria, in
Aboriginal children and particularly in remote communities.
This hypothesis is largely based on studies of adult Aboriginal
people. In remote Aboriginal communities in the Northern
Territory of Australia, where the incidence of ESKD is the
highest in Australia and the world (1000-2500 cases per
million population annually), microalbuminuria and overt
albuminuria in Aboriginal adults are highly prevalent (23 and
30%, respectively). Over 1-8 years follow-up, albuminuria
Kidney International (2007) 71, 787-794
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Table 1 IBaseline sociodemographic and dinical charaderistics
All subjects Aboriginal % Non-Aboriginal %
Variable n=2266 % (n=1248) (n=1018) P-value
--
Gender
Male 1155 51.0 50.8 51.2
0.86
Female 1111 49.0 49.2 48.8
Age groups (years)
4-5.9 211 9.3 11.3 6.8 <0.0001
6-<;.9 281 12.4 13.6 10.9
7-7.9 329 14.5 15.2 13.7
8--8.9 337 14.9 14.8 14.9
9-9.9 351 155 13.5 18.0
10-10.9 361 15.9 13.8 18.6
11-14.8 396 17.5 17.8 17.1
Birth weight quartifes (gl
412-2920 217 25.7 29.6 22.1
0.08
2921-3316 210 24.9 23.1 26.4
3317-3685 210 24.9 24.4 25.3
3686-5272 208 24.6 22.9 26.2
Height s.d. quartiles"
-4.8--0.7 563 25.1 26.9 22.8
0.12
-0.8-0.1 564 25.1 24.6 25.7
0.2-1.0 558 24.8 24.7 25.0
1.1-4.8 562 25.0 23.8 26.6
Weight s.d. quartiles"
-6.6-0.5 560 24.9 28.3 20.8
<0.0001
-0.4-<).3 560 24.9 24.3 25.7
0.4-1.2 567 25.2 21.7 29.7
1.3-13.3 559 24.9 25.7 23.9
BMI S.d. quartiles"
-4.8--0.8 560 24.9 26.9 22.5 0.08
-0.7-0.1 562 25.0 24.0 26.3
0.2-0.7 566 25.2 24.0 26.7
0.8-6.9 558 24.8 25.1 24.6
Isolation category (ARIA score)
least isolation (0-1.1) 610 26.9 25.9 28.2 <0.0001
low-mid isolation (l.2-2.4) 639 28.2 27.2 29.4
High-mid isolation (2.5-4.9) 521 23.0 19.4 27.4
Highest isolation (5.0-14.0) 496 21.9 27.5 15.0
Disadvantage category (SE/FA score)
least disadvantage (989-1103) 548 24.2 21.9 27.0 <0.0001
low-mid disadvantage (960-988) 585 25.8 23.0 29.3
High-mid disadvantage (836-960) 576 25.4 26.8 23.8
Highest disadvantage (680--835) 557 24.6 28.4 19.9
Region
Urban 370 16.3 16.1 16.6
<0.0001
50uth coast 364 16.1 15.4 16.9
North coast 497 21.9 20.8 23.3
Rural 599 26.4 24.4 29.0
Remote 436 19.2 23.3 14.2
Systolic BP quartiles (mm Hg?
62-92 562 25.1 28.2 21.4
<0.0001
93-100 608 27.2 26.6 27.9
101-108 542 24.2 21.6 27.5
109-170 525 23.5 23.6 23.3
Diastolic BP quartiJes (mm Hg?
28-53 522 23.2 25.6 20.5
0.02
54-58 618 27.6 27.9 27.3
59--64 585 26.2 24.6 28.1
65-98 512 22.9 21.8 24.2
ARIA++, Accessibility and Remoteness Index of Australia; BMI, body mass index; BP, blood pressure; s.d., standard deviation; SEIFA, Socia-Economic Indexes For Areas.
alndicates where data does not total 2266.
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Table 21 Prevalence of chronic kidney disease markers in aboriginal and non-aboriginal children
Hematuria
Events (%)
Uiladjusted OR
Adjusted OR"
Proteinuria
Events (%)
Unadjusted OR
Adjusted ORa
Albuminuria (ACR mg/mmol)
Events (%)
Unadjusted OR
Adjusted ORa
Overall
122 (5.5)
161 17.3)
157 17.3)
Non-Aboriginal (referent category)
36 (3.6)
1.00
1.00
75 (7.6)
1.00
1.00
63 16.5)
1.00
1.00
Aboriginal
86 17.1)
2.02 11.30-3.13)
2.25 (1.37-3.69)
86 (7.0)
0.93 (0.65-1.32)
0.93 (0.68-1.27)
94 (8.11
1.27 (0.87-1.84)
1.37 10.93-2.011
P-value
0.002
0.001
0.67
0.65
0.22
0.11
ACR, albumin:creatinine; BMI, body mass index; BP, blood pressure; OR, odds ratios; RBC, red blood cells; s.d., standard deviation.
Definitions: Hematuria;.25 RBC per HPF (1+); proteinuria;:<0.30 gIL (1+); albuminuria, albumin:creatinine (ACR};d.4mg/mmol.
aAdjusted for age, gender, birth weight, height s.d., weight s.d., BMI s.d., systolic BP, diastolic BP, isolation category, disadvantage category, and region.
Table 31 Association between chronic kidney disease markers and geographical isolation
lowest isolation (referent category) low-mid isolation High·mid isolation Highest isolation Trend P-value
Hematuria
Events (%) 34 (5.7) 15 12.4) 40 (7.9) 33 (6.8)
Unadjusted OR 1.00 0.3610.18-{).71) 1.26 (0.75-2.10) 1.07 (0.49-2.37)
Adjusted ORa 1.00 0.31 (0.14-{).66) 1.26 (0.73-2.16) 0.9910.46-2.16)
Race adjusted ORb 1.00 0.29 10.13-{).63) 1.31 10.77-2.23) 0.8410.38-1.85)
Proteinuria
Events (%) 41 (6.9) 58 (9.3) 28 15.5) 34 (7.0)
Unadjusted OR 1.00 1.78 10.89-3.59) 0.96 (0.46-2.00) 1.24 (0.58-2.62)
Adjusted ORa 1.00 1.62 (0.78-3.39) 0.99 (0.46-2.14) 1.16 <0.53-2.55)
Race adjusted ORb 1.00 1.63 (0.78-3.42) 0.9910.46-2.13) 1.17 10.54-2.57)
Albuminuria
Events (%) 45 (7.9) 47 (7.5) 42 (8.3) 23 (5.2)
Unadjusted OR 1.00 0.82 (0.48-1.40) 0.96 10.62-1.50) 0.5910.27-1.27)
Adjusted ORa 1.00 0.6310.35-1.13) 0.87 (0.58-1.31) 0.52 (0.28-{).97)
Race adjusted OR b 1.00 0.6210.35-1.111 0.88 (0.59-1.32) 0.49 (0.26-{).90)
ACR, albumin:creatinine; BMI, body mass index; BP, blood pressure; OR, odds ratios; RBC, red blood cells; s.d., standard deviation.
Definitions: Hematuria;' 25 RBC per HPF (1 +); proteinuria;:. 0.30 gIl (1 +); albuminuria, albumin:creatinine (ACR);. 3.4 mg/mmol.*Non-trend P<0.05.
"Adjusted for age, gender, height s.d., weight s.d., BMI s.d., systolic BP, diastolic BP, disadvantage category, and region.
bAdjusted for race, age, gender, height s.d., weight s.d., BMI s.d., systolic BP, diastolic BP, disadvantage category, and region.
0.05*
0.48*
0.19
was strongly predictive of CKD, although this association was
not followed from childhood. IO The current prevalence of
albuminuria (albumin:creatinine> 3.4 mg/mmol) in those
aged 5-19 years from this community is 7.6%, similar to
the rate seen in our Aboriginal (8.1%) and non-Aboriginal
participants (6.5%).12 However, the lack of non-Aboriginal
control groups and the socioeconomic similarities in these
remote settings forces a presumption of race as the major
contributor. This study has found no significant differences
in albuminuria or proteinuria between Aboriginal and non-
Aboriginal children across New South Wales, even when
controlling for levels of isolation, disadvantage, and region.
From a sociodemographic perspective, when compared with
lower risk determinants, areas of remoteness, high isolation.
and high disadvantage carried no increased risk for CKD in
this cohort.
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The higher prevalence of hematuria in the Aboriginal
children, which was even more significantly associated with
race after adjustment for environmental confounders, was
not due to a higher number of menstruating Aboriginal
female subjects as these children were identified at screening
and tested on another occasion. An excess of hematuria in
cross-sectional studies has been found in Aboriginal children
from remote communities with high rates of post-infectious
glomerulonephritis." In a population of Aboriginal children
aged 5-19 years screened from remote Northern Territory
communities, the rate of asymptomatic hematuria (7.7%)
was similar to that in our Aboriginal cohort (7.1 %) (26). In
non-diabetic Indigenous adults, a higher prevalence of
hematuria has been associated with familial factors,14,15
mesangioproliferative glomerulonephritis,16 and immuno-
globulin A nephropathy.l? In Aboriginal children with
Kidney International (200l) 71, 787-794
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Table 41 Association between chronic kidney disease markers and social disadvantage
original article
Hematuria
Events (%)
Unadjusted OR
Adjusted ORa
Race adjusted ORb
Proteinuria
Events (%)
Unadjusted OR
Adjusted ORa
Race adjusted ORb
Albuminuria
Events (%)
Unadjusted OR
Adjusted ORa
Race adjusted OR b
Least disadvantage
(referent category)
3216.0)
1.00
1.00
1.00
53 (9.9)
1.00
1.00
43 (8.1)
1.00
1.00
1.00
Low-mid High-mid Highest
disadvantage disadvantage disadvantage
25 (4.4) 32 (5.7) 33 (6.0)
0.73 (0.28-1.91) 0.95 (0.40-2.24) 0.99 (0.47-2.12)
0.55 (0.21-1.41) 0.82 10.35-1.93) 0.76 (0.34-1.72)
0.5910.22-1.57) 0.79 10.33-1.91) 0.72 (0.30-1.73)
43 (7.6) 34 (6.0) 31 (5.6)
0.7510.41-1.39) 0.58 10.32-1.05) 0.54 (0.27-1.06)
0.57 (0.21-1.58) 0.53 (0.22-1.28) 0.57 10.27-1.24)
0.57 (0.21 -1 .581 0.53 (0.22-1.28) 0.58 (0.27-1.23)
42 17.5) 41 18.2) 31 15.6)
0.93 (0.53-1.63) 1.02 (0.67-1.57) 0.6810.40-1.16)
0.80 (0.39-1.681 0.87 <0.46-1.65) 0.68 (0.42-1.")
0.82 (0.38-1.74) 0.86 10.45-1.66) 0.66 (0.40-1.10)
Trend
p-value
0.78
0.004
0.18
AeR. albumin:creatinine; BMI, body mass index; BP, blood pressure; OR, odds ratios; s.d., standard deviation.
Definitions: Hematuria;.:.. 25 RBC per HPF (1 +}; proteinuria;.:.. 0.30 gIL (1+); albuminuria, albumin:creatinine (ACR);.:.. 3.4 mg/mmol.
~Adjusted for age, gender, height s.d., weight s.d., 8MI s.d., systolic BP, diastolic BP, isolation category, and region.
DAdjusted for race, age, gender, height s.d., weight s.d., BMI s.d., systolic 8P, diastolic BP, isolation category, and region.
hematuria, ESKD outcomes have not yet been demon-
stratedlll and prospective studies are needed. At 2-year
follow-up, there were no differences in the rates of persistent
and non-persistent hematuria between Aboriginal and non-
Aboriginal children.
What are the possible reasons in this study for the lack of
differentiation in risk for CKD between Aboriginal and non-
Aboriginal children from socia-demographically diverse
environments? The study had an adequate sample size; even
with larger numbers any increase in risk would be small. The
precision in risk for albuminuria is already narrowly defined,
with the upper limit of any 95% CI being 2.3. Cluster
sampling bias appeared minimal and adjustment for this bias
made little difference to the summary estimates.
Measurement of the main predictors of risk (Aboriginal
status and categories of isolation, disadvantage, and region)
was perfurmed using standardized systems. I 9-21 There is
no easy solution to the misclassification bias introduced
when spatially aggregated measures are applied to individual
data, and there is no method available to identify and
measure ecological bias. These standards, however, have
been used reliably in geographically and ethnically similar
population-based samples.'·22 High levels of disadvantage
in some areas of lowest isolation demonstrate the disparities
between environmental determinants of health,23 emphasiz-
ing the importance of using more than one measure,
across urban to very remote regions as we have done. Family
history of CKD and other environmental detenninants
such as physician availability are also important potential
predictors, but collection of this information either before
or at the time of testing was not possible. We determined
the regional prevalence of Aboriginal ESKD patients for the
study period to be almost twice as much as non-Aboriginal
ESKD patients. This is consistent with the difference in
Kidney International (2007) 71. 787-794
ESKD rates for Aboriginal and non-Aboriginal people across
New South Wales' This disparity has not been reflected
in our study findings for risk of CKD in Aboriginal children.
These data suggest that CKD in Aboriginal people starts
in later childhood and early adulthood, and that a window of
opportunity for prevention exists.
It is unlikely there was error in recording the outcome,
as measurement of proteinuria was performed using both
standard machine dipstick analysis, but confirmed with
a more precise albumin:creatinine. Early morning protein:-
creatinine correlates well with 24 h urinary protein in
children with normal renal function. 24 Spot albumin:creati-
nine has been shown to have very good receiver operator
characteristic curves for detecting pathological albuminuria
at the cutoff used in this study.25 Unfortunately, the test
performance for proteinuria screening tests in low prevalence
populations has not been validated. Semiquantitative, one-off
estimations of urinary protein in children vary according
to posture, exercise, illness, and time of day.25 Measurement
error would have been reduced by repeat testing; however,
this was not possible in this study. Prospective testing
to demonstrate persistent markers is likely to be of more
importance, an-d we look forward to reporting the results
of prospective testing over 6 years in this cohort.
Have we misclassified or omitted outcome measures for early
CKD? Proteinuria was found to be the strongest risk factor for
ESKD in the largest community-based study of mass screening,
with an adjusted relative risk of 14.9.26 Creatinine measurement
in a healthy pediatric sample is unlikely to be helpful in
determining risk for CKD. Renal ultrasound added little to the
evaluation of high-risk Aboriginal children and adults with
asymptomatic proteinuria or hematuria. 12
This study indicates that within New South Wales, there
is no increased risk of early CKD in healthy elementary
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school-aged Aboriginal children when compared with non-
Aboriginal children. In addition, the environmental determi-
nants of health measured here are not associated with the
markers for CKD studied in these children. Our findings
suggest, whereas the causal pathways for ESKD in Aboriginal
people may exist in childhood or earlier, an increased risk for
CKD is not yet apparent. There is opportunity for primary
preventative measures addressing health-seeking behaviors,
access to health care, and lifestyle factors such as smoking,
obesity, diet, and alcohol abuse in Aboriginal children and
young adults, and these are likely to make a significant
impact on CKD development. 27
These are preliminary findings based upon cross-
sectional data. This information is novel, and has not been
reported previously. Of even greater importance will be the
reporting of the longitudinal data currently being collected
on this cohort. This will provide unique and valuable
information on the natural history of CKD in Aboriginal
and non-Aboriginal children across different levels of socio-
demographic risk.
MATERIALS AND METHODS
Selection of participants
Government-run elementary schools were approached for testing
from urban, coastal, rural, and remote locations across the state of
New South Wales. This state has the highest Aboriginal population
in Australia. Non-government schools (private and denominational)
have very few Aboriginal enrolments, and were not considered for
recruitment. To maximize power, sampling was carried out to obtain
equal numbers of Aboriginal and non-Aboriginal children, and in
similar proportions from urban, coastal, rural, and remote areas. All
elementary schools in remote communities were approached and
other areas were sampled if more than 20 Aboriginal children in the
relevant age range attended.
Aboriginal status was determined using the Australian Bureau of
Statistics best practice recommendations, asking the Standard
Indigenous Question on the consent form 'Is your child of
Aboriginal or Torres Strait Islander origin?,.19 All Aboriginal children
in the participating elementary schools were offered testing for
height, weight, blood pressure, and urinary dipstick abnormalities.
Non-Aboriginal children were matched for gender and age (nearest
birthday) using class lists. We aimed to recruit equal numbers
of boys and girls, Aboriginal and non-Aboriginal children, and
approximately equal numbers of children from each 12-month-age
group.
Aboriginal community engagement
Consultation with local Aboriginal Medical Services and consent
from community leaders were undertaken before commencement of
the study. Approval was obtained from the Ethics Committees of the
Children's Hospital at Westmead, the University of Sydney, New
South Wales Area Health Services, and the New South Wales
Department of Education and Training. Informed consent was
obtained for each child and, in accordance with NHMRC Guidelines
for Ethical Conduct in Aboriginal and Torres Strait Islander
Research,21' data were collected onto a standardized form and de~
identified for storage and analysis before being returned to each
community after the study visit. Permission to publish data was also
obtained from each community.
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Measurement of markers of CKD and associated risk factors
Markers of CKD measured were hematuria, proteinuria, and
albuminuria. Risk factors known or thought to be associated with
the development of CKD in Aboriginal people were also recorded,
including age, gender, gromh parameters, birth weight, blood
pressure, and environmental health determinants: categories of
isolation, disadvantage. and region.
A morning clean catch specimen of urine was collected from
each child, with dipstick analysis for hematuria, proteinuria, and
albuminuria performed at the survey site on fresh specimens using a
Bayer Clinitek 50 machine. 29 Leukocytes and nitrites were also
recorded for later adjustment for abnormalities of presumed urinary
tract infection. Girls older than 8 years who were found to have
hematuria were questioned about menses, and, if appropriate,
collection was performed at another time. Follow-up urinalysis was
performed 2 years after baseline testing on all available children, and
the frequency of persistent hematuria (hematuria at baseline and
2 year follow-up) and transient hematuria (hematuria detected at
either baseline or 2 year follow-up) was also ascertained.
Hematuria was defined as ~ 25 red blood cells per microliter
(I +), proteinuria as ~0.30 gil (l +), and albuminuria as
albumin:creatinine~ 3.4 mg/mmol.
Standardization of urban, coastal, rural, and remote locality was
made using the Accessibility and Remoteness Index of Australia,
with each subject given an Index score according to their postcode
of residence. 2o Using geographical information system capabilities,
distances, services, and population density for each locality are
converted to a continuous variable with values ranging from zero for
high accessibility, to 18 for extreme remoteness.30 Accessibility and
Remoteness Index of Australia values for this NSW study ranged
from 0 to 14, and for categorical analysis the scores were grouped
into quartiles. Isolation categories (and Accessibility and Remote~
ness Index of Australia score range) used were least isolation (0-1.1),
low-mid isolation (1.2-2.4), high-mid isolation (2.5-4.9), and
highest isolation (5.0-14.0). Locality was also classified by region
(in order of increasing remoteness by Accessibility and Remoteness
Index of Australia score): urban, south coast, north coast, rural, and
remote.
To determine the level of social and economic well-being of areas
studied, the Socio-Economic Indexes for Areas 2001 21 Index of
Disadvantage was applied to subjects at the level of collection district
of residence. This is the smallest geographic area for which the Index
is available. The Index of Disadvantage is a continuous score, and is
based upon characteristics such as low income, lower level of
education, high unemployment, and unskilled jobs. It has been
standardized to a mean of 1000, and a s.d. of 100 across all collection
districts in Australia, that is, 95% of scores are between 800 and
1200. Higher scores indicate higher socioeconomic status and least
disadvantage. For categorical analysis, the scores were grouped into
quartiles: highest disadvantage (68D-835), high-mid disadvantage
(836-960), low-mid disadvantage (961-988), and least disadvantage
(989-1103).
Birth weight was provided by the parent/carer by recall or from
the child's health record. Height was measured in stocking feet to
the nearest 0.1 em with an SECA 220 telescopic portable stadi-
ometer3l that was calibrated between screening visits. Weight was
measured in stocking feet and in school uniform on digital scales to
the nearest 0.01 kg. Body surface area, body mass index, height, and
weight s.d. z-scores were calculated using an age and sex-adjusted
program.32 Blood pressure was measured on the right arm with the
child sitting, using an aneroid sphygmomanometer and the largest
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cuff to encircle the arm and cover at least three-quarters of the
length of the upper arm. 33 In children less than 13 years. diastolic
pressure was measured at the point of muffling (Korotkov 4). For
older children the point of disappearance was used (Korotkov 5).34
For children with diastolic and/or systolic blood pressure greater
than the 90th centile for age and sex. two further blood pressures
were recorded after resting the child, and the lowest blood pressure
according to the systolic reading was recorded in mm Hg.35
Data analysis
Proportions of CKD markers (hematuria, proteinuria, and albumi-
nuria) and associated risk factors (age. gender. birth weight, systolic
and diastolic blood pressure. height s.d., weight s.d., body mass
index s.d.• and category of isolation, disadvantage, and region) were
compared between Aboriginal and non-Aboriginal groups using the
/ test. Rates of persistent and non-persistent (transient) hematuria
were compared between Aboriginal and non-Aboriginal children
using the l test. The Mantel extension test was used to determine
linear trends across categories and quartiles. OR for markers of CKD
by isolation category, disadvantage category. and region were
determined using logistic regression, with 95% Cis. Analyses were
adjusted for age, gender, diastolic and systolic blood pressure, height
s.d., weight s.d., body mass index s.d., and categories of isolation,
disadvantage, and region. Where appropriate, analyses were then
further adjusted for Aboriginal race. Adjustment was made in all
analyses for the effect of cluster sampling by school.
The Hosmer and Lemeshow test for goodness of fit was applied
in the multivariate models. Tests for interactions between race,
gender, age. categories of isolation, disadvantage and region, and
other significant variables in the final model were performed.
Significance was set at a P< 0.05 for main effects and for
interactions. Statistical analysis was completed using SAS36 and
SPSS software. 3?
Data on the incidence of ESKD was supplied by the Australia and
New Zealand Dialysis and Transplant Registry to determine the
background prevalence of ESKD in the areas sampled.38 As point
prevalence data are not available from the Registry, we used
incidence data for each postcode for the years 1967--2004 to calculate
ESKD prevalence for Aboriginal and non-Alxlriginal people.
Presuming Aboriginal and non-Aboriginal population numbers
accessed from the Australian Bureau of Statistics 2001 census were
relatively stable over these 37 years. prevalence was calculated as
total ESKD events over this time period. divided by the population
and multiplied by the time period.]9 This incidence density figure
was multiplied by the duration of disease (approximated at 20 years)
to give point prevalence.
We planned to collect data from 1000 Aboriginal and 1000 non-
Aboriginal children, which were sufficient to detect differences in
prevalence of markers ofCKD between the two groups of2.9 versus
1.1%,4.0 versus 1.8%,5.5 versus 2.9 at 80% power for hematuria,
proteinuria, and albuminuria, respectively.
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ORIGINAL ARTICLE
Cardiovascular risk factors in Australian indigenous and
non-indigenous children: A population-based study
Leigh Haysom",2 Rita E Williams,' Elisabeth M Hodson,'" Pamela Lopez-Vargas,' L Paul Roy,' David M Lyle' and
Jonathan C Craig,,2
lCentre for Kidney Research, and 3Department of Nephrology, The Children's Hospital at Westmead, and 2"fhe School of Public Health, (Department of Rural
Health, University of Sydney, Sydney, Australia
Aim: Indigenous people have atwo- to tenfold increased risk of premature death from cardiovascular disease. We aimed to determine whether
some key risk factors for cardiovascular disease occur more commonly in Aboriginal than non.Aborigini31 Australian children.
Methods: Children were enrolled from primary schools throughout New South Wales. the state with the highest number of Aboriginal people.
Associations between ethnicity, gender, birthweight, socio-demographic status and hypertension, obesity, baseline and persistent albuminuria
were determined.
Results: A total of 2266 children (55% Aboriginal) were enrolled. Mean age was 8.9 years (:t3.8 years). Obesity (body mass index ~2 standard
deviations) was detected in 7.1 %, systolic hypertension (blood pressure >90th percentile) in 7.2%, diastolic hypertension in 5.9%, baseline
albuminuria (albumin: creatinine =::3.4 mg/mmol) in 73% and persistent albuminuria in 1.5% wIth no differences between Aboriginal and
non-Aboriginal children. Hypertension was less common with increasing social disadvantage (trend P < 0.02). Increasing body mass index
standard deviation was strongly associated With systolic and diastolic hypertension (both P < 0.0001).
Conclusions: Many risk factors for cardiovascular disease are already common in young children but not more prevalent in Aboriginal than in
non-Aboriginal children. In all children, overweight and obesity have the strongest association with hypertension, but social disadvantage
appears protective for hypertension. Our findings suggest that risk for cardiovascular health disparities seen in indigenous adults manifests
beyond childhood and that a window of opportunity exists to prevent some of these outcomes.
Key words: epidemiology; hypertension; obesity.
Key Points . .... .•_.__ ... .. _
1 No difference in risk for cardiovascular disease between indig-
enous and non-indigenous children.
2 Some of the difference In risk found in indigenous adults must
manifest beyond childhood.
3 A window of opportunity therefore may exist to prevent these
outcomes.
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Cardiovascular disease is the leading cause of premature death
in indigenous people world-wide, and there is an increasing
disparity in rates of cardiovascular deaths between indigenous
and White people populations that is pronounced by middle
age. Recent data for American Indian and Alaskan Natives show
the cardiovascular death rate in 45- to 55-year-oIds is twice
that of White people in the United States with a 4.1 % annual
increase, compared with a 1.7% annual decrease in White
people. l By age 40, Aboriginal Australians are 10 times more
likely to die of ischaemic heart disease compared with non-
Aboriginal Australians.2
The causal pathways to these health disparities are poorly
researched and are likely to be multideterminant because of
differences in physiological and socia-economic risk factors.
Overall rates of obesity and hypenension in American Indian
and Alaskan native adults are higher than White people in the
United States and the disparity widens with age.3 Australian
Aboriginals more than 15 years of ag~ are 1.5 times more likely
to be overweight or hypertensive.4 Diabetes prevalence is twice
the national rate in American Indians and Alaskan natives and
more than four times the national rate in remote Aboriginal
Australians.3.5 Albuminuria presents early as pan of the meta-
bolic syndrome compl~x in Aboriginal Australians and Native
Americans,6.7 and it robustly predicts cardiovascular morbidity
and death.6This increased burden of risk factors found in indig-
enous adults contributes to the widening gap in cardiovascular
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health outcomes between Indigenous and non-Indigenous
people and to a tendency for disease at a much younger age. 6, 7
The social and environmental inequalities that Indigenous
people are born and raised with, such as the lack of access to
health care, inadequate health-care delivery and social disad·
vantage, are also likely to contribute to these outcomes.'
There are no population-based studies in ethnically and socio-
economically diverse children evaluating the early prevalence of
risk factors for cardiovascular disease. This study aimed to deter-
mine whether established risk factors for cardiovascular disease
(obesity, bypertension and albuminuria) are more prevalent
in Aboriginal than non-Aboriginal Australian children and
whether these risk factors are associated with physiological
determinants of ethnidty. gender and birthweight. and environ-
mental health determinants of geographical isolation and sodal
disadvantage.
Methods
Selection of participants
Government-run primary schools were selected from urban.
coastal rural and remote locations known for their high
Aboriginal population across the state of New South Wales. This
state has the highest proportion of Aboriginal people. To maxi-
mise power, sampling was carried out to obtain equal number of
Aboriginal and non·Aboriginal children and in similar propor-
tions from urban. coastal, rural and remote areas. All primary
schools in remote communities were approached, and other
areas were sampled if greater than 20 Aboriginal children in the
relevant age range attended.
Aboriginal status was determined by using the Australian
Bureau of Statistics best practice recommendations, asking the
standard indigenous question 'Is your child of Aboriginal or
Torres Strait Islander origin7' on the consent form. 9All Aborigi ~
nal children in the participating primary schools were offered
measurement of height. weight, blood pressure and urinary
abnormalities. We aimed to recruit equal number of boys and
girls. equal number of Aboriginal and non-Aboriginal children
and approximately equal number of children from each
12-month age group.
Aboriginal community engagement
Consultation with local Aboriginal Medical Services was under-
taken and consent from community leaders was obtained prior
to commencement of the study. Approval was obtained from
the Ethics Committees of the Children's Hospital at Westmead,
the University of Sydney. New South Wales Area Health Ser-
vices and the New South Wales Department of Education
and Training. Infonned consent was obtained for each child
in accordance with National Health and Medical Research
Council Guidelines for Ethical Conduct in Aboriginal and
Torres Strait Islander Research. 10 Data were collected onto a
standardised form and de-identified for storage and analysis
before being returned to each community after the study
visit. Permission to publish data was also obtained from each
community.
Cardiovascular risk in indigenous children
Measurement of birthweight, growth parameters
and blood pressure
Birthweight was provided by the parent/carer by recall or from
the child's health record. Height was measured in stocking feet to
the nearest 0.1 em with a Seca 220 telescopic portable stadiom-
eter (Seca, Hamberg, Germany) II that was calibrated between
screening visits. Weight was measured on digital scales to the
nearest 0.01 kg, with the child in stockinged feet and in school
uniform. Body mass index (BMI), height and weight standard
deviation (SD) z-scores were calculated by using an age· and
gender-adjusted programme based upon international norma-
tive data. 12 Blood pressure was measured on the right arm 'With
the child sitting. by using an aneroid sphygmomanometer and
the largest cuff to encircle the arm and ,cover at least three-
quarters of the length of the upper arm.n In children less than
13 years old., diastolic pressure was measured at the point of
muffling (Korotkoff 4). For older children, the point of disappear-
ance was used (Korotkoff 5).14 For children with diastolic and/or
systolic blood pressure greater than the 90th percentile for age
and gender (using normative data from Australian children,
including Aboriginal children), two further blood pressures were
recorded after resting the child, and the lowest blood pressure
according to the systolic reading was recorded in mmHg. 15
Measurement of albuminuria
A moming clean catch specimen of urine was collected from each
child., with dipstick analysis for albuminuria performed at the
survey site on fresh specimens using a Bayer Clinitek 50 machine
and Albustix dipsticks (Bayer Healthcare, Pymble, Australia).16
Leukocytes and nitrites were also recorded for later adjustment
for abnormalities of presumed urinary tract infection. Girls older
than 8 years who were found to have haematuria were ques-
tioned about menses and, if appropriate, collection was per-
formed at another time. Because albuminuria is often transient.
follow-up urinalysis was performed 2 years after baseline testing
on all available children, and the frequency of persistent albu-
minuria (albuminuria detected at baseline and follow-up) and
non-persistent or transient albuminuria (albuminuria detected at
either baseline or follow·up) was also ascertained.
Measurement of environmental
health determinants
Standardisation of urban, coastal, rural and remote locality
was made by using the Accessibility and Remoteness Index of
Australia (ARlA++). with each subject given an index score
according to their postcode of residence. 17 Using geographical
information systems capabilities, distances. services and popu~
lation density for each locality are converted to a continuous
variable with values ranging from 0 for high acceSSibility to 18
for extreme remoteness.1I ARIA++ values for this New South
Wales study ranged from 0 to 14. and, for categorical analysis,
the scores were grouped into quartiles. Isolation categories (and
ARIA++ score range) used were least isolation (0-1.1), low·mid
isolation (1.2-2.4), high-mid isolation (2.5-4.9) and highest
isolation (5.0-14.0).
To determine the level of social and economic well-being of
areas studied. the Sodo-Economic Indexes for Areas 2001 19
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Cardiovascular risk in indigenous children
Index of Disadvantage was applied to subjects at the level of
collection district of residence. This is the smallest geographic
area for which the Index is available and includes approximately
200 households. The Index of Disadvantage is a continuous
score and is based upon characteristics such as low income,
lower level of education. high unemployment and unskilled
jobs. It has been standardised to a mean of 1000 and an SD of
100 across all collection districts in Australia; that is. 95% of
scores are between 800 and 1200. Higher scores indicate higher
soda-economic status (SES) and least disadvantage. For cat-
egorical analysis, the scores were grouped into quaniles: Highest
disadvantage (68tJ-.835), high-mid disadvantage (836-960),
low-mid disadvantage (961-988) and least disadvantage (989-
1103).
Data analysis
Cardiovascular risk factors considered were systolic and diastolic
hypertension (blood pressure greater than the 90th percentile for
age and gender). obesity (BMI SD ~2), albuminuria at baseline
[albumin: creatinine (ACR) greater than Or equal to 3.4 mgl
mmol] and persistent albuminuria (albuminuria at both baseline
and at 2-year follow-up). Potential predictors of cardiovascular
risk factors were Aboriginal status, female gender, low birth-
weight (:52500 g), higher isolation categories (ARIA score 1.2-
14.0) and higher disadvantage categories (sodo-economic
indexes for areas score 680-988). Categories of gender, age
group, systolic and diastolic blood pressure percentiles, isolation
and disadvantage, quartiles of birthweight, height SO, weight SD.
BMI SO and cardiovascular risk factors were compared between
Aboriginal and non-Aboriginal groups by using the chi-squared
test. The assodation between predictors and cardiovascular risk
factors was determined by using odds ratios and 95% confidence
intervals with the presumed lowest risk category of predictor as
the relerent group. Logistic regression was used to adjust for
differences in ethnidty, age. gender. diastolic and systolic blood
pressure, BMI SD and categories of isolation and disadvantage.
The Mantel extension test was used to determine linear trends
across categories and quartiles. Adjustment was made in all
analyses for the effect of duster sampling by school. Tests for
interactions between ethnidty, gender, age, categories of isola-
tion and disadvantage and other significant variables in the final
model were performed. Significance was set at a Pvalue of <0.05.
Statistical analysis was completed by using SAS (SAS Institute.
Cary, NC, USA)" and SPSS (Chicago, IL, USA) software.'1
VVith data collection planned from 1000 Aboriginal and 1000
non-Aboriginal children. the study was adequately powered to
detect ~erences in prevalence of albuminuria, hypertension
and obesity between the two groups of 5.5 vs. 2.9%. 12.0 vs.
10.0% and 9.0 vs. 7.0% given a two-tailed significance of less
than 0.05.
Results
Baseline characteristics
From February 2002 to June 2004, 2266 children were enrolled
from 37 primary schools across New South Wales. There were
1248 (55.1 %) Aboriginal and 1018 (44.9%) non-Aboriginal
LHaysom et al.
children. 51 % were male and the mean age was 8.9 years (±
3.8 years). There were proportionally more Aboriginal children
in the youngest age group (4-6 years), in the lowest weight SO
quartile, in the most isolated area and in the most disadvantaged
category (all P < 0.000l). There were no differences between
the groups for gender, birthwetght, height SD, BMI SO quartiles
and blood pressure percentile categories. At 2-year follow-up,
there were 1334 children available for urinalysis. Tw"enty chil-
dren (1.5°/1,)) had persistent albuminuria and 157 children
(11.8%) had transient albuminuria (albuminuria at either base-
line or at follow-up) (Table 1).
Prevalence of cardiovascular risk factors
The observed frequencies of outcomes of interest were systolic
hypertension (7.2%), diastolic hypertension (5.9%), obeSity
(7.1 %), baseline albuminuria (7.3%) and persistent albuminuria
(1.5%).
Physiological predictors of cardiovascular
risk factors
Aboriginal children were no more likely to have cardiovascular
risk factors than non-Aboriginal children. At baseline testing,
girls were at higher risk of albuminuria than boys (adjusted
odds ratio 1.81. 95% confidence interval 1.46-2.15. P = 0.001).
There were no differences in rates of persistent and transient
albuminuria between boys and girls (X2 = 2.12, P= 0.15) nor
between Aboriginal and non-Aboriginal children ('X2 = 0.15.
p= 0.70). When compared with higher birthweight. low birth-
weight was not assodated with any cardiovascular risk facror.
None of these physiological determinants were assodated with
obesity or hypertension (Table 2).
Environmental predictors of cardiovascular
risk factors
There was a trend for higher risk of systolic and diastolic hyper-
tension in less disadvantaged children (trend P = 0.01 and 0.02,
respectively). There were no significant trends across isolation
categories for any cardiovascular risk factor. None of these envi-
ronmental determinants were associated with albuminuria or
obesity (Table 2).
Association between cardiovascular risk factors
Increasing systolic blood pressure percentiles were assodated
with diastolic hypertension. and increasing diastolic blood pres-
sure percentiles were associated with systolic hypertension
(both trend P < 0.0001). There was a strong association between
increasing BMI SO and risk of systolic and diastolic hypertension
(both trend P < 0.0001). Compared with children in the lowest
BMI SD quanile, the adjusted risk of systolic and diastolic hy-
pertension for children in the highest BM! SO quartile was
12.37 (6.17-24.78) and 5.05 (2.74-9.32), respecttvely, both
P < 0.0001. Conversely. higher systolic and diastolic blood pres-
SUre percentiles were strongly associated with obeSity (both
trend P < 0.0001). There was a trend for lower risk of albu-
minuria in children with higher BM! SO (trend P = 0.005).
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Table 1 Baseline characteristics
Variable All subjects Aboriginal Non-Aboriginal
n = 2266 % n = 1248 % n =: 1018 %
Gender IP = 0.86)
Male 1155 51.0 634 SO.8 521 51.2
Female 1111 49.0 614 49.2 497 48.8
Age groups (yea~ IP < 0.0001)
4-5.9 211 9.3 142 113 69 6.8
tH.9 281 12.4 170 13.6 111 10.9
7-7.9 329 14.5 189 15.2 140 13.7
1Hl.9 337 14.9 185 14.8 152 14.9
9-'1.9 351 15.5 168 13.5 183 18.0
10-10.9 361 15.9 172 13.8 189 18.6
11-14.8 396 17.5 22.2 17.8 174 17.1
Birthwelght quartiles (g)' IP = 0.08)
412-2920 217 25.7 119 29.6 98 22.1
2921-3316 210 24.9 92 23.1 118 26.4
•
3317-3685 210 24.9 98 24.4 112 25.3
3686-5272 208 24.6 92 22.9 116 262
HeIght SO quartiles· (P = O.l2)
-4.8 to -0.7 563 25.1 334 26.9 229 22.8
-{l.8to 0.1 564 25.1 306 24.6 258 25.7
02 to 1.0 558 24.8 305 24.7 253 25.0
1.1104.8 562 25.0 295 23.8 267 26.6
Weight SO quartiles· (P < 0.0001)
-6.6 to-D.S 560 24.9 351 283 209 20.8
-0.04 to 03 560 24.9 301 24.3 259 25.7
0.4 to 1.2 567 25.2 269 21.7 298 29.7
1.3 to 13.3 559 24.9 319 25.7 240 23.9
8MI 50 quartileS' IP ~ 0.08)
-4.8 to -{l.8 560 24.9 333 26.9 227 22.5
-0.7 to 0.1 562 25.0 298 24.0 264 263
0.2 to 0.7 566 25.2 298 24.0 268 26.7
0.8 to 6.9 558 24.8 311 25. , 247 24.6
Isolation category (ARIA score) (p < 0.0001)
least Isolation l~1. 1J 610 26.9 323 25.9 287 28.2
Low-mid Isolation (1.2-2.4) 639 28.2 340 27.2 299 29.4
Hlgh-mld ISolation {2.5-4.9} 521 23.0 242 19.4 279 27.4
Highest Isolation 15.0-14.0) 496 21.9 343 27.5 153 15.0
Disadvantage category (SEIFA score] fP < 0.0001 J
least disadvantage (989-11031 548 24.2 273 21.9 275 27.0
low-mid disadvantage 1960-988) 585 25.8 287 23.0 298 293
High-mid disadvantage 1836-959) 576 25.4 334 26.8 242 23.8
Highest dIsadvantage 168D-835) 557 24.6 354 28.4 203 19.9
Systolic BP percentiles"" (P = 0.091
<5Oth 1258 56.2 711 57.7 547 54.4
50th to 90th 817 36.5 426 34.6 391 38.9
>9Oth 162 7.2 95 7.7 67 6.7
Diastolic BP percentiles· {P = 0.34)
<5Oth 1410 63.0 793 64.4 617 61.4
50th to 90th 696 31.2 370 30.0 326 32.4
>9Oth 131 5.9 69 5.6 62 6.2
-Indicates where data does not total 2266. ARIA, Accessibility and Remoteness Index of Australia; BMI, body mass Index; BP, blood pressure; SO, standard
deviation; SElFA, Socio-Economic Index for Areas.
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Table 2 Physiological and environmental predictors of cardiovascular risk factors
Predictor Systolic hypertension Diastolic hypertension Albuminuria Obesity
--
_._______!'J%l_ ___.~QRJJ~5%9L_ !!J!l _____6QBt 1~2%_q) _ _ __I]J;).__..AQRj [25~.CU. _. .._D jl:1-- .__AORt j95% _CU __
Aboriginality
Non-Aboriginalt 6716.71 1.00 6216.21 1.00 6316.5) 1.00 63 [6.7) 1.00
Aboriginal 95 [7.71 1.22 [0.87-1.57) 69[5.6) 0.9410.57-1.31) 94[8.11 1.3710.93--2.011 8217.4) 1.10[0.76-1.44)
Gender
Malet 7616.7) 1.00 7016.11 1.00 5915A) 1.00 72 [7.0) 1.00
Female 8617.81 1.34 [0.99-1.69) 6115.6) 0.8810.50--1.25) 98 [9A) 1.81 (1.46-2.15)* 7317.2) 1.03 [0.69--1.37)
Birthweight
> 2500t 100[7.81 1.00 8016.31 1.00 9417.7) 1.00 86 [7.3) 1.00
s2500g 11 [8.7} 1.10 (OA3-1.76) 5 [4.0) 0.6310.33--1.63) 6[5.0) 0.5810.25--1.53) 716.0) 0.77 (0.32-1.81)
Isolation
least isolationt 34[5.61 1.00 1913.1) 1.00 4517.9) 1.00 44 [7.8) 1.00
low-mid isolation 71[11.3) 2.20 [1.38--3.51) 62[9.9) 3.75 [2.14-6.55) 47 [7.5) 0.9110.58-1A2) 45(7.9) 1.01 [0.66-1.56)
High-mid isolation 25(4.9) 0.8910.50--1.49) 34 [6.7) 2.24 [1.2>-4.01) .4218.3) 1..04 [0.67-1..641 . 2715.71 0.7°10Ab1.17)
Highest isolation 32(6.5) 1..20 (0.72-1..95) 16(3.21 1..0410.52-2.061 2315.2) 0.61 (0.36-1.09) 29[6.5) 0.83(0.50--1..36)
Social disadvantage
least disadvantaget 55[10.21 1..00 33(6.11 1.00 43 (8.1) 1.00 3416.9) 1.00
low-mid disadvantage 4317.41 0.70 (OA6-1.1 01 4718.1) 1.3710.84--2.231 42 [7.5) 0.8710.66-1.37) 27[5.0) 0.89 [0.57-1.39}
High-mid disadvantage 30[5.31 0.51 (0.30--0.83) 31 [5.5) 0.96 [0.59-1 .54) 41 [8.21 1..00 (0.70--1.621 44(8.51 1.22 (0.76-2.001
Highest disadvantage 3416.2) 0.59 [0.35--0.951* 20[3.61 0.6210.36-1.051* 31 (5.6) 0.70 [0.46-1.11) 40 [8.1) 1.2010.72-1.891
*Trend P < 0.05. tReferent category. :j:Adjusted for ethnicity, age, gender, BMI, birthweight, blood pressure and categories of isolation and disadvantage.
Definitions: Systolic hypertension, systolic blood pressure> 90th percentile; diastolic hypertension, diastolic blood pressure> 90th percentile; albuminuria,
. albumin: creatinine (ACR) :2: 3.4 mg/mmol; obesity, BMI :2:: 2 SD; least isolation, ARIA score 0-1.1; low·mid isolation, ARIA score' .2-2.4; high-mid Isolation,
ARIA score 2.5-4.9; highest Isolation, ARIA score 5.0-14.0; least disadvantage, SEIFA score 989-1103; low-mid disadvantage, SEIFA score 960-988;
hlgh·mid disadvantage, 5EIFA score 836-959; highest disadvantage, SE1FA score 680-835. ACR, albumin: creatinine; AOR, adjusted odds ratio; ARIA,
AccessibIlity and Remoteness Index of Australia; BMI, body mass index; CI, confidence interVal; SO, standard deviation; SEIFA, Socio-Economic Index for
Areas.
Compared with children in the lowest BMI SD quartile, the
adjusted risk of albuminuria for children in the highest BMl SD
quartile was 0.5! (0.32--0.82), P= O.OO! (Table 3).
There were no interactions found between ethnidty. age,
gender, isolation and disadvantage categories, or other covari·
ates in any model.
Discussion
Aboriginal children in New South Wales have no increased
prevalence of traditional cardiovascular risk factors (hyperten·
sion.. albuminuria and obesity) when compared with non-
Aboriginal chIldren. Ethnidty is prone to misuse as a proxy
of disadvantage,22.2) although it is likely that the soda·
demographic factors associated with being Aboriginal contribute
cumulatively to the poor cardiovascular health of Aboriginal
adults. Such faerors include lower income and education levels,
geographical isolation, limited access to health care and disec-
onomies of scale due to sparsely distributed populations.24 This
is one of the few studies that differentiate the contributions of
ethnidty and environmental health detenninants towards risk
of cardiovascular disease in children. We have found that eth·
Didty is not associated with increased cardiovasCl:llar risk, even
aher adjustment for differences in sodo~demographicstatus.
The lack of non~indigenous control groups and the sooo-
economic similarities in studies of Indigenous adults from
non·population-based, remote community settings force the
presumption that indigenous status is the major contributor of
disease.2s However, in Aboriginal communities with the highest
rates of cardiovascular death in Australia,26 a similar prevalence
of albuminuria to our study findings has been found on cross-
sectional testing of the children. The frequency of albuminuria
(ACR > 3.4 mg/mmol) in those aged 5-19 years from such com·
munities was 7.6%, which is not different to the baseline rate
seen in our Aboriginal (8.1 %) and non·Aboriginal (6.5%) chil·
dren. Accepting that much of this albuminuria is likely to be
only transient 27 at 2·year follow~up, we found no significant
differences in transient or persistent albuminuria between
Aboriginal and non·Aboriginal children.
Study design issues are unlikely to explain the reasons for
a lack of differentiation in risk for cardiovascular disease be-
tween Aboriginal and non·Aboriginal children from sodo-
demographically diverse environments. The study was
adequately powered in terms of sample size for the cardiovas·
cular risk factors. Adjustment for cluster sampling bias made
little difference to the summary estimates. Measurement of the
ethnic and environmental predictors of risk was performed by
using standardised systems.8.16.18 We. accept that unmeasured
24 Journal of Paediatrics and Child Health 45 (2009) 20-27
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Table 3 Association between cardiovascu];u risk factors
-
,
cardiovascular risk factors
Systolic BP cent/les
~5Otht
51Sl-9Oth
>9Oth
Diastolic BP centlles
SSOtht
51Sl-9Oth
- ,.qOth
Albuminuria (ACR mg/mmoO
<3.4
~.4
8MI SO quartiles
-4.8 to~.8 .
......(J.7 to 0.1
0..2 to 0.7
0.8 to 6.9
Systolic hypertension
AOR 195% CI)*
1.00
3.9512.65-5.87)
54.80 134.O-SS.0i*
'.00
0.6110.27-135)
1.00
25011.14--5.49)
4.2612.04-8.91 )
123716.17-24.78)*
Diastolic hypertension
AOR 195% CI)*
1.00
5.36 (3.18-9.02)
29.1 1 (16.59-51.09)*
1.00
1.0610.52-2.161
, .00
1.8810.95-3.74)
2.6711.40-5.12)
5.0512.74--932)*
Albuminuria
AOR 195% CO*
1.00
0.98 (0.70-1.38)
0.5510.25-1.22)
1.00
0.6510....Hl.95)
0.7310.35-1.53)t
1.00
0.6710.44-1.04)
0.6510.42-1.02)
0.51 10.32-0.82)*
Obesity
AOR (95%C1)*
1.00
3.651236--5.66)
15.4119.32-25.49)*
1.00
3.01 12.05-4.43)
8.75 (531-14.4\)*
1.00
0.4510.18-1.11)
'*Trend P< 0.p5. tReferent category. tAdJusted for ethnlcity, age, gender. body mass Index, blrthwelght, blood pressure and categories of isolation,
di5a~ntage and region. Definitions: Systolic hypertension, systolic blood pressure> 90th percentile; diastolic hypertension, diastolic blood pressure >9Oth
percentile; albuminurla, albumin; creatinine tACR) ~ 3.4 mgfmmol; obesity, 8MI ~ 2 SD. ACR. albumin; aeatinine; AOR, adjusted odds ratio; 8MI, body
mass jndeJt; BP. blood pressure; CI, confidence interval; SO. standard deviation.
I
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confounding from individual-level socio-economic factors
remains as a Study bias. With funher data colJeetion. multilevel
analyses could be used to identify. measure and correct for
ecological bias when spatially aggregated measures aTe applied
to individual data.2& The standards used in this study. however,
have been appUed reUably in geographically and ethnically
similar samples.J9•JO Parentally recalled binhweight has been
shown as a reliable proxy for recorded birthweight in
population-based research.1U1
It is unlikely that there was an error in recording the out-
comes. Blood pressure was measured by using appropriate cuff
sizes. particularly for obese and older children. and repeat mea-
sures were performed in hypenensive children. Spot ACR has
been shown to have good receiver operator characteristic curves
for detecting pathological albuminuria at the cut-off used in this
study.n Obesity was determined by using BMI SO. which has
been validated for usc in this age group of children. l4 Overall
prevalence of obesity of 7.1 % in our cohon is comparable with
6% for Australian children." Waist cirrumference has been
shown to be more predictive of cardiovascular risk in indigenous
adults. U and measurement of outcomes such as central obesity.
blood Upid, glucose, HbAle and insuUn levels would have been
desirable for evidence of metabolic syndrome.J7 Measuring all
possible cardiovascular risk factors was beyond the practicalities
of such a large school-based screening study and painfuI or
~mbarrassing prOC'~dureswould have ~en counter-productive
to th~ current success of our folJow-up r~cruitIDent rates.
Ov~rweight and o~sity wae most significantly assodat~d
with hypenension. Without early intervention, these obese and
hypertensive pre-pubertal children are at high risk for diabetes
and cardiovascular disease in adulthood and are likely to have
shoner life expectances than their parents.lI,n The increasing
risk for hypenension in socally advantaged children seems con·
tradictory to other studies."Q.41 Our Study sampled children from
where Aboriginal populations reside. in areas of the lowest
SES.u The highest SES quartile in OUI cobort (indicating lesser
disadvantage) correlates with mid-range SES categories in oIher
comparative studies.n .... Our findings are consistent with these
studies that show that the prevalence of disease risk factors
follows a bell·shaped rurve across different sodo-economic
environments. Lowest risk ocrurs at either extreme of SES.
while highest risk occurs in mid-range SES categories.4l.44
Girls were found to be at increased risk of albuminuria at
baseline. even alta adjustment for presumed urinary tract
infection and testing m~nsuuating females at another time.
n-ansient proteinuria is a common cause of albuminuria in this
age group1'. and most of the albuminuria found in these chil-
dren was transient. At 2-year follow-up. there was no difference
in rates of persistent and transient albuminuria between boys
and girls.
Low birthweight was Dot associated with any cardiovascular
disease risk factor but bas been associated with higher risk of
hypertension in ch.ildren from observational studies with well-
and poorly defined study bases.n44 A systematic review of 55
studies showed that birthweight had little association to blood-
pressure levels in later life. Being rurrently overweight had a
much more relevant and significant assodation with hypenen·
sion:1 as we have shown in our study.
Microalbllminuria is an established marker with obesity as
pan of Ihe metabolic syndrome in adults;U however. our finding
that children in higher BMI SD quartiles have no increased risk
for albuminuria is not new and has been found even in children
with insulin resistance."7 Measurement error may also COD-
tribute to a spurious increase in risk for albuminuria in
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underweight children. An overestimation of microalbuminuria
by ACR may result in these children with low muscle mass as a
result of a combination of normal excretion of urinary albumin
with a low urinary creatinine excretion.4B Whether albuminuria
is predictive of cardiovascular disease in youth, as it is in adults,
remains to be proven.
This study indicates that, within New South Wales, there is no
increase in prevalence of these risk factors for cardiovascular
disease in primary-school aged Aboriginal children when com-
pared with non·Aboriginal children. Children who are obese
and those from .areas of mid-range SES are at higher risk of
developing cardiovascular disease. This suggests that some of
the difference in cardiovascular risk for Indigenous people
manifests beyond childhood and may therefore result from
broader sodaI inequalities. It also suggests that a window of
opportunity exists to develop strategies that deal with obesity
and underlying sodal disparities for all children, which in tum
may prevent some of the cardiovascular disease inequality in
Aboriginal adults.
What This Study Adds
Population-based data on the prevalence of risk factors for
cardiovascular disease from a large cohort of Indigenous and
non-Indigenous children.
2 Measurement and adjustment for the confounded relation-
ship between soda-demographic factors and risk for cardio-
vascular disease.
3 This large population-based study has found no difference in
risk for cardiovascular disease between Indigenous and non-
indigenous children, after accounting for soao-demographic
differences.
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Diagnostic accuracy of urine dipsticks for detecting
albuminuria in indigenous and non-indigenous children
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Abstract Albuminuria predicts cardiovascular and end-
stage kidney disease in indigenous pOpululions. Early
detection in indigenous children may identify those who
could benefit from earty treatment. Community·based
detection of albuminuria needs to be pcrfonned using a
reliable, inexpensive, and widely available test, such as a
proteinuria dipslick. Dipstick accuracy for detceting albu-
minuriu in a community setling has not been evaluated. We
a»cssed the accuracy of Multistix 10 SG dipsticks to detect
baseline albuminuria and predict for persistent albuminuria
at a 2-year follow-up in a population-based cohort of
Australian Aboriginal and non-Aboriginal elcmentary-
school-aged children. Variability in 'he accuracy of dip-
sticks in subgroups of higher risk children was analyzed
using the relative diMgnostic odds ratio (RDOR). Using
Multi>!ix 10 SG dipsticks. index-test-positi,e cases werc
dcfined as >0.30 giL (I~) protcinuria and index-test-
negative cases as <0.30 giL (negative or trace) proteinuria.
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Referent-lest-positive cases were defined as spot albumin:
creatinine (ACR) >3.4 mglmmol, and refercnt-test-negative
cases as ACR <3.4 mglmmol. There were 2.266 children
(55.1 % Aboriginal, 51.0% boys. mean age 8.9 years)
enrolled. At the 2-year follow-up, 1,432 (63.0%) children
were retested (54.0% Aboriginal. 50.5% boys, mean age
10.5 years). Prevalence of baseline albuminuria was 7.3%.
and persistent albuminuria was 1.5%. Dipsticks had a
sensitivity of 62% and specificity of 97% 31 baseline. In
predicting persistent albuminuria. sensitivity was 75% and
specificity 93%. Accuracy did nor vary with ethnicity.
gender, or body mass index. Accuracy was less in younger
children (4.0--7.9 years), and in 'hosc with hema,uriM. The
pcrfonnance char.lctcristics of Multistix dipsticks make
Ihem suitable for albuminuria detection in Aboriginal and
other higher-risk groups of children. More than two thirds
ofchildrel1 detected at a single test will have tnmsicnt rather
than persistent albuminuria. Muhistix dipsticks are pal1ic-
ularly useful for detecting children" ho will have pcrsistent
albuminuria.
Keywords Proteinuria· Albuminuria· Diagno~tic test·
ACR· Aboriginal· Children
l"troduction
Morbidity and premature mortality from c1uonic disease are
a much greater burden for indigenous than for non-
indigenous populations. Cardiovascular disease is [he
leading cause of premature death in indigcnous people
from 45 years of age, which is 20 years earlicr than in non-
indigenous populations. Death ratcs from cardiovascular
disease in indigenous people are two- to tenfold higher than
in non-indigenous people [I]. In 2005, 'here were record
~ Springe.r
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numbers of new cases of kidney-failure patients entering
dialysis or transplant programs across the world [2, 3], and
indigenous people were vastly overrepresented in this
group [2, 4] Indigenous Australians are, on average, eight
times more likely than non-indigenous Australians of the
same age and gender to develop end-stage kidney disease
(ESKD) [5]. ESKD occurs almost 10 years earlier in
indigenous people, at a median age of 51, versus 60 years
in non-indigenous people [6]. With treatments now avail-
able to reduce the rate of progression of these chronic
diseases, health interest groups have called for governments
to commence national programs for early identification of
those at greatest risk [2, 3, 7, ~J.
Albuminuria presents early in indigenous populations,
with high background rates of cardiovascular and kidney
disease ['J, J0]. Even after adjustment for other tmditional
risk factors, albuminuria strongly predicts all-cause mortal-
ity, cardiovascular morbidity, cardiovascular mortality, and
ESKD [X]. Tn Australian Aboriginal communities, an
albuminuria secondary prevention program has demonstrat-
ed significant reduction in mortality and morbidity from
cardiovascular and chronic kidney disease [11]. A program
·aimed at early detection and monitoring of albuminuria in
Aboriginal children should provide an inexpensive, porta-
ble, point-of-care. diagnostic service given the remoteness
of many indigenous communities [12]. Urine dipsticks for
spot albumin:creatinine have been shown to be accurate in
diagnosing albuminuria [13]; however, their cost prohibits
them as a screening instlUment. Inexpensive urine dipsticks
for proteinuria could serve this purpose, but there are
currently no data on thcir accuracy to detcct albuminuria in
children in community-based settings.
The aims of our study were to evaluate the accuracy of
Multistix proteinuria dipsticks for detecting albuminuria in
Aboriginal children, to determine whether accuracy varies
with subject characteristics, and to detennine the predictive
ability of dipsticks to idcntify thosc childrcn with persistent
albuminuria over 2 years of follow-up, who are at greatest
risk of chronic disease.
Methods
The Standards for Reporting of Diagnostic Accuracy
(STARD) chccklist was adoptcd for thc reporting of these
data [14].
Selection of participants Government-run elementary
schools were approached for testing from urban. coastal.
rural. and remote locations across the state of New South
Wales. This state has the highest Aboriginal population in
Australia [! 5]. Nongovernment schools (private and de-
nominational) have very f~w Aboriginal enrollments and
~ Springer
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were not considered for recruitment. To maximize power
and generalizability, consecutive sampling was done to
obtain equal numbers of Aboriginal and non-Aboriginal
children, boys and girls, and in similar proportions from
urban, coastal, rural, and remote areas. All elementary
schools in remote communities were approached, and other
areas were sampled if greater than 20 Aboriginal children in
the relevant age range attended.
Aboriginal status was detennined using the Australian
Bureau of Statistics best-practice recommendations, asking
the Standard Indigenous Question on the consent form "Is
your child of Aboriginal or Torres Strait Islander origin?"
[15]. All Aboriginal children in the participating CICmCll!ary
schools were offered testing. Non-Aboriginal children wcre
matched for gender and age from the same class. We aimed
to recruit equal numbers of boys and girls, Aboriginal and
non-Aboriginal children, and equal numbers of children
from each l2-month age group.
Approval was obtained from the Ethics Committees of
the Childrcn's Hospital at Westmead, the University of
Sydney, New South Wales Area Health Services, and the
New South Wales Department of Education and Training.
lnfonned consent was obtained for each child and, in
accordance with National Health and Medical Research
Council (NHMRC) Goidelines for Ethical Conduct in
Aboriginal and Torres Strait Islander Rescarch [16], data
was collected onto a standardized f01TIl and deidentified for
storage and analysis before being returned to each
community after the study visit. PClmission to publish data
was also obtained from each community.
Multistix proteinuria dipstick (index test) The Multistix-IO
SG reagent dipstick (Bayer Diagnostics Manufacturing
Ltd., Bridgend, South Walcs, UK) costs approximately US
$0.80 per stick and detects urine protein by the protein error
of indicators principle. At a constant pH, the development
of any green color is due to the presence of protein. The
color is then read speetrophotomctrically by the Baycr
Clinitek 50 urinalysis machine within four proteinuria
categories: negative/trace (protein<0.30 giL), 1+ (protein
0.30 giL), 2+ (protein I giL), 3+ (protein 3 giL), and 4+ (":
20 giL) (Bayer Healthcare, Bayer Australia Ltd).
Spot urine albumin:creatinine dipstick (referent test) The
Clinitek (Bayer Austr'dlia Ltd. Pymble, NSW, Austr'dlia)
dipstick detects urine albumin and creatinine concentrations
at an approximate cost of US $3.80 per stick. Urine
albumin is measured by dye binding of albumin with
sulphonephthalcin dye. resulting in a color shi ft at a
constant pH. This is referred to as the protein error of pH
indicators. Urine creatinine complexes with copper and the
copper--creatinine complex reacts with hydropcroxide and a
dye to produce a color change. Color changes are then read
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spectrophotometrically by the Bayer Clinitek 50 urinalysis
machine as a ratio of albumin:creatinine concentration
within three categories: nonnallno pathological albuminuria
(ACR < 3.4 mg/mmol), microalbuminuria (ACR 3.4-
33.9 mg/mmol), and macroalbuminuria (ACR > 33.9 mgl
mmol). This method has been validated as a referent
standard test for verifying albuminuria in children [17].
Sample collection and handling All children were given
verbal lnstructions by the study nurse about the method of
urinc collcction. Parent/carer assistance was provided in the
younger age group. A morning clean-catch urine specimen
was collected frol11 cach child into a stcrile container and
analyzed immediately with thc index and referent tests by
the nurse at the survey site. Girls older than 8 years who
were found to have hematuria were questioned about
menses, and if this was present, collection was performed
at another time.
Definition ofpositivi~v All samples werc tested according to
the manufacturer's instructions (Clinitek 50 User's Guide,
Bayer Corporation, Elkhart, lN, USA) by the index and
referent tests at the same time point by thc study nurse. A
computer printout of results at the following cutoffs was
produced by the urinalysis machine at the end of each test.
Kidney Diseasc Outcomes Quality Initiative (KDOQI) rec-
ommendations for cut-off values were used to define
proteinuria, albuminuria. and hematuria [17]. Test-positive
cases were defined as 2: 0.30 giL proteinuria (Multistix dipstick
1+), and tcst-negative cases were defined as < 0.30 gIL
proteinuria (Multistix dipstick negative or trace). Rcferent-tcst-
positive cases were defined as albumin:crcatinine (ACR)
? 3.4 mg/mmol at initial testing (baseline albuminuria present)
and referent-test-negativc cases as ACR < 3.4 mglmmol at
initial testing (no baseline albuminuria).
Because albuminuria can be a benign transient phenom-
enon in the pediatric age group [18], we also assessed test
performance of Multistix dipsticks in predicting persistent
albuminuria, with referent-test-positlve cases classified as
children \\lith spot urine ACR 2: 3.4 mglmmol at both initial
testing and 2-year follow-up. Referent-test-negative cases
were then defined as ACR < 3.4 mg/mmol at both initial
testing and 2-ycar follow-up, or a combination of positive
and negative tests at baseline and follow-up (none or
transient albuminuria). Hematuria was defined as ? 25 rcd
blood cells per microliter (RBC/~I) (Multistix dipstick 1+)
at baseline testing and no hematurla as < 25 RBC/~I
(Multistix dipstick negative or trace) at baseline testing.
Albuminuria in association with suspected urinary tract
infection (leucoeytes and/or nitrites on Multistix dipstick
testing) and macroalbuminuria (ACR ?. 34 mg/mmol) were
found in less than I% of children. These children were
included in the analyses.
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Precision of the referent and index tests was assessed by
the study nurse using quality control calibration materials at
each screening center prior to testing any samples. All
positive and negative control calibrations fell within the
acceptable cutoffs designated by the manufacturer (Bayer
HealthCare, Bayer Corporation, Elkhart, IN, USA), based
upon national and intemational precision goals derived
from biological variation and international consensus data
on performance criteria [19, 20J.
Statistical methods
For albuminuria at baseline and for persistent albuminuria,
comparisons between the index and referent tests for the
entirc cohort and subgroups were represented in two-by-
two contingency tables. Indicators of test performance
derived from these tables were sensitivity, specificity, and
relative diagnostic odds ratios (RDOR) with 95% confi-
dence intervals (CI). The diagnostic OR is the ratio of the
odds of albuminuria in proteinuria dipstick positives
relative to the odds of albuminuria in proteinuria dipstick
negatives. The value of the diagnostic OR ranges from zero
to infinity, with higher values indicating better discrimina-
tory test pcrformance [21). The RDOR compares this ratio
of test performance in at-risk subgroups (Aboriginal
children. boys, older children, children with hematuria,
and nonnal weight and oveIVIcight/obesc children) against
the presumed lower-risk referent group (non-Aboriginal
children, girls, younger children, children without hematu-
ria, and underweight children) with 95% CI for proportions
calculated using exact binomial methods. Age was divided
into tertilcs, with younger children defined as 4.0-·7.7 years
at baseline and 6.0-9.4 years at the 2-year follow-up. Older
children were defined as 7.8-14.8 years at baseline and
9.5-15.4 at the 2-year follow-up. Underweight was defined
as body mass index (BMIl standard deviation (SD) <:1,
ovcrv..'eight and obese as 8MI SD > I, and nOlTI1aI weight as
BM] SD -I to +1 [22]. Statistical analyses were completed
using SAS (SAS Institute Inc., Cary. NC, USA) and SPSS
(SPSS Inc. Chicago, IL, USA).
Results
Participants From February 2002 to Septcmber 2004,
2,266 healthy children were enrolled in this study tr0111 37
elementary schools across New South Wales, including
1.248 (55.1%) Aboriginal children. Overall. 51.0% were
boys, and the mean age was 8.9 (± 2.0 years). There were
proportionally more Aboriginal children in the youngest
age tcrtile (37.4% versus 28.5%. X" 20.01,2 df, p<O.OOO J),
with no significant ditlerences between Aboriginal and
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non-Aboriginal children for gender and BMI categories.
There were significantly more Aboriginal children with
hematuria at baseline testing compared with non-Aboriginal
children (7.1% versus 3.6%, X2 12.31, I df, p=0.OO2). A
morc detailed description of subject characteristics at
baseline is available elsewhere [23]. At 2-year folJow-up
from March 2004 to December 2006, there were 1,432
(63.0%) children available for retesting; 773 (54.0%) were
Aboriginal, 50.4% were boys, and mean age was 10.5 (±
2.0 years). When comparing the overall group at follow-up
to those children lost to follow-up, there were significantly
more children fl'OO1 the oldest age group who were lost to
follow-up compared with YOllnger age groups (p<0.0001).
There were no ditlerences in cthnicity, gender, or BMl SD
between children at follow-up and those children lost to
follow-up.
Figures 1 and 2 show the process ofpaticnt recruitment,
order of tests, and crude test results. Of the 2,266 children
enrolled at baseline. 53 (2.3%) would not provide a urine
sample on the test day, and 78 (3.4%) did not receive an ACR
due to equipment tailure at the study site. Ofthe 1,432 (63%)
children available for 2-year follow-up testing, 74 (5.2%) did
Fig. 1 Recruitment and testing
of children at baseline
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not have either an initial Multistix dipstick test or initial
ACR, and 17 (1.2%) did not receive a follow-up ACR.
The prevalence of baseline albuminuria was 7.3%, and
persistent albuminuria (at the 2-year folJow-up) was 1.5%.
There was no significant difference in the prevalence of
baseline or persistent albuminuria between Aboriginal and
non-Aboriginal children (8.1 % versus 6.5%, X2 1.97, 1 df,
p~0.16 and 1.4% versus 1.5%, X2 0.03, I df, p~0.86).
Baseline and follow-up data for the cohort have been
described in more detail elsewhere [~3].
Accuracy for baseline albuminuria Table I shows the
accuracy of the Multistix dipstick for the diagnosis of
albuminuria at baseline. Overall sensitivity was 62% (55····
70%) and overall specificity was 97% (96-98%). There
were no significant differences in the accurdcy of Multistix
dipsticks in detecting baseline albuminuria in Aboriginal
compared with non-Aboriginal children (RDOR 0.97, 95%
CI 0.42-2.25, p~0.62), girls compared with boys (RDOR
0.53, 95% Cl 0.23-1.23, p~0.56), and overweightJobese
and normal-weight children compared with underweight
children (RDOR <0.5), although there was a trend toward
Eligible children, n = 2266
I"""~"'"1- j
,
Multistix dipstick test, 0=2213
~ Springer
I No ACR, o~" I--1
I ACR.o=t57 I
---=--~I ACR +ve, 0=98 I I ACR -ve, 0:=59
"'Child refused to void
**Equipmeot failure
I No AeR. 0=74** , ----+
•I ACR,0=1978 I
--'-----,~----=-------,I ACR+ve, 0:=59 I I ACR -ve, 0=19\9
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Eligible children at baseline, n=2266
Fig. 2 Recruitment and testing
of children at the 2-year
follow-up
Away during screen week, n=80
Refused or no consent, n=33
Unknown or moved to schools
outside of screening area, n=721
~j
Eligible children at two year follow-up. n=1431
I Excluded. noW I-1
Ini(ial ACR and Multistix dipstick (cst n= 1358
Initial Multistix proteinuria dipstick test +ve, n= 105 I IInitial Multistix proteinuria dipstick test -ve, n= 1253
No follow-up
AeR, n=I**
-----+ No follow-up
ACR, n=16** -
I Follow-up AeR, n= I 04 I
~
Follow-up ACR. n=I237
ACR +VC, n=5 I I ACR -ve, 0=1232/, ACR -ve. n=89ACR +ve, n=15 I~,---,
*No initial Multistix dipstick test. and/or no initial ACR
** Equipment failure
lower accuracy with increasing BMI (trend p~O.OI).
Multistix dipsticks were more accurate in diagnosing
baseline albuminuria in older children (8.0-15.0 years)
compared with the youngest age terti Ie (4.0-7.9 years),
RDOR>4, trend p~O.O I and in children with hematuria
compared with children without hematuria (RDOR 7.51,
95% CI 2.n·24.82, rO.OI).
Accuracy for persistent albuminuria Table 2 shows the
results of Multistix dipsticks in predicting pcrsistent
albuminuria. Overall sensitivity was 75% (53-89%), and
overall specificity was 93% (92-94%). There were no
significant differences in the accuracy of Multistix dipsticks
in predicting pcrsistent albuminuria in Aboriginal compared
witl1 non-Aboriginal children (RDOR 0.81, 95% CI 0.10-
6.60, p~0.82), girls compared with boys (RDOR LOS, 95%
Cl 0.13-8.55, p~0.36), older children (8.0-15.0 years)
compared with the youngest age tertile (4.0-7.9 years),
RDOR <0.9, trend p~O.3I, and overweight/obese and
normal-weight children compared with underweight chil-
dren, although there was a trend toward better accuracy
with increasing BMI (RDOR> 1.6, trend p~O.O I). Multistix
dipsticks were substantially less accurate in predicting
persistent albuminuria in children with hematuria compared
with children without hematuria (RDOR 0.03, 95% CI
0.001-0.93, p~0.02).
Absolute accuracy Table 3 shows the absolute accuracy per
1,000 children tested using ACR and Multistix dipsticks.
Out of a hypothetical cohort of 1,000 children, with 73
~ Springer
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Table 1 Accuracy of Multistix dipsticks in detecting albuminuria at baseline (prevalence 7.3%)
Characteristics Prevalence TP TN FP FN Sensitivity % Specificity % Relative diagnostic
albuminuria % (95% el) (95% el) odds ratio (95% el)
Whole cohort 7.3 98 1919 59 59 62 (55-70) 97 (91r98) NA
Ethnicity
Non-Aboriginal'l 6.5 42 877 31 21 67 (54-77) 97 (95-98) 1.00
Aboriginal 8.1 56 1042 28 38 60 (49-69) 97 (91r98) 0.97 (0.42-2.25)
Gender
Maleo 5.4 38 1014 24 21 64 (52-75) 98 (97-98) 1.00
Female 9.4 60 905 35 38 61 (51-70) 96 (95-97) 0.53 (0.23-1.23)
Age tertiles (years)
4.o-7.9u 6.0 12 633 14 29 29 (19-40) 98 (97-99) 1.00
8.0-9.9 7.2 37 658 20 16 70 (59-79) 97 (96-··98) 4.07 (1.31 .12.(8)
10.0.---15.0 8.8 49 62X 25 14 78 (68-85) 98 (97·99) 4.70 (1.54 14.36)
Other sediment
Hematuria abscnt" 6.8 83 \823 58 55 60 (52-68) 97 (96-98) 1.00
Hematuria present 16.5 15 9 1 4 79 (57-91) 99 (94-100) 7.51 (2.27-24.82)
8M! SD
Undenvcighta 11.1 31 299 13 8 80 (68-88) 96 (94-97) 1.00
Nonnal wcight 7.2 57 1237 36 42 58 (5(H;5) 97 (91r98) 0.52 (0.18-1.53)
Overweight/obese 4.8 10 364 10 9 53 (34-69) 97 (91r98) 0.45 (0.11-1.92)
BM! body mass index. FN false negative, FP false positive. SD standard deviation. TN nue negative, TP true positive.
Definitions: Albuminuria. ACR?: 3.4 mg/mmol; hematuria?: 25 red blood cells per high-power field (1 +); undem'cight. BMI SD < 1; nonnal
weight, BMI SD -·1 to +1; overweight and obese. BMI SD > +\
° Referent group
Table 2 Accuracy of Multistix dipsticks in detecting persistent albuminuria (prevalence 1.5%)
Characteristics Prevalence TP TN FP FN Sensitivity % Specificity % Relative diagnostic
albuminuria % (95% el) (95% cn odds ratio (95% cn
Whole coh0l1 1.5 15 1232 89 5 75 (53-89) 93 (92-94) NA
Ethnicity
Non-Aboriginaln 1.4 7 576 43 2 78 (45-94) 93 (91-95) 1.00
Aboriginal 1.5 8 656 46 3 73 (43-90) 93 (91-95) 0.81 (0. Hl-6.601
Gender
Malc3 1.5 7 640 35 3 70 (40-89) 95 (93-96) 1.00
Female 1.5 8 592 54 2 80 (49··94) 92 (89-94) 1.05 (0.13-8.55)
Age ICltilcs (years)
6.0-9.4" 0.9 3 412 20 1 75 (31-95) 95 (94-96) 1.00
l>.5--11.4 1.l 4 415 31 1 80 (38-·96) 93 (92-94) 0.87 (0.04-·21.23)
11.5-15.4 2.4 8 405 38 3 73 (44-90) 91 (90-92) 0.46 (0.03-6.74)
Other sedimentb• "
Hematuria absent3 1.5 15 1190 77 4 78 (51r90) 94 (93-95) 1.00
HematuJia prescnt 1.9 0 41 12 I 25 (21-27) 77 (71r79) 0.Q3 (0.001-0.93)
BMI SD
UndelVveight~ 1.8 3 204 21 1 70 (31-93) 91 (90-92) 1.00
Normal weight 1.9 11 740 53 4 n (48-88) 93 (93-94) 1.59(0.17··15.15)
Overweight/obese OJ 1 281 15 0 75 (20-97) 95 (94-96) 2.46 lO. 10-1 08.09)
.t Referent group
b 0.5 was added to all cells to obtain an estimate that deals with the zero cell
~ Hematuria absent or present at baseline
BM! body muss index. FN false negative, FP false positive, TN true negative, TP true positive, SD standatd deviation.
Definitions: Albuminuria. ACR?: 3.4 mglmmol; hematuria?:. 25 red blood cells per high~power field (\+); underweight, BMI SD < -1; nonnal
weight. 8Ml SD -\ to +1; overweight and obese. BMI SD> +1
~ Springer
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Table 3 Absolute accuracy per 1,000 children screened by Multistix dipsticks (assuming a point prevalence of7.3% fur albuminuria at baseline
and 1.5% for persistent albuminuria)
Target condition Number detected Number detected Difference Number excluded Number excluded Difference
with ACR with dipstick with ACR with dipstick
Baseline albuminuria 73 45 28 927 899 28
Persistent albuminuria 15 11 4 985 916 69
ACR albumin:creatinine
having baseline albuminuria (a prevalence of 7.3%),
Multistix dipsticks would correctly identify 45 children
with albuminuria at the expense of 20 false positives and 28
false negatives. At 2-year follow-up, IS children will have
persistent albuminuria. Multistix dipsticks would identify
11, at the expense of 60 false positives (including those
with transient albuminuria) and four falsc negatives.
Discussion
Tn this first large-scalc community-based cohort study of
the test performance of urine dipsticks in detection of
albuminuria in indigenous children, we show that Multistix
dipsticks are accurate for cross-sectional detection and very
accurate for detecting children with persistent albuminuria.
We also show that accuracy does not vary with ethnicity.
Multistix dipsticks arc an inexpensive, convenient, and
portable diagnostic method for albuminuria detection.
Many of the design features of this study suggest the
results are valid and generalizable. This was a prospective
evaluation of dipstick urinalysis testing for albuminuria in a
consecutive series of children from a clinically relevant and
generalizable population. The children tested at follow-up
were similar in demographic characteristics to the original
population-based cohOlt at baseline. Many previous studies
have used diseased cases with controls for dipstick
evaluation, which leads to an overestimate of the true test
performance (spectrum bias) [24-26J. There was no
verification bias in our study, because all children received
both the dipstick and referent tests. The study nurse was not
blinded to the results of either tcst; however, interpretation
of each was quantitative. The nurse had no infomlation on
the previous referent test result at the follow-up testing, and
therefore, no significant effect from unblinding is expeetcd
[27, 28]. A single referent test was used, and there was no
time interval or treatment between the dipstick and baseline
rcferent tests. We accept that because some of the samplcs
wcre collected at a time othcr than first-morning urine,
some of the proteinuria detected would be orthostatic,
particularly for adolescents. Persistence of proteinuria in
these children at first-morning follow-up testing would
make orthostatic proteinuria less likely.
Twenty-four-hour proteinuria is conventionally consid-
ered the gold standard for diagnosing albuminuria, but this
method is unreliable due to collection errors and inconve-
nience [29, 30]. These problems are compounded in the
pediatric population and in highly mobile, remotc popula-
tions with limited access to health services, as seen in
Aboriginal communities [12], For these reasons, we used
spot urine ACR as our surrogate referent test in this study.
Replacement of 24-h urine protein by spot wine ACR for
follow-up diagnostic purposes has been justified by
substantial agreement between the two methods for all age
groups with a wide spectrum of renal function and over the
entire proteinuria range [13, 31-33]. There was no specific
treatment for any child with albuminuria found at baseline
before the follow-up referent test was perfonned, and we
used predefined, ~1andard cut-off values for index and
referent-test positives and negatives [17],
We found that test performance varied with a number of
subjcct characteristics. Multistix dipsticks were more
accurate in detecting albuminuria in older children at
baseline due to a low sensitivity, but this finding was not
confinned for the more important outcome of persistent
albuminuria. However, this result may have been intlu-
enced by the disproportionate losses at follow-up between
the oldest age group and the younger age groups. Dipsticks
were less accurate for detecting albuminuria in children
with higher BMI at baseline but more accurate in predicting
persistent albuminuria in children with highcr BMT at
follow-up (again due to differences in sensitivity). Dipsticks
were better at detecting albuminuria in the presence of
hematuria, although hematuria worscned the prediction of
persistent albuminuria at follow-up. These inconsistent
findings in children with hematuria need to be interpreted
cautiously. There arc no comparable data from other
studies, and these results are largely influcnced by the
continuity correction of 0.5, resulting in unstable estimates.
Long-tenn prospective studics are needed to dctermine
the risk of ESKD in Aboriginal children and young adults
with albuminuria and how the risks change in association
with other comorbidities such as hypertension and diabetes.
~ Springer
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Compared with the cost of relocation, dialysis and other
treatments for sustaining an Aboriginal Australian on
dialysis for an average survival period of 20 years [34], it
may eventuate that health dollars and much psychological
suffering could be saved through a primary prevention
program, as has been proposed for other high-risk pop-
ulations [35, 36]. Point-of-care testing for community risk
assessment is culturally appropriate and widely accepted
within Aboriginal communities [II, 12]. Our results
support thc lISC of Multistix dipsticks as a reliable. low-
cost. diagnostic instrumcnt for albuminuria in Aboriginal
and other children.
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Risk of CKD in Australian Indigenous and Nonindigenous Children:
A Population-Based Cohort Study
Leigh Haysom, MD, ',2 Rita Williams, BA,' Elisabeth Hodson, MD,z,3 Pamela Lopez-Vargas, BN,1
L. Paul Roy, MD! David Lyle, MD, PhD,s andJonathan C. Craig, MD, PhD,,6
Background: Aboriginal Australians have a 9·fold increased risk of end-stage renal disease. There is
no information about the natural history and risk of chronic kidney disease (CKD) in Aboriginal and
non-Aboriginal children.
Study Design: Using a prospective study design, we aimed to determine the prevalence of persistent
markers and risk factors for CKD in Australian Aboriginal and non-Aboriginal children and whether
Aboriginal children are at increased risk of persistent markers of CKD after accounting for sociodemo-
graphic differences.
setting & Participants: ChUdren were enrolled from elementary schools throughout New South Wales.
Predictor: Aboriginal (Aboriginal and Torres Strait Islander Australians) versus non-AborIginal ethnicity.
Outcomes & Measurements: Urine analysis, height, weight, blood pressure, birth weight, and
sociodemographic status were measured at baseline and 2-year follow-up. Albuminuria was defined as
albumin-creatinine ratio of3.4 mg/mmol or greater, hematuria as 25 or greater red bloodcells/pL (~1 +),
obesity as body mass index of 2 SOs or greater, and systolic and diastolic hypertension as blood
pressure greater than the 90th percentile.
Results: 2,266 children (55.1% Aboriginal; 51.0% boys; mean age, 8.9 ::!: 2.0 years [SO] years) were
enrolled at baseline. Early markers and predictors of CKO at baseline were frequent: hematuria (5.5%),
albuminuria (7.3%), obesity (7.1%), systolic hypertension (7.2%), and diastolic hypertension (5.8%).
1,432 children (63%) were available for retesting at 2-yearfollow·up (54.0% Aboriginal; 50.5% boys;
mean age, 10.5 ::!: 2.0 years). Persistent obesity (5.3%) was frequent, but persistent markers of CKD
were infrequent (systolic hypertension, 1.1%; diastolic hypertension, 0.2%; hematuria, 1.1%; and
albuminuria, 1.5%). Although there were more Aboriginal than non-Aboriginal children with baseline
hematuria (7.1% versus 3.6%,; P = 0.001), after adjustment for age, sex, birth weight, and sociodemo-
graphic status, there was no increased risk of persistent hematuria, albuminuria, obesity, or hyperten-
sion in Aboriginal children.
Limitations: Persistent markers of CKD were much less frequent than anticipated, which may have
affected study power. The group lost at follow-up was older children, which may have biased results.
Conclusions: Overall, only 20% of children found to have markers of early CKD had persistent
abnormalities (diastolic and systolic hypertension, albuminuria, and hematuria) 2 years later, equivalent
to a population point prevalence of 1% to 2'%' in children with a mean age of 10 years. Aboriginal children
had greater rates of baseline and transient hematuria, but no increased risk of persistent markers of
CKD, suggesting that adolescence and young adulthood is a critical"time for preventative strategies.
Am J Kidney Dis 53:229-237. © 2009 by the National Kidney Foundation, Inc.
INDEX WORDS: Aboriginal; albuminuria; disadvantage; end-stage renal disease; follow-up; health
determinants; hypertension; isolation; obesity; remoteness.
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Canadian population.2 Aboriginal and Torres
Strait Islander Australians (hereafter referred to
as Aboriginal) are 9 times more likely than
non-Aboriginal Australians to develop ESRD.'
ESRD occurs almost to years earlier in Austra-
lian Aboriginal people, at a median age of 51
versus 60 years in non-Aboriginal Australians.'
A much greater proportion ofESRD in Aborigi-
nal Australians is attributed to diabetic nephropa-
thy (47%) compared with non-Aboriginal Austra-
lians (17%), but little is known about the early
causal pathways leading to these health dispari-
ties.' Most research to date has documented
disease end points in high-risk communities,I.2.'
with few studies measuring or adjusting for envi-
ronmental risk factors that will also affect nonin-
digenous people, such as lack of access to health
care and remote and lower standards of living.'
There are several studies from high-risk indig-
enous communities describing the prevalence of
early CKD markers,6-8 but there are no popula-
tion-based studies that document the persistence
of early CKD markers in indigenous compared
with nonindigenous children.
Our aim is to determine the prevalence of
persistent markers and risk factors for CKD in
Australian Aboriginal and non-Aboriginal chil-
dren and whether Aboriginal children are at
increased risk of CKD after accounting for socia-
demographic differences.
METHODS
Selection ofPartklpanlS
Govemment·run elementary schools were approached for
testing from urban, coastal, rural. and remote locations
across the state of New South Wales. This state has the
largest Aboriginal population in Australia, and Aboriginal
people within New South Wales have 3 times the risk of
ESRD than non-Aboriginals.3 To maximize power, sam-
pling was performed to obtain equal numbers of Aboriginal
and non-Aboriginal children and similar proportions from
urban. coastal, rural. and remote areas. All elementaiy schools
in remote communities were approached and other areas
were sampled if more than 20 Aboriginal children in the
relevant age range attended. We attempted to enroll all
Aboriginal students from participating schools and match
them for age and sex with a random sample of non-
Aboriginal students.
Aboriginal status was determined by using the Australian
Bureau of Statistics best practice recommendations, asking
the Standard Indigenous Question on the consent form "Is
your child of Aboriginal or Tones Strait Islander origin?"9
All Aboriginal children in the participating elementary
schools were offered testing for height, weight, blood pres-
Haysom etal
sure, and urinary abnormalities by means of dipstick. We
aimed to recruit equal numbers of boys and girls, Aborigin al
and non-Aboriginal children, and approximately equal num-
bers of children from each l2-month age group.
Aboriginal Community Engagement
Consultation with local Aboriginal Medical Services and
consent from community leaders was undertaken before the
start of the study. Approval was obtained from the Ethics
Committees of the OJildren's Hospital at Westmead, Univer-
sity of Sydney, New South Wales Area Health Services, and
New South Wales Department of Education and Training.
Informed consent was obtained for each child, and in accor-
dance with National Health and Medical Research Centre
Guidelines for Ethical Conduct in Aboriginal and Torres
Strait Islander Research,tO data were collected by using a
standardized form and de-identified for storage and analysis
before being returned to each community after the study
visit. Pennission to publish data also was obtained from each
community.
MeasurementofMarkers ofCKD
Markers and predictors of CKD measured were hematu-
ria, albuminuria, systolic and diastolic hypertension, and
obesity. Risk factors known and believed to be associated
with the development of these markers in Aboriginal and
non-Aboriginal people also were recorded, including age,
sex, growth parameters, birth weight, and environmental
health determinants: measures of geographic isolation and
social disadvantage.
A morning clean-catch urine specimen was collected from
each child, with dipstick analysis for hematuria and albumin-
uria petformed at the survey site on fresh specimens using a
Bayer Oinitek 50 machine (Bayer Healthcare, Australia).ll
Leukocyte and nitrite levels also were recorded for later
adjustment for abnormalities ofpresumed urinary tract infec-
tion. Girls older than 8 years who were found to have
hematuria were questioned about menses, and, if appropri-
ate, collection was petfonned at another time. According to
Kidney Disease Outcomes Quality Initiative (KIXJQI) defi-
nitions, hematuria was defined as dipstick 1+ or greater
(equivalent to 25 red blood cells/p.L; 1+), and albuminuria,
as albumin-creatinine ratio of 3.4 mg/mmol or greater. 12
Birth weight was provided by the parent/carer by recall or
from the child's health record. Height was measured in
stocking feet to the nearest 0.1 cm using a SECA 220
telescopic portable stadiometer (Beomed, NSW, Australia)l)
that was calibrated between screening visits. Weight was
measured in stocking feet and school unifonn on digital
scales to the nearest 0.01 kg. Body mass index (BMI) SO z
score (SO) was calculated using an age- and sex-adjusted
program. 14 Blood pressure was measured on the right arm
with the child sitting, using an aneroid sphygmomanometer
and the largest cuff to encircle the arm and cover at least
three-quarters of the length of the upper arm. IS In children
younger than 13 years, diastolic pressure was measured at
the point of muffling (Korotkov 4). For older children, the
point of disappearance was used (Korotkov 5).16 Systolic
and diastolic hypertension was defined as blood pressure
greater than the 90th percentile for age and sex.
CKD Risk in Indigenous and Nonindigenous Children
Follow-up measurements were perfonned 2 years after
baseline testing at the elementary or new high school for all
available children. and the frequency of persistent CKD
markers (markers detected at baseline and follow-up) was
ascertained.
Standardization of urban, coastal. rural, and remote local-
ity was made using ARIA ++. a successor to the original
AccessibilitylRemoteness Index ofAustralia, with each sub-
ject given an index score according to their postcode of
residence. I? Using geographic information system capabili-
ties. distances, services. and population density for each
locality are converted to a continuous variable with values
ranging from 0 fOT high accessibility to 18 for extreme
remoteness. ARIA++ values for this NSW study ranged
from 0 to 14, and for categorical analysis, scores were
grouped into quartiles. Isolation categories (and ARIA++
score range) used were least isolation (0 to I.l), low-mid
isolation (1.2 to 2.4), high-mid isolation (2.5 to 4.9), and
highest isolation (5.0 to 14.0).
To detennine the level of social and economic well-being
of areas studied, the Socio-Economic Indexes for Areas
2001 J81ndex of Disadvantage was applied to subjects at the
level of collection district of residence. This is the smallest
geographic area for which the index is available and in-
cludes approximately 200 households. The Index of Disad-
vantage is a continuous score based on such characteristics
as low income, lower level of education, high unemploy-
ment, and unskilled jobs. It has been standardized to a mean
of 1,000 and an SD of 100 across all collection districts in
Australia, ie, 95% of scores are 800 to 1,200. Higher scores
indicate higher socioeconomic status and least disadvantage.
For categorical analysis, scores were grouped into quartiles:
highest disadvantage (680 to 835), high-mid disadvantage
(836 to 960), low-mid disadvantage (961 to 988), and least
disadvantage (989 to 1,103).
Data Analysis
Comparisons between children followed up and those
with only baseline data were made according to ethnicity,
sex, age groups, birth-weight quartiles, BMI SD quartiles,
and categories of isolation and disadvantage by using x! test.
Odds ratios and relative risks for baseline and persistent
markers of CKD in Aboriginal compared with non-Aborigi-
nal children (referent group) were detennined by using
logistic regression with 95% confidence inteIVals (CIs). 1be
relative risk between other potential predictors (sex, age,
birth weight, BMI, geographic isolation, and social disadvan-
tage) and persistent markers of CKD was determined by
using logistic regression with 95% CIs. The presumed low-
est risk category of each predictor was used as the referent
group. The Mantel extension test was used to detennine
linear trends across categories. Analyses were adjusted for
age, sex, BMI SD, birth weight, categories of isolation and
disadvantage, and school by using a random·effects model.
Tests for interactions between ethnicity, sex, age, catego-
ries of isolation and disadvantage, and other significant
variables in the final model were performed. Significance
was set at P less than 0.05 for main effects and interactions.
Statistical analysis was completed using SAS (SAS Institute,
Cary, NC) and SPSS (SPSS Inc, Chicago, IL) software.
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We planned to collect data at baseline from 1,OClOAborigi-
nal and 1,000 non-Aboriginal children, which were suffi.
cient to detect differences in prevalence of markers of CKD
between the 2 groups of 2.9% versus 1.1 %, 5.5% versus
2.9%, 8.2% versus 6.0%, and 9.4% versus 7.2% at 80%
power for hematuria, albuminuria, obesity, and systolic
hypertension, respectively. We anticipated a 60% to 70%
follow-up rate, which would allow detection of differences
in persistent marlcers between Aboriginal and non-Aborigi-
nal children of 3.8% versus 1.5%,3.2% versus 1.0%,7.6%
versus 5.3%, and 7.3% versus 5.0% at 80% power for
hematuria, albuminuria, obesity, and systolic hypertension,
respectively.
RESULTS
From February 2001 to June 2004, a total of
2,266 children were enrolled from 37 primary
schools across New South Wales. Participation
rates for both Aboriginal and non-Aboriginal
students were 85% to 100%.
There were 1,248 (55.1%) Aboriginal chil-
dren, 51 % were boys, and mean age was 8.9 :t
2.0 (SD) years. A more detailed description of
baseline characteristics has been reported else-
where. 19
Characteristicsat 2-Year Follow-up
At 2-year follow-up from March 2004 to De-
cember 2006, there were 1,432 (63.0%) children
available for retesting; 773 (54.0%) were Aborigi-
nal, 50.4% were boys, and mean age was 10.5 :t
2.0 years (Table I). Comparing the overall group
at follow-up with children with only baseline
data, there were significantly more children from
the older age groups and urban areas who had no
follow-up data (P < 0.001). There were no
differences in ethnicity, sex, birth weight, BMI
SD, and social disadvantage category between
children at follOW-Up and children with only
baseline data.
Prevalenceof Baseline Markers ofCKD in
Aboriginal and Non-Aboriginal Children
Obesity (7.1 %) and early markers of CKD at
baseline were common: hematuria (5.5%), albu-
minuria (7.3%), systolic hypertension (7.2%),
and diastolic hypertension (5.8%; Table 2). There
was no increased risk of these early markers of
CKD in Aboriginal compared with non-Aborigi-
nal children, with the exception of hematuria
(7.1 % versus 3.6%; adjusted odds ratio, 2.25;
95% CI, 1.37 to 3.69; P = 0.001).
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Table 1. Characteristics of Children at Baseline StratHied by Follow·up Status
Haysom elal
Follow-up Oats Available Baseline Data Only Available
Variable (n ~ 1,432) % (n ~ 834) % p
Elhnicity
Aboriginal 773 54.0 475 57.0 0.2
Non-Aboriginal 659 46.0 359 43.0
Sex
Boys 723 50.5 432 51.8 0.5
Girls 709 49.5 402 48.2
Age groups (y)
4-5.9 144 10.1 67 8.0 <0.001
6-6.9 192 13.4 89 10.7
7-7.9 237 16.6 93 11.2
8-8.9 221 15.4 112 13.4
9-9.9 231 16.1 120 14.4
10-10.9 196 13.7 165 19.8
11-14.8 211 14.7 188 22.5
Birth weight quartiles (g)*
412-2,920 259 25.6 86 21.1 0.3
2,921-3,318 255 25.2 107 26.2
3,317-3,685 246 24.4 111 27.2
3,686-5,272 250 24.8 104 29.4
Body mass index SO qU8rtiles·
-4.810 -0.8 355 25.0 205 24.9 O.g
-0.7100.1 352 24.8 210 25.5
0.2100.7 363 25.5 203 24.6
0.8106.9 352 24.8 206 25.0
Geographic isolation (ARIA++ score)
Least (0-1.1) 358 25.0 252 30.2 <0.001
Low-mid (1 .2-2.4) 453 31.6 186 22.3
High-mid (2.5-4.9) 261 18.2 260 31.2
Highest (5.0-14.0) 360 25.2 136 16.3
SOCial disadvantage (SEIFA score)
Leest (989-1,103) 342 23.9 206 24.7 0.3
Low-mid (960-988) 385 26.9 200 24.0
High-mid (836-960) 370 25.8 206 24.7
Highest (68Q-835) 335 23.4 222 26.6
Abbreviations: ARIA, Accessibility and Remoteness Index of Australia; SEIFA. Socia-Economic Indexes For Areas.
'Data do not equal column totals.
Prevalence of Persistent Markersof CKD in
Aboriginal and Non-Aboriginal Children
At 2-year follow-up, the overall prevalence of
persistent markers of CKD was much less fre-
quent: hematuria (1.1%), albuminuria (1.5%),
systolic hypertension (1.0%), and diastolic hyper-
tension (0.1 %; Table 2). Obesity remained rela-
tively frequent at 5.3%. There was no increased
risk of any persistent marker in Aboriginal com-
pared with non-Aboriginal children.
Physiological and Sociodemographlc Predictors
for Persistent Markers of CKD
There was no increased risk of any persistent
marker of CKD for girls compared with boys or
for lower birth weight compared with higher
birth weight (Table 3). Risk of persistent hematu-
ria increased with increasing age (trend P =
0.004). Increasing age was not a risk factor for
any other persistent marker of CKD. Risk of
persistent systolic hypertension increased with
increasing BMI SD (trend P = 0.(01), and the
highest BMI SD quartile was significantly asso-
ciated with risk of persistent systolic hyperten-
sion (adjusted relative risk, 5.78; 95% CI, 1.24 to
26.73; P =0.03). There was a decreasing risk of
persistent systolic hypertension and persistent
albuminuria with increasing social disadvantage
(both trend P < 0.02). The quartile with the
highest social disadvantage had a significantly
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Table 2. Prevalence of Ba88l1ne and Persistent Markers of CKD In Aboriginal and Non-Aboriginal Children at
2-Year Follow~up
Baseline Markers Persistent Markers
Non-Aboriginal
(referent
Overall category) Aboriginal p
Non-Aboriginal
(referent
Overall category) Aboriginal p
11 (1.5)
I.BO (0.70-4.65) 0.6
1 (0.1)
9 (1.2)
1.36 (0.29-6.36) 0.9
41 (5.4)
1.09 (0.67-1.7B) 0.2
B (1.1)
1.25 (0.45-3.47) 0.7
9 (1.4)
1.00
6 (0.9)
1.00
1 (0.2)
1.00
6 (0.9)
1.00
33 (5.1)
1.00
63 (6.5)
1.00
157 (7.3)
122 (5.5)
162 (7.2)
145(7.1)
Events (%)
Adjusted OR'
Events (%)
Adjusted OR'
Events (%)
Adiusted OR'
Hematuria (dipstick'" 25 RBClHPF)
36(3.6) B6(7.1) 15(1.1)
1.00 2.25 (1.37-3.69) 0.001
Albuminuria (ACR '" 3.4 mglmmol)
94 (B.l) 20 (1.5)
1.37 (0.93-2.01) 0.1
Obesity (BMI '" 2 SO)
63 (6.7) B2 (7.4) 74 (5.3)
1.00 1.10(0.76-1.44) 0.5
Systolic hypertension (SBP > 90th cemlle)
67 (6.7) 95 (7.7) 14 (1.0)
1.00 1.22 (0.B7-1.57) 0.3
Olaatollc hypertension (OBP > 90th cemile)
Events(%) 131 (5.B) 62(6.2) 69(5.6) 2(0.1)
Adiusted OR' 1.00 0.94 (0.57-1.31) 0.6
Events (%)
Adjusted OR'
Note: Persistent marker found at both baseline and follow-up.
Abbreviations: AeR, albumin-creatinine ratio; 8MI, body mass index; CKD, chronic kidney disease; DBP, diastolic blood
pressure; HPF. high power field; OR, odds raUo; RBC, red blood cell; SSP, systolic blood pressure.
*Adjusted when appropriate for age. sex, birth weight. 8MI SO, systolic blood pressure, diastolic blood pressure, isolation
category, and disadvantage category.
lower risk of persistent albuminuria (adjusted
relative risk, 0.17; 95% CI, 0.05 to 0.57; P =
0.004). There were no physiological or sociogeo-
graphic predictors of persistent obesity found.
There were no interactions found between
environmenlal health detenninants of geographic
isolation and social disadvanlage and ethnicily,
age, sex, or other covariates in any model.
DISCUSSION
This is the first population-based cohort study
describing the natural history of early CKD in
indigenous children that includes a nonindig-
enous comparator group and measures and ad-
justs for social disadvantage and geographic iso-
lation. Nonindigenous comparators are essential
in deciding the level of increased risk of indig-
enous children against the background popula-
tion rates, and measurement of sociodemo-
graphic factors is important in adjusting for the
potentially confounded relationship between
health, isolated living, and social disadvantage.
In our prospective study of 2,266 children, 50%
of whom areAborigina~ during 2 years offollow-
up, we show that persistent markers of CKD are
infrequent and lhere is no increased risk of persis-
tent markers in AbOtiginal children compared
with non-Aboriginal children, even afler adjust-
ment for social disadvantage and geographic
isolation.
The follow-up data show that although base-
line markers were frequent in Aboriginal and
non-Aboriginal elementary school-aged chil-
dren, most of these abnonnalities were transient.
At a single test, Aboriginal children had twice
the risk of hematuria as non-Aboriginal children,
but no increased risk of persistent hematuria.
Other Australian indigenous studies had a simi-
larly high cross-sectional prevalence of hematu-
ria and albuminuria in children.6•2• These sludies
were from extremely disadvantaged communi-
ties with the highest rates of ESRD and cardiovas-
cular disease in the world. Without follow-up
testing or comparative clata from a nonindig-
enous group, the assumption is that these fre-
quenl one-off markers lead to the high states of
disease seen in adulthood, and ethnically based
biological effects are causative_2! Our baseline
results show that almost 80% of baseline urinary
abnormalities are transient. Semiquantitative
Table 3. Physiological and Environmental Predictors of Persistent Markers of CKD
~
Hematuria (dipstick ~ 25 RBClHPF) Albuminuria {ACR -i!::. 3.4 mg'mmol} Obesity (8MI ;;.: 2 SO)
Systolic Hypertension (SSP> 90Ih
centile)
Predictor No.(%) AORO (95% CI) No.(%) AOR" (95%CI) No.(%) AORO (95% CI) No.(%)
AORO (95% CI)
if
'OJ
~
sa
!l!.
1.00
4.00 (0.81-19.77)
2.20 (0.19-25.40)
0.95 (0.07-4.62)
1.00
1.45 (0.01-3.94)
2.35 (0.31-5.90)
5.78 (1.24-26.73)t
1.00
1.03 (0.13-8.21)
1.00
0.92 (0.28-3.08)
1.36 (0.50-3.71)
1.00
1.18 (0.31-4.45)
1 (0.3)
2 (0.6)
4(1.1)
7 (2.0)
9 (1.0)
1 (1.0)
4 (0.9)
4 (0.9)
6 (1.3)
8 (0.8)
8 (1.1)
1(0.3)
10 (2.2)
2(0.8)
1 (0.3)
1.00
1.00
0.81 (0.27-2.42)
0.35 (0.1"'.09)
0.60 (0.17-2.13)
1.00
1.17 (0.50-2.85)
1.00
0.89 (0.51-1.55)
1.00
1.00 (0.5"'.96)
1.00 (0.55-2.26)
22 (6.2)
27 (6.0)
8(2.4)
19 (5.4)
0(0)
0(0)
0(0)
74 (5.3)
48 (5.1)
6 (5.9)
25 (5.3)
25(5.3)
24 (5.1)
41 (5.8)
33 (4.7)
1.00
0.20 (0.05-0.87)
0.49 (0.11-2.24)
0.44(0.11-1.82)
1.00
0.83 (0.24-2.96)
1.31 (0.31-5.57)
0.15 (0.01-2.05)
1.00
0.24 (0.01-4.05)
1.00
1.07 (0.17-5.66)
2.95 (0.76-11.48)
1.00
1.12(0.47-2.70)
7 (2.1)
5(1.1)
4 (1.6)
4 (1.3)
6 (1.8)
6 (1.8)
7 (2.1)
1 (0.3)
19 (2.1)
o(O)§
4 (0.9)
5 (1.1)
11 (2.4)
10(1.5)
10 (1.5)
1.00
1.77 (0.16-19.18)
5.90 (0.74-47.32)
2.42 (0.22-26.58)
1.00
0.44 (0.04-5.27)
1.81 (0.25-13.10)
1.00 (0.89-3.59)
1.00
0.43 (0.02-7.31)
1.00
1.50 (0.21-10.50)
3.21 (0.62-16.56)*
1.00
1.37 (0.50-3.79)
1 (0.3)
6 (1.4)
6 (2.3)
2(0.6)
4 (1.2)
1 (0.3)
6 (1.7)
4 (1.2)
3 (0.7)
5(1.1)
7 (1.5)
11 (1.2)
o(O)§
5 (0.7)
10 (1.5)
Sex
Boyst
Girls
Age tertiles (y)
4.0-7.9t
8.0-9.g
10.0-15.0
Birth weight (g)
>2,SOOt
:52,500
8MI SO quartiles
-4.8 to -0.8t
-0.7 to 0.1
0.2100.7
0.8 t06.9
Isolation
Leastt
Low-mid
High-mid
Highest
Social disadvantage
Leaslt 2 (0.6) 1.00 7 (2.1) 1.00 20 (5.9) 1.00 7 (2.1) 1.00
Low-mid 6 (1.7) 1.79 (0.06-9.65) 6 (1.6) 0.95 (0.26-3.40) 20 (5.2) 0.75 (0.34-1.67) 4 (1.0) 0.66 (0.25-1.72)
High-mid 4 (1.1) 1.19 (0.30-4.73) 5 (1.6) 0.95 (0.08-2.43) 13 (3.7) 0.62 (0.22-1.71) 2 (0.6) 0.32 (0.09-1.08)
Highest 3 (0.9) 1.00 (0.21-4.69) 2 (0.6) 0.17 (0.05-0.57) 21 (6.4) 1.38 (0.26-3.67) 1 (0.3) 0.16 (0.05-2.52)t
Note: Persistent marker found at both baseline and follow-up. ARIA+ + score 0 to 1.1 indicates least isolation; ARIA+ + score 1.210 2.4, low-mid isolation; ARIA+ + score 2.5
to 4.9; high-mid isolation; AR1A+ + score 5.0 to 14.0. highest isolation. SEIFA score 989 to 1,103 indicates least disadvantage; SEIFA score 960 to 988, low-mid disadvantage;
SEIFA score 836 to 959, high-mid disadvantage; SEIFA score 680 to 835, highest disadvantage.
Abbreviations: ACR, albumin-creatinine ratio; ADR, adjusted odds ratio; ARIA, Accessibility and Remoteness Index of Australia; 6MI, body mass index; GI, confidence
intelVaI; CKD, chronic kidney disease; HPF, high-power field; RBC, red blood cell; S6P, systolic blood pressure; SEIFA, Socio-Economic Indexes For Areas.
*Adjusted when appropriate for ethnicity, age, sex, birth weight, 8MI SO, systolic blood pressure, diastolic blood pressure, isolation category, and disadvantage categoIY.
tReferent group.
Frend P < 0.05.
§To allow analysis, 0.5 added to cells.
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single estimations of urinary blood and protein in
children vary according to posture, illness, exer-
cise, and time of day." A 2 times greater rate of
transient hematuria may rellect the greater inci-
dence of transient disease seen in indigenous
children, such as postinfectious glomerulonephri-
tis." Persistence of these markers is infrequent in
our cohort and does not occur more frequently in
Aboriginal children.
Obesity is a frequent predictor of CKD in
these children, although no more so in Aborigi-
nal children. Rates of persistent obesity of 5.3%
found in our study are similar to national rates of
obesity in Australian elementary school-aged
children of6%.23 Increasing BMI was predictive
of persistent systolic hypertension, and these
children are at risk ofearly-onset diabetes, cardio-
vascular disease,24.2s and most likely CKD. They
will be closely followed up during the final 2
years of the study.
There was a decreasing risk of persistent sys-
tolic hypertension and persistent albuminuria in
the most disadvantaged children. These associa-
tions seem contradictory to other studies.s.26,27
Our study sampled children in areas where Ab-
original children reside, in areas ofgreatest disad-
vantage for the state of New South Wales,'"
Therefore, the highest socioeconomic quartile in
our cohort (indicating lesser disadvantage) corre-
lates with mid-range socioeconomic categories
in other comparative studies,'"·3o Our findings
are consistent with these studies, showing risk
factors for chronic disease with a bell-shaped
curve across different socioeconomic environ-
ments; lowest risk occurs at either extreme of
socioeconomic status, with highest risk occur-
ring in mid-range socioeconomic categories.
A potential limitation of our study was the
37% lost to follow-up, but we have shown that
this group was not significantly different from
children who were followed up, except for age
and geographic location. There were proportion-
ally more children followed up in remote areas
compared with urban areas. This rellects the
close relationships originally established be-
tween area health workers in remote communi-
ties and shows a greater degree of disengage-
ment in urban children. The greater proportion of
older children lost to follow-up results from
older children absent or no longer at school, and
we accept that they are likely to be the children
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most at risk of chronic disease. We are attempt-
ing to address these differences at our final
4-year follow-up. Although these issues are a
concern in terms of sampling bias, regression
analyses for risk of CKD markers in Aboriginal
children were adjusted for age and location in an
attempt to account for these imbalances.
The study was adequately powered to find
relatively small differences in risk of persistent
markers ofCKD if they existed between Aborigi-
nal and non-Aboriginal children. However, per-
sistent markers were much less frequent than
anticipated, which may have affected the study
power. Measurement of the main predictor of
risk, Aboriginal status, was performed using best
practice recommendations." Measurement of so-
cial disadvantage and geographic isolation was
made by using standardized systems that have
been applied reliably in geographically and ethni-
cally similar population-based samples.'·3! We
accept that unmeasured confounding from indi-
vidual-level socioeconomic factors remains as a
study bias.'o With further data collection, multi-
level analyses could be used to identify, measure,
and correct for ecological bias when spatially
aggregated measures are applied to individual
data, an approach we will use for future follow-
Up,32 Parentally recalled birth weight has been
shown as a reliable proxy for recorded birth
weight in population-based research.33
Albuminuria is the strongest predictor ofdeath,
cardiovascular disease, and ESRD in Aboriginal
adults, which is why it was used in our study.34.3S
Spot albumin-creatinine ratio at the cut-off value
used in this study has good receiver operator
curve characteristics for detecting pathological
albuminuria.'6 Blood pressure was measured us-
ing appropriate cuff sizes, with repeated measure-
ments performed in hypertensive children. A
90th percentile cutoff was used to classify hyper-
tension because we anticipated insufficient out-
comes to perform analyses at a 95th percentile
cutoff. Obesity was determined using BMI SDs,
which has been validated for use in this age
group of children,37 and our prevalence of obe-
sity is similar to national surveys.23 Measure-
ment of such outcomes as central obesity and
blood lipid, glucose, and insulin levels would
have been desirable for evidence of prediabetes
and metabolic syndrome2S ; however, measuring
all possible risk factors was beyond the practicali-
236
ties of such a large school-based screening study.
Painful and embarrassing procedures would have
been counterproductive to the current success of
our follOw-up recruitment rates.
Within New South Wales, there is no in-
creased Iisk of persistent markers of CKD in
Aboriginal children compared with non-Aborigi-
nal children, and the 3-fold increased Iisk of
CKD experienced by Aboriginal adults in New
South Wales and 9-fold increased risk of all
indigenous Australians is not yet established in
this age group. This suggests that adolescence
and young adulthood are likely to be critical
times for preventative strategies. These results
also show that a single measurement of markers
ofCKD in children is misleading because almost
80% of all ahnormalities are transient. Increasing
BMI is the strongest Iisk factor for persistent
hypertension and persistent hematuria in these
children, and obesity remains the most concern-
ing and persistent predictor of CKD in this age
group. This suggests that overweight and obesity
in children should be addressed from an elemen-
tary school age. These results provide useful
information for primary health care practitioners,
pediatricians, nephrologists, policy makers, and
families.
We look forward to reporting the 4-year fol-
low-up of these children and adolescents. This
study highlights a need for long-term prospective
observational studies of risk of CKD in Aborigi-
nal and non-Aboriginal young adults over a
range of sociogeographic areas. We plan to fol-
low up this cohort of children for an additional 8
years into young adulthood.'·
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